{"meta":{"query_hash":"1574a31d792e","filters":{"venue":"Endocrine Related Cancer"},"cohort_total":133,"direct_labels_cover":0,"predictions_cover":133,"exported":133,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/1574a31d792e","api":"https://metacan.xera.ac/api/v1/cohort?venue=Endocrine+Related+Cancer"},"results":[{"id":"W1990584739","doi":"10.1530/erc-13-0349","title":"Genetic modifiers of menopausal hormone replacement therapy and breast cancer risk: a genome–wide interaction study","year":2013,"lang":"en","type":"article","venue":"Endocrine Related Cancer","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":29,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Lunenfeld-Tanenbaum Research Institute; Public Health Ontario; University of Toronto; Mount Sinai Hospital","funders":"National Cancer Institute; Universitätsklinikum Hamburg-Eppendorf; Cancer Council Tasmania; Canadian Institutes of Health Research; U.S. Army; Rheinische Friedrich-Wilhelms-Universität Bonn; National Health and Medical Research Council; Institut National Du Cancer; Cancer Council Victoria; Deutsche Krebshilfe; National Institutes of Health; Deutsche Gesetzliche Unfallversicherung; CHIST-ERA; Agence Nationale de la Recherche; Bundesministerium für Bildung und Forschung; National Breast Cancer Foundation; Fondation de France; Deutsches Krebsforschungszentrum; Ligue Contre le Cancer; National Institute for Health and Care Research; Robert Bosch Stiftung; U.S. Department of Health and Human Services; Ovarian Cancer Research Fund; Medical Research and Materiel Command; Agence Nationale de Sécurité Sanitaire de l’Alimentation, de l’Environnement et du Travail; McGill University; European Commission; Breast Cancer Research Foundation; Cancer Research UK","keywords":"Single-nucleotide polymorphism; Breast cancer; SNP; Genome-wide association study; Genetic association; Oncology; Medicine; Internal medicine; Biology; Genetics; Cancer; Genotype; Gene","score_opus":0.006269507330037659,"score_gpt":0.25490830177661755,"score_spread":0.24863879444657988,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1990584739","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7499299,0.24017924,0.0037963295,0.0017114565,0.00040996587,0.00011946712,0.0022663928,0.00014605862,0.0014410891],"genre_scores_gemma":[0.98506665,0.011096243,0.0018388341,0.00055346533,0.0001646906,0.00009050743,0.00075189996,0.000027101034,0.00041067635],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9959078,0.0020107357,0.0004180442,0.0009832714,0.00034844162,0.00033168597],"domain_scores_gemma":[0.99284714,0.004848568,0.001065117,0.0005550342,0.00037502186,0.00030911007],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0043920027,0.0013259813,0.0026291357,0.00130784,0.00066248776,0.0018529474,0.0009985351,0.0017036524,0.0026472944],"category_scores_gemma":[0.009017658,0.00079660927,0.012074426,0.0025064682,0.00046888465,0.00059228274,0.00105892,0.0016422363,0.00020288692],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01817588,0.00023105557,0.4910051,0.0046837777,0.4584278,0.0009877017,0.00025561912,0.0012527274,0.0047618826,0.0004082346,0.0012050762,0.01860518],"study_design_scores_gemma":[0.001605766,0.0012437887,0.5009449,0.00044798068,0.48871487,0.0007342617,0.0001508704,0.002158574,0.000775136,0.0008519965,0.0023128777,0.000059042723],"about_ca_topic_score_codex":0.00853741,"about_ca_topic_score_gemma":0.011119925,"teacher_disagreement_score":0.00853741,"about_ca_system_score_codex":0.0007322141,"about_ca_system_score_gemma":0.0007263,"threshold_uncertainty_score":0.023227394},"labels":[],"label_agreement":null},{"id":"W2045440590","doi":"10.1530/erc-14-0465","title":"Is IGSF1 involved in human pituitary tumor formation?","year":2014,"lang":"en","type":"article","venue":"Endocrine Related Cancer","topic":"Pituitary Gland Disorders and Treatments","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"National Institutes of Health; Canadian Institutes of Health Research; Conselho Nacional de Desenvolvimento Científico e Tecnológico; Government of Canada","keywords":"Gigantism; Biology; Acromegaly; Germline; Adenoma; Pituitary adenoma; Hyperplasia; Internal medicine; Endocrinology; Immunohistochemistry; Population; Pathology; Gene; Hormone; Genetics; Medicine; Growth hormone","score_opus":0.014463509985765935,"score_gpt":0.2952028099007312,"score_spread":0.28073929991496527,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2045440590","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9869732,0.008775061,0.0006950255,0.0007446352,0.000050649433,0.000007908095,0.00024962428,0.00007116043,0.002432728],"genre_scores_gemma":[0.9977744,0.001251515,0.00024690747,0.000089639805,0.000038474333,0.0000026112716,0.00018363816,0.0000053959793,0.0004073944],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998623,0.000022446546,0.0000087888275,0.00003446578,0.00002833137,0.000043578217],"domain_scores_gemma":[0.99982005,0.000021565864,0.00007966554,0.00002085218,0.000013865702,0.000044105345],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001829232,0.00030196784,0.0002874753,0.00033079737,0.00028371776,0.00034221172,0.00031653288,0.0006212809,0.0016154004],"category_scores_gemma":[0.00028208355,0.000097143835,0.00031972319,0.0003559123,0.00046786756,0.00021268365,0.00019312458,0.0002939039,0.0004775426],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002727953,0.0000943982,0.42051217,0.0005975073,0.00017854788,0.028761465,0.0008435159,0.00065640797,0.4763969,0.0020520487,0.0017018314,0.0654772],"study_design_scores_gemma":[0.00017634837,0.0013740078,0.71013093,0.0001969405,0.0003980714,0.10773245,0.00115585,0.0029607695,0.13285698,0.003251563,0.039697416,0.000068628],"about_ca_topic_score_codex":0.0012266149,"about_ca_topic_score_gemma":0.00042531418,"teacher_disagreement_score":0.0016154004,"about_ca_system_score_codex":0.00038034766,"about_ca_system_score_gemma":0.000160208,"threshold_uncertainty_score":0.005404055},"labels":[],"label_agreement":null},{"id":"W2058126552","doi":"10.1677/erc.0.0100225","title":"Prostate cancer susceptibility genes: lessons learned and challenges posed.","year":2003,"lang":"en","type":"review","venue":"Endocrine Related Cancer","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":103,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Université Laval","funders":"","keywords":"Prostate cancer; Genetics; Biology; Breast cancer; Genetic predisposition; Candidate gene; Cancer; Ovarian cancer; Genetic linkage; Gene; Oncology; Medicine","score_opus":0.08343600812111382,"score_gpt":0.38991444283555177,"score_spread":0.3064784347144379,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2058126552","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0018712002,0.7560914,0.005316734,0.22822206,0.005801384,0.000017866938,0.00028356074,0.00014779567,0.0022480178],"genre_scores_gemma":[0.023720693,0.8825156,0.015193833,0.058660798,0.015993135,0.000082398765,0.00048982067,0.000068282185,0.003275453],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99816304,0.0006758125,0.0002168342,0.000375196,0.0003880513,0.00018112942],"domain_scores_gemma":[0.9818147,0.010610273,0.0005483354,0.0008652538,0.004355078,0.0018062949],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.014880157,0.0015542249,0.0024310874,0.0022147463,0.0009129155,0.003830194,0.002736277,0.006737793,0.005444044],"category_scores_gemma":[0.014929979,0.00060529954,0.0013816733,0.0013693117,0.0045483373,0.007305865,0.002492595,0.011794671,0.002213855],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00047209693,0.0001716252,0.0064379186,0.0037504823,0.00033862898,0.0017000798,0.0007874193,0.002110866,0.0013205621,0.045501128,0.16023538,0.7771737],"study_design_scores_gemma":[0.00015272335,0.00031480755,0.007877398,0.0061712586,0.00033960474,0.0034878822,0.0028992235,0.0027278967,0.00053636794,0.17407724,0.80124384,0.00017183763],"about_ca_topic_score_codex":0.010685921,"about_ca_topic_score_gemma":0.015504027,"teacher_disagreement_score":0.014880157,"about_ca_system_score_codex":0.0033062038,"about_ca_system_score_gemma":0.0060591353,"threshold_uncertainty_score":0.0786947},"labels":[],"label_agreement":null},{"id":"W2072744994","doi":"10.1530/erc-12-0250","title":"IGF2 increases de novo steroidogenesis in prostate cancer cells","year":2013,"lang":"en","type":"article","venue":"Endocrine Related Cancer","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":52,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital; McGill University; University of British Columbia","funders":"Prostate Cancer Foundation of Australia; Pfizer; National Cancer Institute; Prostate Cancer Foundation","keywords":"LNCaP; Endocrinology; Insulin-like growth factor 1 receptor; Androgen receptor; Biology; Internal medicine; Prostate cancer; Receptor; Androgen; Growth factor; Insulin-like growth factor; Insulin-like growth factor 2; Cancer research; Hormone; Cancer; Medicine","score_opus":0.005434775953347526,"score_gpt":0.24558713231058105,"score_spread":0.24015235635723353,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2072744994","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95571274,0.020559238,0.004063607,0.0006552053,0.00038769792,0.000093920025,0.0021934272,0.00058300566,0.015751086],"genre_scores_gemma":[0.9818494,0.0039454536,0.0019025141,0.00027020575,0.00007255759,0.00004641467,0.0016676853,0.000033170243,0.010212533],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99991226,0.0000139643635,0.0000044713693,0.000015759557,0.00003023122,0.000023176473],"domain_scores_gemma":[0.99993587,0.000013033854,0.000008146341,0.0000062945064,0.000011626141,0.000025033007],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008796163,0.00026782145,0.0002579002,0.00026470586,0.00019262896,0.00029647193,0.00009372516,0.00015654454,0.0027357568],"category_scores_gemma":[0.000058046808,0.00009288339,0.00020946088,0.00024412014,0.00012428021,0.0001135434,0.00019145248,0.0004396346,0.00054701685],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003385369,0.00009102251,0.00042275182,0.000085667634,0.000008558618,0.000083365245,0.000038421644,0.000074351155,0.99279505,0.00010573327,0.00053832575,0.005418285],"study_design_scores_gemma":[0.000058105114,0.0012544405,0.02224947,0.000014409386,0.000026843982,0.0003575312,0.00010958744,0.00090799946,0.945323,0.00009081799,0.029593175,0.000014596797],"about_ca_topic_score_codex":0.0035673922,"about_ca_topic_score_gemma":0.006469856,"teacher_disagreement_score":0.0035673922,"about_ca_system_score_codex":0.00034120702,"about_ca_system_score_gemma":0.00025812376,"threshold_uncertainty_score":0.009152055},"labels":[],"label_agreement":null},{"id":"W2074161808","doi":"10.1530/erc-13-0450","title":"COX2 and PGE2 mediate EGF-induced E-cadherin-independent human ovarian cancer cell invasion","year":2014,"lang":"en","type":"article","venue":"Endocrine Related Cancer","topic":"Inflammatory mediators and NSAID effects","field":"Medicine","cited_by":61,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Child and Family Research Institute; University of British Columbia","funders":"Canadian Institutes of Health Research","keywords":"Downregulation and upregulation; Epidermal growth factor; PI3K/AKT/mTOR pathway; Cancer research; Ovarian cancer; CREB; Protein kinase B; Cell growth; Cadherin; Signal transduction; Biology; Cancer cell; Cell biology; Cell; Cancer; Cell culture; Internal medicine; Medicine; Transcription factor","score_opus":0.01233573774889245,"score_gpt":0.2800495222313698,"score_spread":0.26771378448247735,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2074161808","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9902221,0.0032202555,0.0016216841,0.000115462586,0.00005799028,0.00007879663,0.00053677143,0.00003204266,0.00411503],"genre_scores_gemma":[0.9882867,0.0018734504,0.001154015,0.00008462199,0.000022805605,0.00009656691,0.0011127468,0.0000058524192,0.007363212],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99987745,0.000024150622,0.000008297796,0.000010354209,0.00003261312,0.00004696755],"domain_scores_gemma":[0.9999502,0.000009803487,0.000007428995,0.0000064263045,0.0000075090143,0.000018700606],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014042186,0.00032626776,0.00018969715,0.00020792909,0.00016850376,0.00021737504,0.00010307332,0.00015358216,0.0029907366],"category_scores_gemma":[0.00009791772,0.000110584704,0.0002987065,0.00014683424,0.00012879116,0.00017180285,0.00025377722,0.00049505744,0.00051425566],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00064136105,0.00029596747,0.000699729,0.00013502815,0.000013455465,0.00020472307,0.0000459571,0.00006913811,0.99458486,0.00022749556,0.0002658498,0.0028165686],"study_design_scores_gemma":[0.0001479657,0.0009690052,0.0193276,0.000012119754,0.00002419732,0.0005021503,0.00009826756,0.001633313,0.96967244,0.00009171091,0.007514232,0.0000070603874],"about_ca_topic_score_codex":0.0008731031,"about_ca_topic_score_gemma":0.0014309979,"teacher_disagreement_score":0.0029907366,"about_ca_system_score_codex":0.00016528941,"about_ca_system_score_gemma":0.00029445166,"threshold_uncertainty_score":0.010004938},"labels":[],"label_agreement":null},{"id":"W2077083761","doi":"10.1530/erc-14-0188","title":"The PI3K/AKT/mTOR pathway in the pathophysiology and treatment of pituitary adenomas","year":2014,"lang":"en","type":"review","venue":"Endocrine Related Cancer","topic":"Pituitary Gland Disorders and Treatments","field":"Medicine","cited_by":77,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Toronto Western Hospital; University of Toronto; Ontario Institute for Cancer Research","funders":"","keywords":"PI3K/AKT/mTOR pathway; Pituitary tumors; Protein kinase B; Medicine; Pituitary adenoma; Therapeutic modalities; Cancer research; Adenoma; Pathophysiology; Pituitary neoplasm; Therapeutic approach; Internal medicine; Pituitary gland; Oncology; Bioinformatics; Hormone; Signal transduction; Biology","score_opus":0.023620419471311046,"score_gpt":0.32293785317264934,"score_spread":0.2993174337013383,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2077083761","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0002506268,0.99827194,0.00011383043,0.00016001797,0.00011713966,0.000004858054,0.000016147575,0.0000074278237,0.0010579614],"genre_scores_gemma":[0.0011332144,0.99801946,0.00016756002,0.000093345734,0.00008376727,0.0000049811147,0.000026316318,0.0000012164713,0.0004701354],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99988174,0.00001725326,0.000020114781,0.000017633412,0.00005044703,0.000012767141],"domain_scores_gemma":[0.9999138,0.000031837688,0.000015959577,0.0000023134053,0.000025680052,0.000010413249],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025159592,0.0005420553,0.0008042315,0.0018895702,0.0002486413,0.0006509182,0.00047497175,0.000602134,0.0025326011],"category_scores_gemma":[0.00031731662,0.00015034317,0.0004504291,0.001418749,0.00028211635,0.00065171585,0.0005097759,0.0013377316,0.0012726082],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008926258,0.00011360652,0.00019924747,0.016639829,0.000091290276,0.0004123758,0.000076357035,0.00037987554,0.003568187,0.0023241497,0.01696632,0.9591396],"study_design_scores_gemma":[0.000029711535,0.00017650732,0.0014093082,0.003809131,0.00015877472,0.00334946,0.00008854658,0.00014631018,0.0013200243,0.0018570704,0.98763347,0.000021754886],"about_ca_topic_score_codex":0.0007365727,"about_ca_topic_score_gemma":0.0016450061,"teacher_disagreement_score":0.0025326011,"about_ca_system_score_codex":0.00042019834,"about_ca_system_score_gemma":0.0006382217,"threshold_uncertainty_score":0.008472383},"labels":[],"label_agreement":null},{"id":"W2095673803","doi":"10.1530/erc-12-0229","title":"Obesity-related hormones and endometrial cancer among postmenopausal women: a nested case–control study within the B∼FIT cohort","year":2012,"lang":"en","type":"article","venue":"Endocrine Related Cancer","topic":"Cancer Risks and Factors","field":"Medicine","cited_by":57,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"National Institute of Arthritis and Musculoskeletal and Skin Diseases; National Cancer Institute; Wake Forest University; University of Pittsburgh; University of Miami; University of California, San Francisco; University of California, San Diego; Kaiser Permanente","keywords":"Nested case-control study; Endometrial cancer; Postmenopausal women; Medicine; Obesity; Hormone; Cohort study; Cohort; Case-control study; Oncology; Internal medicine; Physiology; Obstetrics; Cancer; Gynecology; Endocrinology","score_opus":0.0138618815743322,"score_gpt":0.29752862944209735,"score_spread":0.28366674786776513,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2095673803","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9995122,0.00013927244,0.000098489385,0.000014761049,0.0000025518027,0.00001237813,0.00010990901,0.000002049819,0.00010844469],"genre_scores_gemma":[0.9993243,0.000091984824,0.00018386853,0.000028072627,0.0000066527414,0.000019520312,0.00020192812,0.0000019213217,0.00014179561],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995229,0.00013776125,0.000036994228,0.00014927157,0.00008602434,0.00006707163],"domain_scores_gemma":[0.9993118,0.000113702365,0.0002167511,0.00016342253,0.00005780776,0.00013659504],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009570554,0.00030420697,0.00046208396,0.00050285744,0.0006518824,0.00060137693,0.00041643908,0.00048731704,0.0008133007],"category_scores_gemma":[0.0017300888,0.0005470323,0.0005525187,0.0007918087,0.00032248814,0.00024643177,0.0004132434,0.0005357867,0.00015214497],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007521235,0.00011394625,0.9965487,0.000009969396,0.00018552893,0.0002297468,0.00015431459,0.00002424002,0.00095971907,0.00001936014,0.000088371686,0.00091407273],"study_design_scores_gemma":[0.00012822017,0.00031951597,0.9983096,0.0000064087535,0.00013301826,0.00044815344,0.0001230659,0.00015695863,0.00007327613,0.00001893361,0.0002782515,0.0000045701727],"about_ca_topic_score_codex":0.02089613,"about_ca_topic_score_gemma":0.020160498,"teacher_disagreement_score":0.02089613,"about_ca_system_score_codex":0.00033552028,"about_ca_system_score_gemma":0.00035073224,"threshold_uncertainty_score":0.041549027},"labels":[],"label_agreement":null},{"id":"W2097150975","doi":"10.1677/erc-06-0080","title":"Body shape throughout life and correlations with IGFs and GH","year":2007,"lang":"en","type":"article","venue":"Endocrine Related Cancer","topic":"Cancer Risks and Factors","field":"Medicine","cited_by":68,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Cancer Institute; Canadian Breast Cancer Research Alliance; Breast Cancer Alliance","keywords":"Anthropometry; Body mass index; Waist; Medicine; Internal medicine; Endocrinology; Breast cancer; Waist–hip ratio; Cross-sectional study; Demography; Young adult; Physiology; Cancer","score_opus":0.012347460513524594,"score_gpt":0.3145323565576772,"score_spread":0.3021848960441526,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2097150975","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9983734,0.0006692273,0.00008794352,0.000037356323,0.0000062661784,0.0000030202184,0.00027665443,0.0000051813813,0.00054094545],"genre_scores_gemma":[0.99914145,0.0001651707,0.00011485512,0.000010651896,0.0000055425667,0.000002810819,0.00019650752,0.0000019551585,0.00036103942],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9999014,0.000025749036,0.000008982716,0.000024422212,0.000020002832,0.000019434725],"domain_scores_gemma":[0.99909544,0.0001510809,0.00043575972,0.00006632789,0.00008338603,0.00016799939],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027157788,0.00020306923,0.00014953381,0.00051960937,0.00020605829,0.00031939262,0.0002048496,0.00022287913,0.0012546346],"category_scores_gemma":[0.0013727648,0.00016267078,0.00028812862,0.00047604626,0.00021738686,0.0001447112,0.00025800715,0.0003153981,0.00018707592],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001150369,0.00001077855,0.99660647,0.000005351894,0.000053725253,0.000039406976,0.000048198428,0.0000627961,0.00052775245,0.000020583635,0.00003700517,0.0024728433],"study_design_scores_gemma":[7.7901944e-7,0.000030287743,0.99974984,0.0000013787468,0.000005520486,0.00006102087,0.0000173666,0.00005128896,0.000025481399,0.000009273995,0.00004682739,8.050469e-7],"about_ca_topic_score_codex":0.0047127856,"about_ca_topic_score_gemma":0.0071547865,"teacher_disagreement_score":0.0047127856,"about_ca_system_score_codex":0.00017933635,"about_ca_system_score_gemma":0.00009239469,"threshold_uncertainty_score":0.009370744},"labels":[],"label_agreement":null},{"id":"W2098524712","doi":"10.1530/erc-12-0389","title":"A bi-faceted role of estrogen receptor β in breast cancer","year":2013,"lang":"en","type":"review","venue":"Endocrine Related Cancer","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":75,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"Cure Brain Cancer Foundation; Canadian Institutes of Health Research; Canadian Breast Cancer Research Alliance; CancerCare Manitoba Foundation; Manitoba Health Research Council","keywords":"Estrogen receptor; Breast cancer; Cancer research; Estrogen; In vivo; Cancer; In vitro; Human breast; Estrogen receptor alpha; Apoptosis; Estrogen receptor beta; Internal medicine; Oncology; Receptor; Biology; Medicine","score_opus":0.008586919141592047,"score_gpt":0.29730630680022974,"score_spread":0.2887193876586377,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2098524712","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000113975686,0.99848735,0.00010491675,0.00023674016,0.00012339634,0.000001967266,0.000014042029,0.00000671413,0.0009108156],"genre_scores_gemma":[0.0004727541,0.9988373,0.00009600749,0.00009560528,0.00008347578,0.0000019763097,0.000016982714,9.26579e-7,0.00039496526],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998859,0.000015699663,0.00001778452,0.00002261944,0.000044808927,0.0000131798815],"domain_scores_gemma":[0.9998448,0.00005786226,0.000022775832,0.0000047794765,0.000051573963,0.000018211684],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033126,0.0005948764,0.00089981715,0.0018978737,0.0002836312,0.0007746307,0.00055969175,0.0006893642,0.0030726576],"category_scores_gemma":[0.00040746256,0.00020218187,0.0002835585,0.0020972118,0.00036577776,0.0010263489,0.00063361676,0.001290367,0.001999439],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004832254,0.000039661874,0.00025181222,0.01109652,0.000046659177,0.00031358868,0.00006869794,0.00027120105,0.0024098726,0.0034622764,0.02751678,0.9544745],"study_design_scores_gemma":[0.0000055624014,0.00005386796,0.0008287472,0.0019622992,0.000058071382,0.0019395897,0.00006602665,0.00004681955,0.00049154216,0.0017161819,0.9928181,0.000013206716],"about_ca_topic_score_codex":0.0010780961,"about_ca_topic_score_gemma":0.0020855246,"teacher_disagreement_score":0.0030726576,"about_ca_system_score_codex":0.00058699783,"about_ca_system_score_gemma":0.000939656,"threshold_uncertainty_score":0.010279059},"labels":[],"label_agreement":null},{"id":"W2099643741","doi":"10.1530/erc-11-0136","title":"IGF1/insulin receptor kinase inhibition by BMS-536924 is better tolerated than alloxan-induced hypoinsulinemia and more effective than metformin in the treatment of experimental insulin-responsive breast cancer","year":2011,"lang":"en","type":"article","venue":"Endocrine Related Cancer","topic":"Metabolism, Diabetes, and Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"Canadian Cancer Society Research Institute; McGill University; Terry Fox Research Institute; Joslin Diabetes Center","keywords":"Insulin receptor; Insulin; Hyperinsulinemia; Metformin; Endocrinology; Internal medicine; Tyrosine kinase; Medicine; Tyrosine-kinase inhibitor; Pharmacology; Cancer; Insulin resistance; Receptor","score_opus":0.011098154442006678,"score_gpt":0.26730728257571285,"score_spread":0.25620912813370617,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2099643741","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99486095,0.0023349507,0.0006193166,0.00023671526,0.00008901237,0.00003215285,0.0002675825,0.00009321071,0.001466107],"genre_scores_gemma":[0.9956743,0.0014456664,0.0008397104,0.00011372864,0.000042222022,0.000037952395,0.00045690502,0.000023258937,0.0013661637],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99989843,0.000023824297,0.00001222929,0.000015811547,0.000022840637,0.000026747397],"domain_scores_gemma":[0.9999087,0.00001198899,0.00002937304,0.000011315561,0.0000070056517,0.00003168526],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002081705,0.0003107906,0.00074380386,0.00044379386,0.00018984445,0.00033862705,0.00021342003,0.00033054737,0.0017711502],"category_scores_gemma":[0.00016613427,0.00010836065,0.0003228453,0.0003267132,0.00019344654,0.00038512144,0.00008340198,0.00088478765,0.00021419],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006049458,0.0014762018,0.00058284664,0.00009329611,0.000058560483,0.000113789865,0.000017259148,0.00037199623,0.96563196,0.00023119588,0.00036647666,0.025006892],"study_design_scores_gemma":[0.0021126438,0.07001737,0.027746698,0.000027926659,0.0002265342,0.0011198225,0.00008225121,0.0021051774,0.8863961,0.0003291125,0.009783707,0.000052656138],"about_ca_topic_score_codex":0.00033226894,"about_ca_topic_score_gemma":0.0010738642,"teacher_disagreement_score":0.0017711502,"about_ca_system_score_codex":0.0002242042,"about_ca_system_score_gemma":0.00024053414,"threshold_uncertainty_score":0.005925119},"labels":[],"label_agreement":null},{"id":"W2099691308","doi":"10.1530/erc-14-0088","title":"Relaxin receptor antagonist AT-001 synergizes with docetaxel in androgen-independent prostate xenografts","year":2014,"lang":"en","type":"article","venue":"Endocrine Related Cancer","topic":"Pregnancy-related medical research","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Guelph; Toronto General Hospital; University of Toronto; University Health Network; Canadian Blood Services; Mount Sinai Hospital","funders":"","keywords":"Prostate cancer; Relaxin; Docetaxel; Androgen receptor; Androgen; Internal medicine; Medicine; Prostate; Endocrinology; Hormone; Hormonal therapy; Cancer research; Cancer","score_opus":0.008825798346866707,"score_gpt":0.2843311878937023,"score_spread":0.2755053895468356,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2099691308","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9941924,0.0015690874,0.00052008906,0.00013534108,0.000062233594,0.00008264007,0.0004285269,0.0001164643,0.00289327],"genre_scores_gemma":[0.9930391,0.001987554,0.00066423806,0.00007349395,0.000024340106,0.000053326985,0.00081349927,0.00002535048,0.0033191561],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99989367,0.000029338195,0.000007155378,0.000011569795,0.000023313482,0.000034902958],"domain_scores_gemma":[0.99988925,0.000025106527,0.000022486338,0.000010370517,0.0000072492253,0.000045477835],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017594661,0.0004249332,0.0004990056,0.00031194653,0.000171065,0.00036046063,0.00034670447,0.00019179324,0.001192618],"category_scores_gemma":[0.00011257452,0.00018296069,0.000365979,0.00026182437,0.00018179178,0.00021982464,0.00012215537,0.00075091876,0.00036028336],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0028868406,0.002496353,0.00066177966,0.0001560646,0.00005439541,0.00019705307,0.0000843874,0.0016058473,0.9752045,0.00030709832,0.0012161925,0.015129504],"study_design_scores_gemma":[0.0008138418,0.029589267,0.009741448,0.00002094158,0.00011879463,0.0005469219,0.00008486089,0.0033423805,0.9490566,0.000077307406,0.0065801754,0.000027514903],"about_ca_topic_score_codex":0.0019678946,"about_ca_topic_score_gemma":0.006019535,"teacher_disagreement_score":0.0019678946,"about_ca_system_score_codex":0.00040692883,"about_ca_system_score_gemma":0.00054111576,"threshold_uncertainty_score":0.003989756},"labels":[],"label_agreement":null},{"id":"W2101695180","doi":"10.1677/erc.1.00883","title":"Future perspectives of selective estrogen receptor modulators used alone and in combination with DHEA","year":2006,"lang":"en","type":"review","venue":"Endocrine Related Cancer","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"National Cancer Institute","keywords":"Raloxifene; Tamoxifen; Selective estrogen receptor modulator; Aromatase; Breast cancer; Medicine; Estrogen; Internal medicine; Cancer; Endocrinology; Endometrial cancer; Estrogen receptor; Cancer research; Oncology","score_opus":0.005495821984045674,"score_gpt":0.27149832543571495,"score_spread":0.26600250345166926,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2101695180","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.008745498,0.90457666,0.0035928884,0.045949973,0.0047984254,0.00016814478,0.00063063885,0.00023256284,0.031305164],"genre_scores_gemma":[0.042335607,0.8869048,0.008303585,0.023334058,0.011390552,0.00045930964,0.0012016853,0.000083689265,0.025986735],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9990951,0.00035872954,0.00007421712,0.000107253494,0.00021598938,0.00014883006],"domain_scores_gemma":[0.9978175,0.0008828015,0.00019307899,0.00008584546,0.0006207437,0.0003999793],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003631976,0.00084485445,0.0016165538,0.00079010276,0.00043694832,0.0018275175,0.0014450916,0.0030852905,0.02236895],"category_scores_gemma":[0.0024406477,0.0003027782,0.0017252062,0.0007652088,0.00081499084,0.0019052095,0.0006262894,0.0027335745,0.0044043115],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005236925,0.0017881993,0.001479715,0.006678538,0.00047467116,0.001626135,0.00022833399,0.0010904955,0.008940332,0.011937069,0.07530629,0.8852133],"study_design_scores_gemma":[0.0012535803,0.007315899,0.003079524,0.0020859193,0.0006580963,0.0028025508,0.000501238,0.0005863291,0.0028716929,0.010690568,0.9680695,0.000085213906],"about_ca_topic_score_codex":0.00082478387,"about_ca_topic_score_gemma":0.003726942,"teacher_disagreement_score":0.02236895,"about_ca_system_score_codex":0.0006954631,"about_ca_system_score_gemma":0.001830068,"threshold_uncertainty_score":0.074831545},"labels":[],"label_agreement":null},{"id":"W2110104390","doi":"10.1677/erc-08-0266","title":"Resistance to chemotherapy and hormone therapy in endometrial cancer","year":2009,"lang":"en","type":"review","venue":"Endocrine Related Cancer","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":154,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université du Québec à Trois-Rivières","funders":"Canadian Institutes of Health Research; Natural Sciences and Engineering Research Council of Canada; Canada Research Chairs","keywords":"Endometrial cancer; Medicine; Cancer; Malignancy; Oncology; Hormone therapy; Internal medicine; Chemotherapy; Targeted therapy; Ovarian cancer; Uterine cancer; Cancer research; Bioinformatics; Breast cancer; Biology","score_opus":0.01561313703578337,"score_gpt":0.33372719996739825,"score_spread":0.31811406293161487,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2110104390","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0007390885,0.99833363,0.00007885313,0.00020420925,0.000059974514,0.0000029284977,0.000015013216,0.000002386166,0.0005638369],"genre_scores_gemma":[0.0066949623,0.9923143,0.00021367591,0.0002329179,0.00017552296,0.0000065631657,0.000036164984,0.0000010485874,0.00032488297],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99976534,0.00006971709,0.000049559407,0.000028971695,0.00006827012,0.000018136352],"domain_scores_gemma":[0.9997179,0.00016919903,0.00005637244,0.00000539147,0.000043306627,0.000007914328],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035729256,0.0002512045,0.00065458275,0.0008570024,0.00013061726,0.00055185024,0.00031404968,0.00051480177,0.0011597422],"category_scores_gemma":[0.00073798356,0.00012478049,0.00035289652,0.0009783026,0.00019745274,0.00044628966,0.00022617329,0.0005317922,0.00030250123],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015999141,0.000054035354,0.0014845382,0.026915774,0.00022091538,0.0016408608,0.00027553155,0.00063763815,0.007812391,0.0024042146,0.012122696,0.9462714],"study_design_scores_gemma":[0.000048122947,0.00058758294,0.012476513,0.008246094,0.00062605285,0.01580591,0.00039270602,0.00039980278,0.0055814306,0.0034344033,0.9523503,0.00005117748],"about_ca_topic_score_codex":0.0006435832,"about_ca_topic_score_gemma":0.0014105566,"teacher_disagreement_score":0.0011597422,"about_ca_system_score_codex":0.00036383903,"about_ca_system_score_gemma":0.00057458295,"threshold_uncertainty_score":0.0038796663},"labels":[],"label_agreement":null},{"id":"W2112031253","doi":"10.1530/erc-11-0180","title":"Low residual proliferation after short-term letrozole therapy is an early predictive marker of response in high proliferative ER-positive breast cancer","year":2011,"lang":"en","type":"article","venue":"Endocrine Related Cancer","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"Fondation Medic; Breast Cancer Research Foundation","keywords":"Letrozole; Breast cancer; Oncology; Medicine; Estrogen receptor; Neoadjuvant therapy; Internal medicine; Cancer; Cancer research; Aromatase","score_opus":0.010611062138524894,"score_gpt":0.2623182601018027,"score_spread":0.2517071979632778,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2112031253","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9994388,0.00025496914,0.00012722606,0.000013208734,0.0000016712835,0.0000025277755,0.00003646906,0.000006344302,0.000118760094],"genre_scores_gemma":[0.9996656,0.000060219474,0.00010539567,0.0000055528944,0.000003084356,0.0000022104955,0.000094111776,8.6499057e-7,0.00006295912],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99990475,0.000026083173,0.0000075890653,0.000015879845,0.000028473425,0.000017129614],"domain_scores_gemma":[0.99963844,0.0001095217,0.00014490377,0.000018340757,0.000026516283,0.00006222815],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019895897,0.00012528064,0.00020478848,0.000383955,0.000079480946,0.00021761641,0.00010116244,0.00014980369,0.0003741766],"category_scores_gemma":[0.0006769345,0.000090847956,0.000101743375,0.00020513262,0.00015372956,0.00010562459,0.000109326,0.0002082537,0.00009272711],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024169367,0.000067523644,0.92370504,0.00003312654,0.0000440041,0.00015324162,0.000089264504,0.00038631304,0.05550666,0.00002045401,0.00007207479,0.017505238],"study_design_scores_gemma":[0.000010768004,0.00050239445,0.9921301,0.0000024675712,0.000025187139,0.00035724632,0.000057769405,0.0006922254,0.0060103745,0.000027963179,0.00017986307,0.0000035689861],"about_ca_topic_score_codex":0.00051480666,"about_ca_topic_score_gemma":0.0011889781,"teacher_disagreement_score":0.00051480666,"about_ca_system_score_codex":0.00015692385,"about_ca_system_score_gemma":0.00008561852,"threshold_uncertainty_score":0.0012516975},"labels":[],"label_agreement":null},{"id":"W2112187558","doi":"10.1677/erc.1.01010","title":"Progesterone metabolites in breast cancer","year":2006,"lang":"en","type":"review","venue":"Endocrine Related Cancer","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":103,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"Canadian Institutes of Health Research; Susan G. Komen","keywords":"Corpus luteum; Enzyme; Cell growth; Reductase; Internal medicine; Metabolism; Pregnane; Cell; Chemistry; Cell culture; Endocrinology; Oxidoreductase; Biology; Biochemistry; Hormone; Medicine; Stereochemistry; Genetics","score_opus":0.0109600901615291,"score_gpt":0.3199203581185874,"score_spread":0.3089602679570583,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2112187558","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0014924475,0.9917503,0.00007969514,0.0008281587,0.0002973085,0.0000080970185,0.000031898384,0.000008576618,0.005503665],"genre_scores_gemma":[0.01662702,0.9770831,0.00019736131,0.0007416448,0.0006368161,0.000012459576,0.00009507477,0.000002650827,0.004603897],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997495,0.000063021784,0.00003002725,0.000029287869,0.000098662065,0.000029544133],"domain_scores_gemma":[0.99974805,0.00007827341,0.00006379187,0.000011321255,0.00007071548,0.000027913904],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039750917,0.00032052983,0.00057418086,0.0013416844,0.00029841444,0.0007919853,0.00040903332,0.0008614948,0.004743295],"category_scores_gemma":[0.0006014683,0.0001224761,0.0002676262,0.001988041,0.00029263255,0.0004409754,0.00053217274,0.0006430344,0.001851313],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00047526456,0.000121162,0.00476282,0.011561823,0.00013196323,0.005692207,0.00034062567,0.00052409887,0.012699322,0.007458156,0.035950884,0.9202817],"study_design_scores_gemma":[0.000031048705,0.00033586114,0.0095430305,0.0010776134,0.00012128593,0.009701033,0.00016044882,0.00009309679,0.0030425414,0.0019463389,0.9739347,0.000013012806],"about_ca_topic_score_codex":0.0020851833,"about_ca_topic_score_gemma":0.002976746,"teacher_disagreement_score":0.004743295,"about_ca_system_score_codex":0.0008104085,"about_ca_system_score_gemma":0.00072500715,"threshold_uncertainty_score":0.015867949},"labels":[],"label_agreement":null},{"id":"W2113902100","doi":"10.1530/erc-14-0516","title":"Deubiquitinases and the new therapeutic opportunities offered to cancer","year":2015,"lang":"en","type":"review","venue":"Endocrine Related Cancer","topic":"Ubiquitin and proteasome pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":136,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"York University","funders":"Canadian Institutes of Health Research; University of Sydney","keywords":"Neurodegeneration; Prostate cancer; Carcinogenesis; Cancer; Thyroid cancer; Biology; Cancer research; Deubiquitinating enzyme; Medicine; Bioinformatics; Neuroscience; Computational biology; Disease; Ubiquitin; Internal medicine; Gene; Genetics","score_opus":0.09523177076560643,"score_gpt":0.3638748980179886,"score_spread":0.26864312725238215,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2113902100","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00021621291,0.99764365,0.0002435918,0.00030937477,0.00015179405,0.0000031762575,0.000017381308,0.000009711795,0.0014050538],"genre_scores_gemma":[0.0014985997,0.9966281,0.00029423976,0.00020666706,0.00014274946,0.0000058281867,0.000032510052,0.0000020827802,0.001189241],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998342,0.000026937178,0.000021488115,0.00003170889,0.00006552958,0.000020106194],"domain_scores_gemma":[0.9998616,0.000055451947,0.000020827783,0.000007988008,0.000036267116,0.000017881892],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004017942,0.000630223,0.00082065864,0.0022375346,0.00032656218,0.00090136175,0.00052828726,0.0010075436,0.0039352146],"category_scores_gemma":[0.00042558162,0.00022834683,0.0004033754,0.0016231502,0.0004974382,0.0012043288,0.0007668253,0.0015978538,0.00198935],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007532624,0.000069923975,0.0002567275,0.01047848,0.00008010962,0.00043410785,0.000094357994,0.00046836634,0.0064603803,0.011798874,0.025416415,0.944367],"study_design_scores_gemma":[0.0000067208443,0.00005181225,0.0004331097,0.00089281576,0.000032204352,0.0016326368,0.000042128846,0.00006919895,0.00092859037,0.0027143823,0.9931853,0.000011102261],"about_ca_topic_score_codex":0.0005027367,"about_ca_topic_score_gemma":0.0010434297,"teacher_disagreement_score":0.0039352146,"about_ca_system_score_codex":0.0006091783,"about_ca_system_score_gemma":0.00058014836,"threshold_uncertainty_score":0.0131646395},"labels":[],"label_agreement":null},{"id":"W2115163916","doi":"10.1530/erc-15-0137","title":"Regulation of tumor cell plasticity by the androgen receptor in prostate cancer","year":2015,"lang":"en","type":"review","venue":"Endocrine Related Cancer","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":55,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Prostate Cancer Canada; Movember Foundation; Prostate Cancer Foundation","keywords":"Prostate cancer; Androgen receptor; Transdifferentiation; Androgen deprivation therapy; Cancer research; Cancer; Biology; Androgen; Tumor progression; Medicine; Bioinformatics; Internal medicine; Stem cell; Hormone; Cell biology","score_opus":0.03718822712498839,"score_gpt":0.3640658753312958,"score_spread":0.32687764820630744,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2115163916","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0001544764,0.99853885,0.000096663985,0.00012406304,0.00010427755,0.000004071806,0.000016385076,0.000005850207,0.00095538184],"genre_scores_gemma":[0.0008487526,0.998367,0.000104591425,0.00008542547,0.000055732908,0.000003909707,0.000025184692,9.350521e-7,0.0005084234],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998832,0.00001654279,0.000017086511,0.000019289935,0.000051187315,0.000012795303],"domain_scores_gemma":[0.9998585,0.00005615981,0.000022122984,0.000004442126,0.00004282538,0.000015899022],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003307075,0.00054961356,0.0009256375,0.0017614681,0.00024495038,0.0007456807,0.0005709469,0.00069833116,0.0028387886],"category_scores_gemma":[0.00037984888,0.00023448971,0.00041573407,0.001522544,0.0003341954,0.000826514,0.0005217628,0.0012673163,0.0015908608],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006773725,0.00007369939,0.00025389373,0.019467466,0.00007214018,0.00021059754,0.00007380954,0.0004294094,0.004238307,0.00482839,0.021827757,0.94845676],"study_design_scores_gemma":[0.0000119113265,0.00008861211,0.00094482634,0.002200769,0.000072983545,0.0011809866,0.00004678989,0.000077442615,0.00082925527,0.0016789776,0.9928518,0.000015633957],"about_ca_topic_score_codex":0.0008732583,"about_ca_topic_score_gemma":0.001918032,"teacher_disagreement_score":0.0028387886,"about_ca_system_score_codex":0.00048491816,"about_ca_system_score_gemma":0.0007538505,"threshold_uncertainty_score":0.009496689},"labels":[],"label_agreement":null},{"id":"W2116534677","doi":"10.1530/erc-10-0204","title":"Androgen receptor levels are upregulated by Akt in prostate cancer","year":2011,"lang":"en","type":"article","venue":"Endocrine Related Cancer","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":60,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Cancer Institute; National Institutes of Health; University of California, Los Angeles; School of Medicine, New York University; York University; American Cancer Society","keywords":"LNCaP; Protein kinase B; Androgen receptor; Prostate cancer; AKT1; PI3K/AKT/mTOR pathway; Biology; AKT2; Endocrinology; Cancer research; Internal medicine; Transgene; Phosphorylation; Signal transduction; Chemistry; Cell biology; Cancer; Medicine; Biochemistry","score_opus":0.03953331237177583,"score_gpt":0.32293153682708375,"score_spread":0.28339822445530793,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2116534677","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.983442,0.009875189,0.0010841155,0.00017718249,0.000054535132,0.000028719802,0.00087124296,0.00023253249,0.004234372],"genre_scores_gemma":[0.992634,0.0030281637,0.000547352,0.00005967626,0.000013923441,0.000017892653,0.0007351637,0.000014131391,0.0029496723],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998884,0.000013516951,0.0000075595494,0.000019058903,0.0000457873,0.000025660745],"domain_scores_gemma":[0.9999416,0.0000054548336,0.000018750035,0.0000041394624,0.000010385323,0.000019758803],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009734971,0.0001807823,0.000174851,0.0005490745,0.00020878155,0.00040295956,0.000092600385,0.00015270223,0.0019471825],"category_scores_gemma":[0.00007917246,0.00018722868,0.00024694193,0.00043415494,0.0001492623,0.00013400268,0.00013875052,0.00044860953,0.0004223482],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00039853947,0.00008101022,0.004276905,0.00009105098,0.000027603033,0.00018401364,0.00003110381,0.0000834817,0.98922426,0.0002093197,0.00026586102,0.0051268563],"study_design_scores_gemma":[0.0000671318,0.0016418401,0.30112416,0.00002280627,0.00012930925,0.0025671606,0.00018047707,0.001000248,0.67528826,0.00043817278,0.017513003,0.000027537568],"about_ca_topic_score_codex":0.0009479581,"about_ca_topic_score_gemma":0.0012907234,"teacher_disagreement_score":0.0019471825,"about_ca_system_score_codex":0.00030291767,"about_ca_system_score_gemma":0.000321572,"threshold_uncertainty_score":0.006514013},"labels":[],"label_agreement":null},{"id":"W2119255622","doi":"10.1677/erc.1.01057","title":"Differential regulation of two forms of gonadotropin-releasing hormone messenger ribonucleic acid by gonadotropins in human immortalized ovarian surface epithelium and ovarian cancer cells","year":2006,"lang":"en","type":"article","venue":"Endocrine Related Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Child and Family Research Institute; University of British Columbia","funders":"Canadian Institutes of Health Research; Michael Smith Health Research BC","keywords":"GNRHR; Autocrine signalling; Paracrine signalling; Endocrinology; Internal medicine; Gonadotropin-releasing hormone; Luteinizing hormone; Gonadotropin-releasing hormone receptor; Biology; Gonadotropin; Receptor; Hormone; Follicle-stimulating hormone; Ovary; Ovarian cancer; Cancer; Medicine","score_opus":0.007084500605257545,"score_gpt":0.2710778418676892,"score_spread":0.2639933412624316,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2119255622","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.993255,0.0018398056,0.0028041315,0.00005153233,0.000041410472,0.000040828963,0.0005093165,0.000043797525,0.0014141225],"genre_scores_gemma":[0.98798776,0.0016160425,0.004660674,0.00007791944,0.00002405141,0.00009773827,0.0032051776,0.000028771112,0.0023018362],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99977607,0.00003217523,0.00003408593,0.000049716822,0.00006807652,0.00003990533],"domain_scores_gemma":[0.99982834,0.000049718,0.00003104201,0.000033619646,0.000031967884,0.000025371004],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018078832,0.0002050843,0.00025053453,0.00026276842,0.00012216493,0.0003953309,0.000111919464,0.00012956446,0.00072150264],"category_scores_gemma":[0.00021867406,0.00014331903,0.00031317392,0.00021670392,0.00026291425,0.00012362399,0.00015559288,0.0002612578,0.00030600055],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000076918855,0.000010355397,0.00033228646,0.0000141761275,0.0000036660008,0.000028752238,0.000026421978,0.000010867824,0.9989285,0.000033196797,0.000011753835,0.00052312453],"study_design_scores_gemma":[0.000023928564,0.00056689075,0.021693615,0.0000067850174,0.000036341822,0.00039811851,0.00012963235,0.00057273003,0.97286755,0.000047594345,0.0036474804,0.0000093789995],"about_ca_topic_score_codex":0.0006328639,"about_ca_topic_score_gemma":0.0007331413,"teacher_disagreement_score":0.00072150264,"about_ca_system_score_codex":0.00016166322,"about_ca_system_score_gemma":0.00019620957,"threshold_uncertainty_score":0.00241369},"labels":[],"label_agreement":null},{"id":"W2121121428","doi":"10.1677/erc-07-0132","title":"Metabolic syndrome, plasma lipid, lipoprotein and glucose levels, and endometrial cancer risk in the European Prospective Investigation into Cancer and Nutrition (EPIC)","year":2007,"lang":"en","type":"article","venue":"Endocrine Related Cancer","topic":"Cancer, Lipids, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":129,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Cancer Foundation","funders":"Medical Research Council; Canadian Institutes of Health Research; Deutsche Krebshilfe; Fondation pour la Recherche Médicale; Cancerfonden; Fondation de France; Bundesministerium für Bildung und Forschung; Instituto de Salud Carlos III; 3M; University of Sydney; Institut National de la Santé et de la Recherche Médicale; Cancer Institute NSW; European Commission; Wellcome Trust; British Heart Foundation; Norges Forskningsråd; Cancer Research UK; Deutsches Krebsforschungszentrum","keywords":"Medicine; Endometrial cancer; Internal medicine; Endocrinology; Metabolic syndrome; Body mass index; European Prospective Investigation into Cancer and Nutrition; Quartile; Relative risk; Prospective cohort study; Confidence interval; Risk factor; Cancer; Obesity","score_opus":0.009063529339974424,"score_gpt":0.254749518786764,"score_spread":0.24568598944678957,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2121121428","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9969975,0.0019370429,0.00046193876,0.000060785827,0.00001500843,0.000017115468,0.00026634632,0.0000047103326,0.00023954912],"genre_scores_gemma":[0.998334,0.00048610705,0.00054046104,0.000073478404,0.000020722691,0.000024461093,0.00035040185,0.000002479428,0.00016790674],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985569,0.00086719013,0.00013255424,0.0002445644,0.00012518723,0.00007352454],"domain_scores_gemma":[0.9985134,0.0005274295,0.00035430508,0.00031917458,0.000111135196,0.00017449007],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0032095904,0.00037747182,0.0006119559,0.00073646894,0.00034667162,0.0007059998,0.00036338528,0.0005854607,0.0005111799],"category_scores_gemma":[0.0042618695,0.00053168624,0.00084792805,0.0011724337,0.0002943986,0.00025817868,0.0005532095,0.0005977457,0.000068205154],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013514349,0.00006895941,0.9947568,0.000029726778,0.0008821263,0.00018909505,0.00005243674,0.00010008525,0.00060771813,0.000059778275,0.00008869556,0.0018132129],"study_design_scores_gemma":[0.00007594256,0.0001644057,0.9983492,0.000007490417,0.00046148399,0.00029623407,0.000028176273,0.00030476673,0.00007362375,0.000050192095,0.00018425651,0.0000042622896],"about_ca_topic_score_codex":0.0050373683,"about_ca_topic_score_gemma":0.005457377,"teacher_disagreement_score":0.0050373683,"about_ca_system_score_codex":0.00019717355,"about_ca_system_score_gemma":0.0002872739,"threshold_uncertainty_score":0.016974151},"labels":[],"label_agreement":null},{"id":"W2123921391","doi":"10.1530/erc-13-0132","title":"Differential sensitivities to lactate transport inhibitors of breast cancer cell lines","year":2013,"lang":"en","type":"article","venue":"Endocrine Related Cancer","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":68,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"European Regional Development Fund; Fundação para a Ciência e a Tecnologia","keywords":"Cancer research; Monocarboxylate transporter; Breast cancer; Cell culture; Cell growth; Gene silencing; Downregulation and upregulation; Cancer cell; Apoptosis; Cell; Biology; Cancer; Extracellular; Glucose transporter; Programmed cell death; Chemistry; Cell biology; Transporter; Internal medicine; Endocrinology; Medicine; Biochemistry","score_opus":0.004110703754306889,"score_gpt":0.22580470464613406,"score_spread":0.22169400089182717,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2123921391","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96202004,0.014137068,0.010902356,0.000658956,0.00034430626,0.00038481088,0.005804844,0.00027945757,0.0054682875],"genre_scores_gemma":[0.93632877,0.01315533,0.020799581,0.0004901168,0.00007869149,0.0013508262,0.01665532,0.00014968425,0.010991736],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9991167,0.00019004034,0.0001634486,0.000121366495,0.00029744598,0.000111110654],"domain_scores_gemma":[0.99959594,0.00011810601,0.000048155267,0.00005742429,0.0001472697,0.00003315492],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00046470822,0.00050136494,0.000849599,0.00051745394,0.00025824318,0.00047481354,0.0003049312,0.0003693434,0.0014956504],"category_scores_gemma":[0.00041970052,0.00022120496,0.00048138303,0.0007363099,0.00016716987,0.00020743502,0.0002819026,0.00077809265,0.0006980797],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005745319,0.00019763046,0.00057567545,0.00019378631,0.000039112565,0.00008540233,0.00013927839,0.00023370788,0.99382246,0.00013161963,0.0004899821,0.0035167674],"study_design_scores_gemma":[0.000042188232,0.00078695687,0.003485323,0.000014257396,0.00007797839,0.00029085268,0.00008700594,0.0010194809,0.9889936,0.000038604787,0.005149627,0.000014215444],"about_ca_topic_score_codex":0.0026242726,"about_ca_topic_score_gemma":0.0031212664,"teacher_disagreement_score":0.0026242726,"about_ca_system_score_codex":0.0004043319,"about_ca_system_score_gemma":0.00032005712,"threshold_uncertainty_score":0.0052179694},"labels":[],"label_agreement":null},{"id":"W2125056490","doi":"10.1530/erc-12-0125","title":"Stimulation of MC38 tumor growth by insulin analog X10 involves the serine synthesis pathway","year":2012,"lang":"en","type":"article","venue":"Endocrine Related Cancer","topic":"Metabolism, Diabetes, and Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital","funders":"Canadian Institutes of Health Research; Novo Nordisk; Deutsche Forschungsgemeinschaft","keywords":"Hyperinsulinemia; Insulin; Insulin receptor; Endocrinology; Internal medicine; Cell growth; Serine; Cancer research; Downregulation and upregulation; Biology; Neoplastic cell; Gene expression; Chemistry; Gene; Phosphorylation; Cell biology; Cell; Biochemistry; Insulin resistance; Medicine","score_opus":0.007025789224235278,"score_gpt":0.23821543648451096,"score_spread":0.2311896472602757,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2125056490","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99598855,0.0014534763,0.0007214108,0.000075919364,0.000011706028,0.000017101833,0.00020190366,0.000045080797,0.0014847346],"genre_scores_gemma":[0.9943844,0.0016162107,0.0015971595,0.000036844674,0.000009588922,0.000022092758,0.00039601693,0.00001494466,0.0019227015],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999229,0.000015144188,0.0000045818647,0.000017932243,0.000020840565,0.000018623194],"domain_scores_gemma":[0.9999026,0.000022786273,0.000027666347,0.000011495988,0.000008665545,0.000026787511],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0000730478,0.00067476643,0.0001705144,0.0002269412,0.00014439982,0.00022115413,0.00012223228,0.00016889366,0.0019455837],"category_scores_gemma":[0.00008315326,0.000111031346,0.0002050849,0.00018626696,0.00023996104,0.00015853898,0.00014671416,0.00032327586,0.00028080094],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001937062,0.000023993283,0.00027495128,0.000018585964,0.0000018816719,0.00005858373,0.0000069079438,0.00003285704,0.99842274,0.00003195136,0.000014013109,0.0009198308],"study_design_scores_gemma":[0.000014080539,0.00067574607,0.0081324335,0.000003994725,0.000007386034,0.00024957352,0.000019910807,0.0002796723,0.9893289,0.000035610636,0.0012492334,0.0000033573829],"about_ca_topic_score_codex":0.001106603,"about_ca_topic_score_gemma":0.0015631343,"teacher_disagreement_score":0.0019455837,"about_ca_system_score_codex":0.00035978807,"about_ca_system_score_gemma":0.0002134642,"threshold_uncertainty_score":0.0065086484},"labels":[],"label_agreement":null},{"id":"W2125346129","doi":"10.1530/erc-13-0293","title":"TBLR1 as an androgen receptor (AR) coactivator selectively activates AR target genes to inhibit prostate cancer growth","year":2013,"lang":"en","type":"article","venue":"Endocrine Related Cancer","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"York University; National Cancer Institute; National Institutes of Health; DOD Prostate Cancer Research Program; National Center for Research Resources; Office of Research and Development; U.S. Department of Veterans Affairs; U.S. Department of Defense","keywords":"Coactivator; Androgen receptor; Prostate cancer; Cancer research; Corepressor; Nuclear receptor coactivator 3; Nuclear receptor; Endocrinology; Androgen; Biology; Ectopic expression; LNCaP; Internal medicine; Cell growth; Prostate; Cancer; Chemistry; Cell biology; Medicine; Cell culture; Hormone; Gene; Transcription factor; Genetics","score_opus":0.013000437079938474,"score_gpt":0.31160680758527864,"score_spread":0.29860637050534017,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2125346129","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96167076,0.019105997,0.01037047,0.0004489291,0.00018372691,0.00006322639,0.0009164374,0.00056778215,0.0066725803],"genre_scores_gemma":[0.984435,0.0035101324,0.0038125971,0.00013883776,0.000025945346,0.00005181634,0.0011270269,0.000053079035,0.00684549],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99981576,0.000024485416,0.000010352838,0.000048873062,0.000057842815,0.000042753727],"domain_scores_gemma":[0.99995506,0.000004634423,0.000012480836,0.000004972854,0.000005615337,0.000017199849],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012786203,0.00027474397,0.00028601842,0.00017817477,0.00022098023,0.00028624077,0.0002588676,0.00019585576,0.002381842],"category_scores_gemma":[0.00006541914,0.00014572091,0.0003865919,0.00023032723,0.00020912301,0.00014910412,0.00021103551,0.0006674404,0.0009818638],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000046985904,0.000015197069,0.00016223105,0.00004602709,0.000004885069,0.00001929199,0.0000090901485,0.00005127094,0.99774724,0.00007987542,0.00012081124,0.0016970849],"study_design_scores_gemma":[0.000019890593,0.00028050272,0.0035100565,0.000007706961,0.000025222815,0.00032747493,0.000024152509,0.00069671194,0.9859287,0.0000305568,0.009143663,0.0000052863993],"about_ca_topic_score_codex":0.00063742656,"about_ca_topic_score_gemma":0.0013180458,"teacher_disagreement_score":0.002381842,"about_ca_system_score_codex":0.00034224955,"about_ca_system_score_gemma":0.00020823223,"threshold_uncertainty_score":0.0079680085},"labels":[],"label_agreement":null},{"id":"W2126464915","doi":"10.1677/erc-09-0252","title":"Metformin blocks the stimulative effect of a high-energy diet on colon carcinoma growth in vivo and is associated with reduced expression of fatty acid synthase","year":2010,"lang":"en","type":"article","venue":"Endocrine Related Cancer","topic":"Metabolism, Diabetes, and Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":232,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital; McGill University","funders":"Canadian Institutes of Health Research","keywords":"Metformin; Fatty acid synthase; AMPK; Endocrinology; Internal medicine; PI3K/AKT/mTOR pathway; Protein kinase B; Apoptosis; Colorectal cancer; In vivo; Cancer research; Medicine; Insulin; Cancer; Phosphorylation; Biology; Protein kinase A; Lipid metabolism; Biochemistry","score_opus":0.004109245404270566,"score_gpt":0.23381651425769112,"score_spread":0.22970726885342055,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2126464915","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9960705,0.0015722351,0.0008792055,0.00013471047,0.000054999728,0.000042831707,0.00025537948,0.00006366058,0.0009265044],"genre_scores_gemma":[0.9927099,0.0018853534,0.0019501687,0.00009608798,0.000029070025,0.00010132105,0.00073501514,0.000024620544,0.0024684237],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99984634,0.00003420948,0.0000167627,0.000018814415,0.000039145983,0.000044709148],"domain_scores_gemma":[0.9997607,0.000040082,0.000093245435,0.000025886779,0.000016920425,0.00006320498],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019066167,0.0005178548,0.00035476594,0.00041000303,0.00015966022,0.00023280666,0.00025103474,0.00029326993,0.0011951262],"category_scores_gemma":[0.0001771597,0.00022730502,0.0003084336,0.00022377454,0.00022983256,0.00018813813,0.00019926329,0.00092364335,0.00021693856],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013459921,0.00038370743,0.00036134225,0.00006719311,0.000016985483,0.00007413989,0.000010942551,0.0001343048,0.9944612,0.00012080569,0.00008750531,0.0029359846],"study_design_scores_gemma":[0.0002674564,0.0056366874,0.01393276,0.000016776155,0.000035486068,0.00032795517,0.000027494909,0.0016919515,0.97522664,0.000088165136,0.002737457,0.000011075393],"about_ca_topic_score_codex":0.0008948846,"about_ca_topic_score_gemma":0.0022678508,"teacher_disagreement_score":0.0011951262,"about_ca_system_score_codex":0.0003865578,"about_ca_system_score_gemma":0.00048747964,"threshold_uncertainty_score":0.0039981008},"labels":[],"label_agreement":null},{"id":"W2127717082","doi":"10.1530/erc-15-0319","title":"Comprehensive genetic assessment of the ESR1 locus identifies a risk region for endometrial cancer","year":2015,"lang":"en","type":"article","venue":"Endocrine Related Cancer","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":29,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Cancer Institute; National Human Genome Research Institute; Cancer Council Queensland; National Health and Medical Research Council; Medical Research Council; Vincent Fairfax Family Foundation; Cancer Council Victoria; Deutsche Krebshilfe; Norges Forskningsråd; Universitetet i Bergen; Helse Vest; Karolinska Institutet; National Institutes of Health; David F. and Margaret T. Grohne Family Foundation; Deutsche Gesetzliche Unfallversicherung; Canadian Institutes of Health Research; Cancerfonden; Robert Bosch Stiftung; Agency for Science, Technology and Research; Deutsches Krebsforschungszentrum; Hunter Medical Research Institute; Bundesministerium für Bildung und Forschung; National Institute for Health and Care Research; Roswell Park Cancer Institute; Susan G. Komen; Stockholms Läns Landsting; QIMR Berghofer Medical Research Institute; Mayo Foundation for Medical Education and Research; Francis Crick Institute; Cancer Research UK; Wellcome Trust; Breast Cancer Research Foundation; University of Cambridge; Kreftforeningen; Ovarian Cancer Research Fund; European Commission","keywords":"Single-nucleotide polymorphism; Estrogen receptor alpha; Endometrial cancer; Locus (genetics); SNP; Breast cancer; Estrogen receptor; Biology; Cancer; Oncology; Medicine; Genetics; Gene; Internal medicine; Genotype","score_opus":0.02028614065841257,"score_gpt":0.32424924953364703,"score_spread":0.3039631088752345,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2127717082","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.996166,0.0007586558,0.0020040963,0.000059995156,0.0000065636555,0.000014336314,0.0005756978,0.000043246073,0.00037149363],"genre_scores_gemma":[0.9964104,0.00022746106,0.0026990748,0.00003929273,0.000009845364,0.000008878976,0.00037528857,0.000010850846,0.00021879745],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99945027,0.00015705977,0.000049645478,0.00019519524,0.00009844468,0.000049422135],"domain_scores_gemma":[0.9987367,0.00060217734,0.0003026835,0.0001297856,0.00007561193,0.00015315674],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007634964,0.00040189305,0.0006119177,0.0009767713,0.0002817054,0.00043240702,0.00033487123,0.00047103042,0.0018307101],"category_scores_gemma":[0.0019431842,0.00022216054,0.00071955216,0.0009947224,0.00028065854,0.00011506409,0.00065290614,0.00034949274,0.00027170766],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002686898,0.00015252568,0.7134148,0.00022724288,0.0013144122,0.003505412,0.00049376773,0.0026308096,0.2269122,0.00070071337,0.00056757027,0.047393564],"study_design_scores_gemma":[0.0000674769,0.00043931114,0.98541534,0.000029292589,0.00049102545,0.0029393795,0.00010723698,0.0015554358,0.00718577,0.0005253856,0.0012198329,0.000024541838],"about_ca_topic_score_codex":0.00093308924,"about_ca_topic_score_gemma":0.0014260054,"teacher_disagreement_score":0.0018307101,"about_ca_system_score_codex":0.000140095,"about_ca_system_score_gemma":0.00022729594,"threshold_uncertainty_score":0.0061243176},"labels":[],"label_agreement":null},{"id":"W2130691274","doi":"10.1677/erc.0.0100169","title":"Potential role of gonadotrophin-releasing hormone (GnRH)-I and GnRH-II in the ovary and ovarian cancer.","year":2003,"lang":"en","type":"review","venue":"Endocrine Related Cancer","topic":"Hypothalamic control of reproductive hormones","field":"Medicine","cited_by":76,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"College of Veterinary Medicine, Seoul National University; Research Institute for Veterinary Science, College of Veterinary Medicine, Seoul National University; Seoul National University; Canadian Institutes of Health Research; Dongguk University; Michael Smith Health Research BC","keywords":"Internal medicine; Autocrine signalling; Endocrinology; Ovary; Paracrine signalling; Gonadotropin-releasing hormone; Biology; Hypothalamus; Hormone; Receptor; Luteinizing hormone; Medicine","score_opus":0.015848395486196043,"score_gpt":0.30569808566234397,"score_spread":0.2898496901761479,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2130691274","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0003441347,0.99777466,0.00009567506,0.0002257337,0.00014220862,0.0000025785448,0.000007690709,0.000004229945,0.0014030776],"genre_scores_gemma":[0.0021411227,0.99563736,0.0002279897,0.00020807596,0.00015871061,0.0000044515523,0.000025810275,0.0000011654162,0.0015952504],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99991715,0.000014946015,0.000011896517,0.000013744146,0.00003403263,0.000008123613],"domain_scores_gemma":[0.99991775,0.000025367903,0.000017881719,0.0000026437817,0.000021070158,0.000015282638],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024396028,0.00047598567,0.0007212201,0.0013895354,0.00020884565,0.00054884766,0.0004901374,0.0006837776,0.0025034512],"category_scores_gemma":[0.0002639025,0.00015106211,0.00025048965,0.0013813378,0.0003317568,0.00071110704,0.00033682561,0.00064846314,0.0015211811],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011306609,0.000069005204,0.00088151114,0.00927792,0.00007281364,0.0022572828,0.00012412197,0.00033090578,0.007827559,0.0025668426,0.022307115,0.9541719],"study_design_scores_gemma":[0.00003235935,0.000180924,0.004324423,0.001879388,0.00012099043,0.015694633,0.00021342063,0.00012462339,0.001371731,0.0021892255,0.97384757,0.000020762069],"about_ca_topic_score_codex":0.0016008766,"about_ca_topic_score_gemma":0.00271335,"teacher_disagreement_score":0.0025034512,"about_ca_system_score_codex":0.00048131056,"about_ca_system_score_gemma":0.00079982745,"threshold_uncertainty_score":0.00837487},"labels":[],"label_agreement":null},{"id":"W2132323473","doi":"10.1677/erc-09-0004","title":"Antizyme is necessary for conversion of pancreatic tumor cells into glucagon-producing differentiated cells","year":2009,"lang":"en","type":"article","venue":"Endocrine Related Cancer","topic":"Pancreatic function and diabetes","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Public Health Agency of Canada","keywords":"Glucagon; Transfection; Cell culture; Pancreas; Biology; Ornithine decarboxylase antizyme; Cell; Molecular biology; Internal medicine; Chemistry; Ornithine decarboxylase; Insulin; Cell biology; Endocrinology; Biochemistry; Enzyme; Medicine","score_opus":0.01041442938834292,"score_gpt":0.27019991322642867,"score_spread":0.25978548383808575,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2132323473","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98886687,0.0030203732,0.0061458247,0.00012282585,0.00007461396,0.000022824306,0.00058975857,0.00015894906,0.0009979388],"genre_scores_gemma":[0.99325985,0.001014044,0.002121529,0.000045356715,0.000015227542,0.00003335657,0.0014755196,0.000048555103,0.0019865516],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9997348,0.00003357658,0.00003253187,0.00009234393,0.00006115855,0.000045625013],"domain_scores_gemma":[0.9995882,0.000074518925,0.00015220675,0.000046366233,0.00005092427,0.00008784076],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014112632,0.00037071423,0.00036581175,0.00023885987,0.00014520701,0.00051251944,0.00024690074,0.0003015366,0.0011953516],"category_scores_gemma":[0.00025474568,0.00019938605,0.00029323972,0.00017159525,0.000229431,0.00032524476,0.0002939227,0.0006011875,0.0007207745],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005591325,0.0000094137185,0.00031244403,0.000028370334,0.0000025948925,0.00006557438,0.000008723828,0.00001700039,0.9988513,0.000039565937,0.000017979586,0.0005911177],"study_design_scores_gemma":[0.000015155786,0.00012300756,0.012175084,0.0000077201385,0.000013658658,0.00061562815,0.00003534242,0.0005543975,0.9832886,0.000043285425,0.0031223446,0.0000056952636],"about_ca_topic_score_codex":0.00030788744,"about_ca_topic_score_gemma":0.00027212763,"teacher_disagreement_score":0.0011953516,"about_ca_system_score_codex":0.00031472708,"about_ca_system_score_gemma":0.00018858857,"threshold_uncertainty_score":0.003998816},"labels":[],"label_agreement":null},{"id":"W2135141157","doi":"10.1530/erc-14-0096","title":"Intratumoural inflammation and endocrine resistance in breast cancer","year":2014,"lang":"en","type":"review","venue":"Endocrine Related Cancer","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Victoria; Victoria General Hospital; University of British Columbia; BC Cancer Agency; University of Manitoba; CancerCare Manitoba","funders":"BC Cancer Agency; Canadian Cancer Society Research Institute; Canadian Institutes of Health Research; BC Cancer Foundation; CancerCare Manitoba Foundation; Cancer Research Institute","keywords":"Endocrine system; Breast cancer; Inflammation; Medicine; Estrogen receptor alpha; Estrogen receptor; Biomarker; Cancer; Estrogen; Oncology; Internal medicine; Cancer research; Biology; Hormone","score_opus":0.006683266483683017,"score_gpt":0.29257938735187233,"score_spread":0.28589612086818933,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2135141157","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00012028021,0.99869233,0.00007741524,0.00017483352,0.000112626156,0.0000025582808,0.000015063465,0.0000050593417,0.00079992006],"genre_scores_gemma":[0.000601361,0.9987029,0.000078054574,0.00009107802,0.000084298976,0.0000028179898,0.00001934562,7.679792e-7,0.00041940704],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998696,0.000021939366,0.000020524314,0.000021015843,0.00005332082,0.000013605414],"domain_scores_gemma":[0.999811,0.00007726801,0.000032396638,0.0000052023493,0.000053449505,0.00002075543],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034537716,0.0005164637,0.0008484599,0.0021548509,0.00026618538,0.0007917386,0.0004451743,0.0008288776,0.003715995],"category_scores_gemma":[0.0005242854,0.00022099815,0.00036743435,0.0022245676,0.00031194178,0.00088522903,0.0005847435,0.0011182895,0.0018445431],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007507551,0.000061721345,0.00035541833,0.018080484,0.00007766319,0.00029924628,0.000075180986,0.0002796135,0.002095461,0.0028954023,0.025587859,0.9501168],"study_design_scores_gemma":[0.000011610478,0.000083170096,0.0014518872,0.003725847,0.00010006792,0.0024121935,0.00008427367,0.00006963464,0.0005220768,0.0017665008,0.9897552,0.00001761763],"about_ca_topic_score_codex":0.0008892806,"about_ca_topic_score_gemma":0.001617345,"teacher_disagreement_score":0.003715995,"about_ca_system_score_codex":0.0005126428,"about_ca_system_score_gemma":0.0009748353,"threshold_uncertainty_score":0.012431204},"labels":[],"label_agreement":null},{"id":"W2136453695","doi":"10.1677/erc.1.01033","title":"Mechanism of gonadotropin-releasing hormone (GnRH)-I and -II-induced cell growth inhibition in ovarian cancer cells: role of the GnRH-I receptor and protein kinase C pathway","year":2006,"lang":"en","type":"article","venue":"Endocrine Related Cancer","topic":"Hypothalamic control of reproductive hormones","field":"Medicine","cited_by":61,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Child and Family Research Institute; University of British Columbia; BC Children's Hospital","funders":"Canadian Institutes of Health Research; Michael Smith Health Research BC","keywords":"Protein kinase C; Endocrinology; MAPK/ERK pathway; Internal medicine; Ovarian cancer; Gonadotropin-releasing hormone receptor; Gonadotropin-releasing hormone; Kinase; Cell growth; Biology; Signal transduction; Protein kinase A; Cancer research; Chemistry; Cell biology; Hormone; Cancer; Medicine; Luteinizing hormone; Biochemistry","score_opus":0.005134026798583379,"score_gpt":0.2058889019849654,"score_spread":0.20075487518638202,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2136453695","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94419616,0.036953576,0.008129964,0.0011213616,0.00038154222,0.0004735337,0.0012024913,0.00026798144,0.0072733318],"genre_scores_gemma":[0.9803991,0.0119783515,0.0017446667,0.00027958438,0.000053579086,0.00031327317,0.00066259305,0.000016058266,0.0045528696],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998795,0.000019640538,0.000010491369,0.000017911774,0.000033548404,0.000038979422],"domain_scores_gemma":[0.999951,0.0000068245854,0.000015436395,0.0000058516744,0.000009653531,0.000011249693],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014481942,0.00063746615,0.00042335453,0.00030562532,0.00021319347,0.00032938906,0.00034389127,0.00031970156,0.0011109366],"category_scores_gemma":[0.00008645916,0.0001683987,0.00055580563,0.0002179634,0.00024217743,0.00022100826,0.00022276909,0.00058744947,0.000359927],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004955506,0.00019425711,0.0006740001,0.00070583465,0.000037966853,0.00060934236,0.00005499177,0.0002258577,0.9883909,0.0006371068,0.00042952268,0.007544701],"study_design_scores_gemma":[0.00023500288,0.0010560879,0.020148804,0.000040537085,0.000085150314,0.0016389879,0.00012533499,0.002493592,0.964028,0.0002460924,0.0098840315,0.000018365852],"about_ca_topic_score_codex":0.00075024745,"about_ca_topic_score_gemma":0.0007977655,"teacher_disagreement_score":0.0011109366,"about_ca_system_score_codex":0.00041176056,"about_ca_system_score_gemma":0.00036079547,"threshold_uncertainty_score":0.0037164688},"labels":[],"label_agreement":null},{"id":"W2139143788","doi":"10.1677/erc-10-0091","title":"Mammalian target of rapamycin inhibition abrogates insulin-mediated mammary tumor progression in type 2 diabetes","year":2010,"lang":"en","type":"article","venue":"Endocrine Related Cancer","topic":"PI3K/AKT/mTOR signaling in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":39,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Oncosuisse; McGill University; Novartis Foundation; Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung; National Cancer Institute; National Science Foundation","keywords":"PI3K/AKT/mTOR pathway; Hyperinsulinemia; Mammary tumor; Endocrinology; Internal medicine; Insulin; Tumor progression; Cancer research; Type 2 diabetes; Biology; Cancer; Medicine; Diabetes mellitus; Breast cancer; Insulin resistance; Signal transduction; Cell biology","score_opus":0.0046876117734836725,"score_gpt":0.26061239493935145,"score_spread":0.2559247831658678,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2139143788","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9888221,0.0048824167,0.0017882744,0.00025892674,0.00024839502,0.000111940644,0.0008974313,0.00031658055,0.0026738632],"genre_scores_gemma":[0.987751,0.0051874495,0.0027176428,0.00022541289,0.00006484485,0.00019684446,0.0015176338,0.00006332786,0.0022757105],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9997836,0.000044261156,0.000034450644,0.000028840535,0.00004972663,0.000059231592],"domain_scores_gemma":[0.9998714,0.000018814742,0.00003944535,0.000013108791,0.000009788515,0.00004748226],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024188413,0.000622098,0.00062215433,0.00048603065,0.00017654218,0.000359714,0.00035270263,0.000365904,0.0012473245],"category_scores_gemma":[0.00013005824,0.00020969707,0.00044940924,0.00035145553,0.00020139321,0.00017970815,0.00020039143,0.001143802,0.00032516418],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023923402,0.00094246,0.0004017707,0.00015580696,0.000039085848,0.00013133006,0.000020731411,0.00028871195,0.9870843,0.00018007631,0.00032254038,0.008040822],"study_design_scores_gemma":[0.00051406975,0.010089231,0.016653305,0.000042792333,0.000118518044,0.00075375295,0.0000672053,0.003410219,0.9610095,0.00013457534,0.007180104,0.000026721715],"about_ca_topic_score_codex":0.0009176102,"about_ca_topic_score_gemma":0.0015864552,"teacher_disagreement_score":0.0012473245,"about_ca_system_score_codex":0.0002727289,"about_ca_system_score_gemma":0.00045207122,"threshold_uncertainty_score":0.0041726828},"labels":[],"label_agreement":null},{"id":"W2139242212","doi":"10.1677/erc-08-0056","title":"Vitamin D receptor polymorphisms (FokI, BsmI) and breast cancer risk: association replication in two case-control studies within French Canadian population","year":2008,"lang":"en","type":"article","venue":"Endocrine Related Cancer","topic":"Vitamin D Research Studies","field":"Medicine","cited_by":61,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University; Centre hospitalier universitaire de Québec; Université Laval; Hôpital Saint-François d'Assise","funders":"National Cancer Institute; Canadian Institutes of Health Research; Canadian Breast Cancer Research Alliance; Cancer Research Society","keywords":"FokI; Calcitriol receptor; Breast cancer; Odds ratio; Medicine; Oncology; Internal medicine; Vitamin D and neurology; Case-control study; Single-nucleotide polymorphism; Population; Genotype; Confidence interval; Gynecology; Cancer; Gastroenterology; Genetics; Biology; Polymorphism (computer science); Gene","score_opus":0.01626375204889504,"score_gpt":0.3246845836374833,"score_spread":0.3084208315885883,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2139242212","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98836285,0.006534554,0.0015840534,0.0002887638,0.00003847424,0.0003073514,0.0016643839,0.000038842023,0.0011807343],"genre_scores_gemma":[0.9939021,0.0017014517,0.0016652283,0.00014611265,0.000028198981,0.00020277551,0.001172457,0.000015692687,0.001166067],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.995178,0.0012941527,0.0004892844,0.0011809911,0.0012410838,0.00061654876],"domain_scores_gemma":[0.9926865,0.0019947956,0.0011991109,0.0010032447,0.0026931576,0.00042325276],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0060820435,0.0011376776,0.0012699419,0.0023356136,0.0025024274,0.0021306055,0.001458816,0.0012300314,0.0018752543],"category_scores_gemma":[0.013276712,0.0005428005,0.002353684,0.0033939823,0.0010339156,0.000300879,0.0007032932,0.0006596288,0.00016308296],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0027946967,0.0001443254,0.9724386,0.00057773065,0.0038780267,0.0009372862,0.0018245876,0.00023724379,0.0036469938,0.00025539252,0.0008787943,0.0123862745],"study_design_scores_gemma":[0.00037610755,0.00024695546,0.9927078,0.00008665538,0.0023146367,0.0006735762,0.00031971518,0.00022398037,0.000721468,0.0000623045,0.0022319858,0.00003475969],"about_ca_topic_score_codex":0.84928906,"about_ca_topic_score_gemma":0.8558104,"teacher_disagreement_score":0.15071094,"about_ca_system_score_codex":0.007577797,"about_ca_system_score_gemma":0.008334599,"threshold_uncertainty_score":0.30319697},"labels":[],"label_agreement":null},{"id":"W2139923838","doi":"10.1677/erc.1.01141","title":"Is oestrogen receptor- β a predictor of endocrine therapy responsiveness in human breast cancer?","year":2006,"lang":"en","type":"review","venue":"Endocrine Related Cancer","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":73,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"CancerCare Manitoba; University of Manitoba","funders":"Canadian Institutes of Health Research; Canadian Breast Cancer Research Alliance; Strong; CancerCare Manitoba Foundation; U.S. Department of Defense","keywords":"BETA (programming language); Breast cancer; Estrogen receptor alpha; Estrogen receptor beta; Endocrine system; Alpha (finance); Internal medicine; Estrogen receptor; Oncology; Oestrogen receptor; Medicine; Endocrinology; Human breast; Receptor; Cancer; Cancer research; Hormone","score_opus":0.016644800811905468,"score_gpt":0.33738130206538414,"score_spread":0.3207365012534787,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2139923838","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00012358458,0.99916506,0.00008055419,0.00026404922,0.00010796133,0.0000016701963,0.00001210147,0.0000026392179,0.00024244364],"genre_scores_gemma":[0.0012972236,0.99793756,0.00014267363,0.00016323935,0.0002237305,0.0000039879747,0.000023594068,9.948965e-7,0.00020692656],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99965,0.00007668134,0.00006803075,0.00007713262,0.00011116583,0.00001689991],"domain_scores_gemma":[0.9989901,0.00054190226,0.00015038061,0.0000239167,0.00023909118,0.000054562195],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001524851,0.0008396463,0.0027696062,0.0017342673,0.0001807823,0.0010562455,0.0012875232,0.0012325794,0.0018048879],"category_scores_gemma":[0.002070813,0.00031737806,0.00044043388,0.0022249338,0.0007673801,0.0012760339,0.00040554866,0.0014843958,0.0018322765],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024372588,0.000046902773,0.0021460503,0.009532109,0.0001880722,0.00026914987,0.00004096336,0.0002746977,0.00074603414,0.0012697278,0.01424094,0.97100157],"study_design_scores_gemma":[0.00013979146,0.0005401266,0.022052059,0.013614276,0.0012275873,0.008591438,0.00036587944,0.0005415886,0.0013206123,0.0063162073,0.9451877,0.000102690945],"about_ca_topic_score_codex":0.0020229358,"about_ca_topic_score_gemma":0.0016795739,"teacher_disagreement_score":0.0027696062,"about_ca_system_score_codex":0.0006992435,"about_ca_system_score_gemma":0.0010712015,"threshold_uncertainty_score":0.00806427},"labels":[],"label_agreement":null},{"id":"W2140724756","doi":"10.1677/erc-10-0030","title":"A phosphorylation code for oestrogen receptor-α predicts clinical outcome to endocrine therapy in breast cancer","year":2010,"lang":"en","type":"article","venue":"Endocrine Related Cancer","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":45,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; University of Manitoba","funders":"Canadian Institutes of Health Research; Cure Brain Cancer Foundation; CancerCare Manitoba Foundation","keywords":"Breast cancer; Tamoxifen; Oncology; Medicine; Internal medicine; Hazard ratio; Univariate analysis; Estrogen receptor; Multivariate analysis; Oestrogen receptor; Tissue microarray; Cancer; Confidence interval","score_opus":0.01599316687746645,"score_gpt":0.34936681173430245,"score_spread":0.333373644856836,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2140724756","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9994363,0.00028175136,0.00010781055,0.000020746642,0.0000058658497,0.0000020319721,0.000043831555,0.0000026263165,0.00009903032],"genre_scores_gemma":[0.9996481,0.00008319332,0.00007687985,0.0000060815255,0.000008300308,0.0000021106755,0.00010018774,8.297383e-7,0.00007429149],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998745,0.000050064158,0.000011681373,0.000022196162,0.000021721145,0.000019833275],"domain_scores_gemma":[0.99925154,0.0002889263,0.00023783252,0.000051514617,0.0000479313,0.0001222283],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036800155,0.00022465445,0.00024704932,0.00035678523,0.00014931937,0.0003000743,0.00019116227,0.000280851,0.00075512414],"category_scores_gemma":[0.0014439964,0.00012720244,0.00030689573,0.0003637076,0.00019649809,0.00014682711,0.00019822747,0.00033625518,0.00022770371],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010999978,0.000046601424,0.98910356,0.000015810883,0.0001109311,0.000094597526,0.000027621178,0.00025772778,0.004707397,0.000012928563,0.00008281562,0.004440139],"study_design_scores_gemma":[0.000019054276,0.00021838536,0.99727005,0.000003958874,0.00007909416,0.0005520809,0.0000383395,0.0011084328,0.0005331888,0.00006107233,0.000113260205,0.0000030708259],"about_ca_topic_score_codex":0.00072733336,"about_ca_topic_score_gemma":0.0011097103,"teacher_disagreement_score":0.00075512414,"about_ca_system_score_codex":0.000116892814,"about_ca_system_score_gemma":0.00011019344,"threshold_uncertainty_score":0.002526164},"labels":[],"label_agreement":null},{"id":"W2142338868","doi":"10.1677/erc-07-0126","title":"Cytological Ki-67 in pancreatic endocrine tumours: an opportunity for pre-operative grading","year":2008,"lang":"en","type":"article","venue":"Endocrine Related Cancer","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":88,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pancreas Centre (Canada)","funders":"","keywords":"Grading (engineering); Cytology; Medicine; Fine needle aspiration cytology; Pathology; Nuclear medicine; Radiology; Biology","score_opus":0.08607067883810446,"score_gpt":0.4237927335452021,"score_spread":0.3377220547070976,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2142338868","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9948088,0.0012576585,0.002973515,0.000074438045,0.000024610561,0.000019578145,0.000045585068,0.00003226023,0.0007635348],"genre_scores_gemma":[0.9982823,0.00018176575,0.0013221161,0.000019849565,0.000014435014,0.000008870318,0.00006303746,0.000004545806,0.00010301576],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987186,0.0005398277,0.00022455484,0.00012266582,0.0003004701,0.000093879265],"domain_scores_gemma":[0.98756135,0.0071687098,0.0014739485,0.0012845125,0.001973349,0.0005381518],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0033449586,0.00033149947,0.00039353356,0.0018715612,0.0003434139,0.0008361888,0.00044128933,0.00045137474,0.0010166246],"category_scores_gemma":[0.02036079,0.00028911236,0.00022980625,0.00056653464,0.0007225203,0.00081742054,0.0006585025,0.00071117276,0.0004416018],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00033500008,0.00002613772,0.97979707,0.000031978583,0.000018865061,0.0001939737,0.00020792287,0.00012768702,0.0057885037,0.000031749034,0.0000755115,0.013365735],"study_design_scores_gemma":[0.00001858718,0.0004408237,0.98520213,0.000038509817,0.000054859538,0.0031931065,0.000563199,0.0021849573,0.007557942,0.00017925758,0.0005468343,0.000019839195],"about_ca_topic_score_codex":0.00089668034,"about_ca_topic_score_gemma":0.0017263768,"teacher_disagreement_score":0.0033449586,"about_ca_system_score_codex":0.00021988,"about_ca_system_score_gemma":0.00023570147,"threshold_uncertainty_score":0.017690003},"labels":[],"label_agreement":null},{"id":"W2143541838","doi":"10.1677/erc.1.00896","title":"Gonadotropins upregulate the epidermal growth factor receptor through activation of mitogen-activated protein kinases and phosphatidyl-inositol-3-kinase in human ovarian surface epithelial cells","year":2005,"lang":"en","type":"article","venue":"Endocrine Related Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":75,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Canadian Institutes of Health Research; Michael Smith Health Research BC","keywords":"Epidermal growth factor; Endocrinology; Biology; Kinase; Internal medicine; Epidermal growth factor receptor; Cell culture; LY294002; Protein kinase A; Growth factor; Luteinizing hormone; Receptor; Cell biology; Cancer research; Hormone; Phosphatidylinositol; Medicine","score_opus":0.015184780583373232,"score_gpt":0.2784467402773903,"score_spread":0.26326195969401706,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2143541838","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9894554,0.005220854,0.0005337245,0.00010457709,0.000053619704,0.00003359588,0.0004942183,0.00006252783,0.0040413914],"genre_scores_gemma":[0.98897785,0.0039164056,0.0005137317,0.00013110912,0.000023450995,0.00003569761,0.0012437346,0.0000128582615,0.005145135],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999471,0.0000060833213,0.0000050982917,0.0000070163646,0.000017447925,0.000017347875],"domain_scores_gemma":[0.99996734,0.000007709977,0.0000060092448,0.00000571126,0.000005183768,0.000008148672],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000043657616,0.00021792724,0.0001388633,0.0001981211,0.0000900595,0.00025305478,0.000058277146,0.000101929145,0.0013707412],"category_scores_gemma":[0.00008424254,0.00010052249,0.0002643767,0.00016034128,0.00010161618,0.00010597356,0.00010930838,0.00022120771,0.00039633975],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014081354,0.000035757246,0.0006850075,0.0000363104,0.000006827339,0.00014961703,0.000025678166,0.000020176503,0.9970457,0.00005556538,0.00011605828,0.001682536],"study_design_scores_gemma":[0.0000737732,0.0007505049,0.09021423,0.000017512079,0.000051060182,0.0009693203,0.00020036216,0.0006318463,0.89353144,0.00012613747,0.013423398,0.000010348673],"about_ca_topic_score_codex":0.0015264278,"about_ca_topic_score_gemma":0.0016017411,"teacher_disagreement_score":0.0015264278,"about_ca_system_score_codex":0.00013762155,"about_ca_system_score_gemma":0.00014018707,"threshold_uncertainty_score":0.004585564},"labels":[],"label_agreement":null},{"id":"W2144160519","doi":"10.1530/erc-10-0303","title":"Changes in insulin resistance indicators, IGFs, and adipokines in a year-long trial of aerobic exercise in postmenopausal women","year":2011,"lang":"en","type":"article","venue":"Endocrine Related Cancer","topic":"Growth Hormone and Insulin-like Growth Factors","field":"Medicine","cited_by":125,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Alberta; University of Calgary; Dalhousie University; University of British Columbia; Alberta Health Services","funders":"Fondation pour la Recherche Médicale; Canada Research Chairs; Canadian Institutes of Health Research; Canadian Breast Cancer Research Alliance; Alberta Cancer Foundation","keywords":"Medicine; Adiponectin; IGFBP3; Adipokine; Insulin resistance; Leptin; Internal medicine; Aerobic exercise; Endocrinology; Homeostatic model assessment; Breast cancer; Insulin; Randomized controlled trial; Confidence interval; Cancer; Obesity; Receptor","score_opus":0.013378768863917452,"score_gpt":0.2516330503033222,"score_spread":0.23825428143940477,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2144160519","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9973232,0.0018653169,0.00008678322,0.00009188559,0.00006124601,0.00017825962,0.00010334925,0.000015042542,0.00027499336],"genre_scores_gemma":[0.9973961,0.00092386536,0.0002689417,0.00022126993,0.00009450245,0.00036105103,0.00021923165,0.0000020325133,0.0005128737],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.999521,0.0002283307,0.000048145415,0.000072049865,0.0000535377,0.00007702087],"domain_scores_gemma":[0.99949956,0.00009843612,0.00011608048,0.000051388615,0.000041491818,0.00019308875],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00154566,0.0005833096,0.0014977625,0.00020061835,0.00032803306,0.00044526323,0.00036643512,0.0007748492,0.00092756207],"category_scores_gemma":[0.0012436332,0.0003971953,0.0009552708,0.00032352222,0.00039378647,0.00025022324,0.00025523847,0.0009757599,0.00015843894],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.957542,0.008172598,0.008775492,0.0003247141,0.0019102007,0.000034191406,0.00007878319,0.00020920581,0.003922888,0.000030862742,0.00028383394,0.018715212],"study_design_scores_gemma":[0.55855364,0.2894973,0.14505318,0.00010857954,0.0032487775,0.00006276765,0.000077768025,0.0009924241,0.001231104,0.00013844043,0.0010064675,0.000029548675],"about_ca_topic_score_codex":0.0036606062,"about_ca_topic_score_gemma":0.006874207,"teacher_disagreement_score":0.0036606062,"about_ca_system_score_codex":0.00043042883,"about_ca_system_score_gemma":0.0008004367,"threshold_uncertainty_score":0.0081743},"labels":[],"label_agreement":null},{"id":"W2144184261","doi":"10.1530/erc-12-0003","title":"Epigenetic modification and cancer: mark or stamp?","year":2012,"lang":"en","type":"letter","venue":"Endocrine Related Cancer","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Epigenetics; Cancer; Biology; Genetics; Computational biology; Gene","score_opus":0.023702000307412367,"score_gpt":0.308320928211024,"score_spread":0.28461892790361165,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2144184261","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00016434565,0.014270973,0.00019675675,0.9626976,0.02194701,0.0000026722755,0.0000136621065,0.000018875584,0.00068815285],"genre_scores_gemma":[0.00460987,0.01602536,0.0004011596,0.85850203,0.11672711,0.000018481802,0.000017655197,0.000017300115,0.0036809738],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9967823,0.0010795689,0.00032633674,0.0005785133,0.0009755073,0.000257702],"domain_scores_gemma":[0.9913566,0.0055552544,0.0006483929,0.0005231293,0.0011205864,0.0007959671],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00526206,0.0010836957,0.0018364795,0.00069915527,0.0024360465,0.0026861452,0.0026166765,0.027989643,0.004346346],"category_scores_gemma":[0.017040724,0.00054153474,0.000993538,0.0006847986,0.010669405,0.007994753,0.0026323826,0.03484421,0.0038358874],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016291009,0.000052346422,0.00054437976,0.0004196763,0.00004983392,0.0024719215,0.00042484002,0.000120632314,0.00111285,0.02039487,0.92142856,0.05281718],"study_design_scores_gemma":[0.00009406036,0.00013810559,0.00091340696,0.00042818158,0.00003377674,0.004112343,0.0006099818,0.00028694683,0.00053519127,0.066210024,0.9265617,0.00007624638],"about_ca_topic_score_codex":0.0018696452,"about_ca_topic_score_gemma":0.0029656137,"teacher_disagreement_score":0.027989643,"about_ca_system_score_codex":0.0037101458,"about_ca_system_score_gemma":0.0021298514,"threshold_uncertainty_score":0.027828753},"labels":[],"label_agreement":null},{"id":"W2144500191","doi":"10.1677/erc-08-0038","title":"Metformin attenuates the stimulatory effect of a high-energy diet on in vivo LLC1 carcinoma growth","year":2008,"lang":"en","type":"article","venue":"Endocrine Related Cancer","topic":"Metabolism, Diabetes, and Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":184,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"","keywords":"Metformin; Hyperinsulinemia; Internal medicine; Endocrinology; Medicine; Cancer; Insulin resistance; Insulin; AMPK; Lewis lung carcinoma; Biology; Kinase; Protein kinase A; Metastasis","score_opus":0.005693660719074212,"score_gpt":0.2290040648496136,"score_spread":0.2233104041305394,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2144500191","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9985147,0.0005377874,0.00020733412,0.000069606576,0.000021937049,0.000010766837,0.00011360171,0.000019577605,0.00050465815],"genre_scores_gemma":[0.99594396,0.0008544914,0.00065466965,0.00007003384,0.000016864207,0.00003719175,0.000398766,0.000014632746,0.00200932],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99985087,0.00003883749,0.000009632646,0.000015519749,0.000037961705,0.0000472169],"domain_scores_gemma":[0.9997954,0.00003778955,0.00005904144,0.000023233688,0.000015594002,0.000069059686],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001737521,0.00037492125,0.00029004965,0.00026399182,0.00013039973,0.00021969872,0.00017089918,0.00026058787,0.001394755],"category_scores_gemma":[0.00014478478,0.00014771713,0.0002772665,0.00013539084,0.00021657193,0.00016399051,0.0001867067,0.00072482816,0.00020765865],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013615716,0.00040747254,0.0005752488,0.0000296709,0.000008967601,0.000045898643,0.000011577083,0.000090627196,0.9957754,0.000054308766,0.000051624822,0.0015877078],"study_design_scores_gemma":[0.0001584,0.006476015,0.012200636,0.000009815596,0.000032108197,0.00016111077,0.00004546453,0.000978467,0.9784854,0.000060990234,0.0013830025,0.000008624875],"about_ca_topic_score_codex":0.00070247124,"about_ca_topic_score_gemma":0.0017048524,"teacher_disagreement_score":0.001394755,"about_ca_system_score_codex":0.00024809595,"about_ca_system_score_gemma":0.00023572752,"threshold_uncertainty_score":0.004665911},"labels":[],"label_agreement":null},{"id":"W2144800090","doi":"10.1677/erc-08-0012","title":"Pituitary tumor-transforming gene in endocrine and other neoplasms: a review and update","year":2008,"lang":"en","type":"review","venue":"Endocrine Related Cancer","topic":"Pituitary Gland Disorders and Treatments","field":"Medicine","cited_by":127,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital","funders":"Jarislowsky Foundation","keywords":"Cancer research; Securin; Biology; Endocrine system; Pituitary tumors; Thyroid; Angiogenesis; Prostate cancer; Cancer; Pathology; Cell cycle; Internal medicine; Medicine; Endocrinology; Hormone","score_opus":0.020814743753227685,"score_gpt":0.32416638355487176,"score_spread":0.3033516398016441,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2144800090","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00014261913,0.9982615,0.00012609125,0.00021373984,0.0003407582,0.000004954859,0.000027968308,0.00000905828,0.00087326486],"genre_scores_gemma":[0.0005515827,0.9976427,0.00036546786,0.00023571726,0.00037174925,0.000008179727,0.00006063277,0.000002296862,0.000761614],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998267,0.000030456771,0.00003941993,0.000030634,0.000058703274,0.000013989186],"domain_scores_gemma":[0.9995559,0.00021117431,0.00006978196,0.0000122785805,0.00010141177,0.00004938137],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00048846274,0.0010851771,0.0018608317,0.0030944718,0.00029164966,0.0009083716,0.0010232828,0.0010919388,0.0045257476],"category_scores_gemma":[0.0007174549,0.0003117658,0.00048217774,0.0033864519,0.00039178866,0.0015524568,0.00045216476,0.0013542547,0.0030440977],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009513751,0.00010267657,0.00032567902,0.013049574,0.00010528181,0.00089327706,0.000062980005,0.0002605313,0.0013323684,0.00094782386,0.050014194,0.93281037],"study_design_scores_gemma":[0.000025552845,0.00009163436,0.0012107884,0.0025918253,0.0001983448,0.005301972,0.00006582468,0.00006999527,0.00033322666,0.0006017107,0.98948854,0.000020520505],"about_ca_topic_score_codex":0.0015015211,"about_ca_topic_score_gemma":0.002916941,"teacher_disagreement_score":0.0045257476,"about_ca_system_score_codex":0.0005400062,"about_ca_system_score_gemma":0.0010280958,"threshold_uncertainty_score":0.015140116},"labels":[],"label_agreement":null},{"id":"W2148311665","doi":"10.1677/erc-09-0002","title":"Expression of the melanoma-associated antigen is associated with progression of human thyroid cancer","year":2009,"lang":"en","type":"article","venue":"Endocrine Related Cancer","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Ontario Institute for Cancer Research","funders":"Canadian Institutes of Health Research; Canadian Breast Cancer Research Alliance","keywords":"Thyroid cancer; Tissue microarray; Immunohistochemistry; Pathology; Cancer; Thyroid; Cancer research; Biology; Thyroid carcinoma; Medicine; Cytoplasm; Internal medicine","score_opus":0.009335676480627069,"score_gpt":0.2792343146878075,"score_spread":0.26989863820718046,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2148311665","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.997282,0.00074671523,0.00068564765,0.000029208231,0.0000042095744,0.000011202571,0.00041195904,0.000036959194,0.0007921401],"genre_scores_gemma":[0.99814904,0.00022453531,0.0004615739,0.000011909051,0.0000040769446,0.000010814234,0.00054806046,0.0000052909636,0.0005848582],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99988735,0.000018445164,0.0000104829,0.000027270766,0.000039121056,0.000017350694],"domain_scores_gemma":[0.9996648,0.000055498214,0.00012706745,0.000027139242,0.00006516944,0.00006039795],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017979846,0.00010095698,0.00014973427,0.00063878734,0.00020556887,0.00029603162,0.00006723642,0.00015379583,0.0010014653],"category_scores_gemma":[0.00050566136,0.00008251935,0.00012648772,0.00059976336,0.00014113938,0.00012521828,0.00014878044,0.00027835002,0.00021158233],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00072569627,0.000063918545,0.289847,0.00006556501,0.000056833527,0.00034460705,0.00015569024,0.00018999312,0.6991778,0.00011594768,0.00027007074,0.008986866],"study_design_scores_gemma":[0.0000059563463,0.00017678349,0.9705081,0.000002826617,0.00002692496,0.00080660253,0.00006625235,0.00046885136,0.026605807,0.00009058896,0.001236678,0.0000046965415],"about_ca_topic_score_codex":0.0012669486,"about_ca_topic_score_gemma":0.0011343759,"teacher_disagreement_score":0.0012669486,"about_ca_system_score_codex":0.00020252858,"about_ca_system_score_gemma":0.00016994985,"threshold_uncertainty_score":0.0033502579},"labels":[],"label_agreement":null},{"id":"W2148665009","doi":"10.1677/erc.1.01149","title":"Insulin-like growth factor-I, its binding proteins (IGFBP-1 and IGFBP-3), and growth hormone and breast cancer risk in The Nurses Health Study II","year":2006,"lang":"en","type":"article","venue":"Endocrine Related Cancer","topic":"Growth Hormone and Insulin-like Growth Factors","field":"Medicine","cited_by":139,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"National Cancer Institute","keywords":"Breast cancer; Insulin-like growth factor-binding protein; Insulin-like growth factor; Growth hormone; Growth factor; Internal medicine; Medicine; Hormone; Oncology; Cancer; Endocrinology; Receptor","score_opus":0.011655934283273857,"score_gpt":0.2753151585177875,"score_spread":0.2636592242345136,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2148665009","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9981774,0.00094207266,0.00016451479,0.0000637953,0.000020688954,0.000013956883,0.00036192237,0.0000025633194,0.00025310507],"genre_scores_gemma":[0.99810445,0.00044896555,0.00033998888,0.000055432523,0.000026924989,0.000028931978,0.000590142,0.0000025686672,0.00040267163],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99898726,0.00043609584,0.00008197812,0.00018222851,0.00020962594,0.00010284312],"domain_scores_gemma":[0.99839634,0.00042589256,0.0005423247,0.00018356924,0.00018509635,0.00026674598],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021154296,0.00031420813,0.0003587214,0.00048317868,0.00030484164,0.0006091787,0.00039745192,0.00042712115,0.0005447782],"category_scores_gemma":[0.005412398,0.00045545958,0.00052013714,0.00056156894,0.00028415903,0.0002457764,0.0004582832,0.00055396726,0.000111339345],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00047543074,0.000034716093,0.998018,0.000011574808,0.0001322058,0.0000677862,0.00006031076,0.00003664101,0.00017584211,0.00002498016,0.00013477294,0.0008277556],"study_design_scores_gemma":[0.000044793996,0.000104265244,0.99898106,0.000011164696,0.00007438436,0.00016635643,0.000054433687,0.00024072465,0.00005101249,0.00003541287,0.00023290527,0.000003460948],"about_ca_topic_score_codex":0.023725247,"about_ca_topic_score_gemma":0.017958438,"teacher_disagreement_score":0.023725247,"about_ca_system_score_codex":0.00041252436,"about_ca_system_score_gemma":0.00056351424,"threshold_uncertainty_score":0.047174275},"labels":[],"label_agreement":null},{"id":"W2149440394","doi":"10.1530/erc-10-0162","title":"A critical evaluation of the role of aromatase inhibitors as adjuvant therapy for postmenopausal women with breast cancer","year":2011,"lang":"en","type":"review","venue":"Endocrine Related Cancer","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Aromatase; Adjuvant; Breast cancer; Oncology; Adjuvant therapy; Internal medicine; Disease; Aromatase inhibitor; Postmenopausal women; Hormone therapy; Medical prescription; Cancer; Gynecology; Pharmacology","score_opus":0.01308848153215701,"score_gpt":0.32818383722372046,"score_spread":0.31509535569156344,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2149440394","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00005218347,0.998796,0.000048816004,0.00041649365,0.00022157478,0.0000018367529,0.0000056519243,0.0000023147893,0.00045527844],"genre_scores_gemma":[0.00034623957,0.99864763,0.00011842606,0.00036033706,0.00026049375,0.0000037750824,0.000011147811,9.678363e-7,0.00025100991],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9996841,0.000078438105,0.000053188694,0.0000445514,0.00011896678,0.000020892554],"domain_scores_gemma":[0.9990395,0.00052569114,0.00009166266,0.000024351735,0.00026053758,0.000058134563],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014117439,0.00082183804,0.0014844673,0.0018701401,0.0003334739,0.0010318373,0.0010156275,0.0015357594,0.002223205],"category_scores_gemma":[0.001839734,0.00031146867,0.00050134846,0.0020262434,0.00065081497,0.0018709307,0.00058333325,0.0023427524,0.0014118301],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000112419424,0.000057535413,0.00013743105,0.015165547,0.00008391488,0.00027838247,0.000063418134,0.0002586844,0.0010040266,0.003709277,0.04797289,0.9311566],"study_design_scores_gemma":[0.00003541958,0.00010612977,0.0006281274,0.005034822,0.000117425,0.0013800801,0.00006396963,0.0000732286,0.0002676589,0.0015547883,0.99072266,0.000015847341],"about_ca_topic_score_codex":0.0012257869,"about_ca_topic_score_gemma":0.0023684967,"teacher_disagreement_score":0.002223205,"about_ca_system_score_codex":0.0009140722,"about_ca_system_score_gemma":0.001411711,"threshold_uncertainty_score":0.0074661374},"labels":[],"label_agreement":null},{"id":"W2151378093","doi":"10.1677/erc-10-0073","title":"Suppression of relaxin receptor RXFP1 decreases prostate cancer growth and metastasis","year":2010,"lang":"en","type":"article","venue":"Endocrine Related Cancer","topic":"Pregnancy-related medical research","field":"Medicine","cited_by":82,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"Natural Sciences and Engineering Research Council of Canada; China Scholarship Council; University of Texas Health Science Center at Houston; National Cancer Institute; Ovarian Cancer Research Fund","keywords":"Prostate cancer; LNCaP; Cancer research; Downregulation and upregulation; Metastasis; Small interfering RNA; Cell growth; Prostate; Medicine; Cancer cell; Cancer; Gene silencing; Androgen receptor; Internal medicine; Endocrinology; Biology; Cell culture; Transfection","score_opus":0.011766659951580157,"score_gpt":0.3315982691057275,"score_spread":0.3198316091541473,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2151378093","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99094594,0.0036373977,0.002507869,0.00024546945,0.00005513719,0.00004876794,0.00059372035,0.00032302865,0.001642622],"genre_scores_gemma":[0.9914688,0.0019745445,0.001954516,0.00009322543,0.000014032194,0.00007412511,0.0008197097,0.000041018586,0.0035600401],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998265,0.00002558087,0.000015063884,0.000035674933,0.000047893744,0.000049386166],"domain_scores_gemma":[0.9999,0.000015868127,0.000029653937,0.000008768497,0.000012507839,0.00003322889],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016991193,0.0003713198,0.00040312708,0.0002758124,0.00012149692,0.00024283685,0.00023273386,0.00029498103,0.001412041],"category_scores_gemma":[0.00010764416,0.00017005342,0.00032590466,0.00017314745,0.00019786021,0.00015581305,0.0001323815,0.0006875051,0.00030874577],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001226353,0.000051580428,0.000091190195,0.000045470017,0.0000070503797,0.000020693524,0.000008925197,0.00005434461,0.99838924,0.00003735093,0.000086425534,0.0010852402],"study_design_scores_gemma":[0.000043967608,0.0010544138,0.004686089,0.00000578777,0.000043180815,0.00019267717,0.000029499039,0.0014219927,0.98970175,0.00002431454,0.002789781,0.000006512195],"about_ca_topic_score_codex":0.001093258,"about_ca_topic_score_gemma":0.0016660034,"teacher_disagreement_score":0.001412041,"about_ca_system_score_codex":0.00024446414,"about_ca_system_score_gemma":0.00034344944,"threshold_uncertainty_score":0.0047237277},"labels":[],"label_agreement":null},{"id":"W2151995827","doi":"10.1677/erc-10-0070","title":"Clinical significance of estrogen receptor phosphorylation","year":2010,"lang":"en","type":"review","venue":"Endocrine Related Cancer","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":136,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"Canadian Institutes of Health Research","keywords":"Phosphorylation; Estrogen receptor; Estrogen; Estrogen receptor beta; Chemistry; Cancer research; Cell biology; Medicine; Biology; Internal medicine; Breast cancer; Cancer","score_opus":0.02065479380838157,"score_gpt":0.3631965065155283,"score_spread":0.34254171270714673,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2151995827","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00017338466,0.9972344,0.00008727729,0.0003929949,0.00016423386,0.0000030711494,0.000030048472,0.0000049159457,0.001909693],"genre_scores_gemma":[0.0020593,0.9957333,0.00012105048,0.0003508164,0.0002616646,0.0000065332447,0.00006535735,0.0000020916484,0.0013998506],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99977845,0.000047166544,0.00003406317,0.00004712001,0.000074287076,0.000018962246],"domain_scores_gemma":[0.9996829,0.00016038906,0.0000385526,0.0000096443,0.00008417626,0.000024357336],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00053328805,0.00057511823,0.0011817316,0.001355614,0.0001608914,0.00093809416,0.0005969828,0.0009336638,0.0033551524],"category_scores_gemma":[0.0010297411,0.00017142453,0.00025044402,0.001230002,0.00048763605,0.00082351285,0.0004723404,0.0012400664,0.0028167926],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011123122,0.000030803043,0.00059285056,0.0062812683,0.000054728123,0.0004009863,0.00003869607,0.00023021676,0.0014832737,0.0037738285,0.041141134,0.9458609],"study_design_scores_gemma":[0.000026117676,0.000067004556,0.0018463396,0.002298905,0.00006545383,0.003529633,0.000056375997,0.00007071174,0.0007417707,0.0021747563,0.9891043,0.000018613058],"about_ca_topic_score_codex":0.0010667223,"about_ca_topic_score_gemma":0.0014879105,"teacher_disagreement_score":0.0033551524,"about_ca_system_score_codex":0.0006575606,"about_ca_system_score_gemma":0.00073978124,"threshold_uncertainty_score":0.011224091},"labels":[],"label_agreement":null},{"id":"W2154021120","doi":"10.1530/erc-15-0243","title":"Effects of exercise dose on endogenous estrogens in postmenopausal women: a randomized trial","year":2015,"lang":"en","type":"article","venue":"Endocrine Related Cancer","topic":"Cancer Risks and Factors","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Alberta Cancer Foundation; University of Alberta; University of Calgary; Alberta Health Services","funders":"Alberta Innovates; Canada Research Chairs; Alberta Cancer Foundation; Eli Lilly and Company","keywords":"Medicine; Estrone; Sex hormone-binding globulin; Breast cancer; Randomized controlled trial; Internal medicine; Quartile; Biomarker; Aerobic exercise; Endocrinology; Estrogen; Cancer; Hormone; Androgen; Confidence interval; Biology","score_opus":0.020789948027370313,"score_gpt":0.2969840270326952,"score_spread":0.2761940790053249,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2154021120","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95695823,0.016406713,0.0017914538,0.0029305043,0.0024423476,0.013853914,0.0014704097,0.0003229347,0.003823565],"genre_scores_gemma":[0.96510005,0.004041661,0.0035266117,0.0026545448,0.0011795575,0.018958531,0.00080779695,0.000041226944,0.0036900728],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9945857,0.003786929,0.00038955788,0.00064858084,0.0002596808,0.0003296004],"domain_scores_gemma":[0.99625516,0.0018003772,0.0008405954,0.0003742957,0.00021584013,0.0005137732],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0057754554,0.00206054,0.0044027623,0.00069379486,0.00068463705,0.0013967999,0.0012453141,0.004223785,0.0086713405],"category_scores_gemma":[0.009119034,0.00081869855,0.0033900624,0.00069982756,0.0018241196,0.0014235141,0.00085077854,0.0031488244,0.0010172355],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9902194,0.0021425032,0.00032928045,0.000514188,0.0012986293,0.000016445929,0.000026274503,0.00011703608,0.00027028046,0.000100422665,0.0002641597,0.0047013327],"study_design_scores_gemma":[0.9765464,0.02119357,0.0006093759,0.00006487166,0.0008016763,0.000011452843,0.000010745241,0.00019624156,0.000091468784,0.00020851252,0.00025775473,0.000007894051],"about_ca_topic_score_codex":0.0015441388,"about_ca_topic_score_gemma":0.0016620925,"teacher_disagreement_score":0.0086713405,"about_ca_system_score_codex":0.001210536,"about_ca_system_score_gemma":0.0014889345,"threshold_uncertainty_score":0.030543864},"labels":[],"label_agreement":null},{"id":"W2156010365","doi":"10.1677/erc-06-0045","title":"Critical assessment of new risk factors for breast cancer: considerations for development of an improved risk prediction model","year":2007,"lang":"en","type":"review","venue":"Endocrine Related Cancer","topic":"Cancer Risks and Factors","field":"Medicine","cited_by":202,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research","funders":"","keywords":"Breast cancer; Medicine; Raloxifene; Tamoxifen; Family history; Gynecology; Risk factor; Oncology; Prospective cohort study; Risk assessment; Menopause; Obstetrics; Cancer; Internal medicine","score_opus":0.08700715479760872,"score_gpt":0.44594959239450804,"score_spread":0.3589424375968993,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2156010365","genre_codex":"methods","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.06001293,0.007999498,0.9115033,0.013805893,0.000397026,0.0013242735,0.00086645,0.000946379,0.003144269],"genre_scores_gemma":[0.41297182,0.0051217806,0.57313824,0.0019004497,0.0010580596,0.0015444718,0.001981885,0.00012832893,0.002154984],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.9948489,0.0037725556,0.0003917248,0.0003375731,0.00052577903,0.00012353965],"domain_scores_gemma":[0.9691525,0.025913814,0.00083476584,0.0006637203,0.0029433386,0.00049193564],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.020857234,0.0018929238,0.0032745975,0.0025972442,0.00060600607,0.003043445,0.0021045352,0.0012477356,0.0028462086],"category_scores_gemma":[0.05936373,0.0007568312,0.0013896432,0.001024204,0.0005287311,0.0019479295,0.0015645154,0.0027352585,0.00060972583],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019081729,0.0008382153,0.17582667,0.0010166494,0.0013513473,0.0015096035,0.00042907693,0.37490016,0.0021458576,0.014335957,0.017210422,0.40852776],"study_design_scores_gemma":[0.00011681566,0.00030538513,0.009111954,0.0003328292,0.0003380644,0.00029315994,0.00015236143,0.9696735,0.00037056097,0.015469719,0.0037599285,0.00007567569],"about_ca_topic_score_codex":0.0096112,"about_ca_topic_score_gemma":0.010937967,"teacher_disagreement_score":0.020857234,"about_ca_system_score_codex":0.0009961112,"about_ca_system_score_gemma":0.003108178,"threshold_uncertainty_score":0.11030489},"labels":[],"label_agreement":null},{"id":"W2157523573","doi":"10.1530/erc-12-0211","title":"Case–control study of markers of insulin resistance and endometrial cancer risk","year":2012,"lang":"en","type":"article","venue":"Endocrine Related Cancer","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":50,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Alberta; University of Calgary; Alberta Health Services","funders":"Canadian Institutes of Health Research; National Cancer Institute; Alberta Heritage Foundation for Medical Research; Fondation pour la Recherche Médicale; Canada Research Chairs","keywords":"Endometrial cancer; Insulin resistance; Medicine; Adiponectin; Internal medicine; Hyperinsulinemia; Leptin; Endocrinology; Population; Homeostatic model assessment; Insulin; Obesity; Cancer","score_opus":0.017544530778491357,"score_gpt":0.30623233527043286,"score_spread":0.28868780449194154,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2157523573","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.997352,0.0009611923,0.00043662605,0.000055792327,0.000016100572,0.00007102293,0.0003861192,0.000009808125,0.00071131624],"genre_scores_gemma":[0.99848515,0.00023137161,0.0003334243,0.00003752018,0.0000118818825,0.0000373908,0.0004099271,0.0000025995603,0.00045076807],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99844414,0.00047732092,0.0001135953,0.0004026215,0.00038057557,0.00018189926],"domain_scores_gemma":[0.9981906,0.00034040934,0.00043288636,0.00033466725,0.0004481778,0.0002532685],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012106668,0.00030858832,0.00052078126,0.0009952119,0.0009259652,0.0006196384,0.00071041816,0.0004843592,0.0012970003],"category_scores_gemma":[0.0042200624,0.0005171874,0.00044656772,0.0018635676,0.0004372073,0.00017745995,0.00031685893,0.00055565656,0.00016277908],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00037300898,0.000057349003,0.99667585,0.000014401234,0.0002956645,0.00030263214,0.00012600566,0.000039909573,0.0004182611,0.000052123825,0.00022154475,0.0014231969],"study_design_scores_gemma":[0.00004645547,0.00008815379,0.9986926,0.0000062262447,0.00010829357,0.00036360894,0.000065337255,0.00015663,0.00004205456,0.000023400393,0.0004033247,0.000003863881],"about_ca_topic_score_codex":0.23031226,"about_ca_topic_score_gemma":0.16798721,"teacher_disagreement_score":0.23031226,"about_ca_system_score_codex":0.0016738479,"about_ca_system_score_gemma":0.0011241533,"threshold_uncertainty_score":0.45794338},"labels":[],"label_agreement":null},{"id":"W2158435543","doi":"10.1530/erc-10-0235","title":"Decreased progesterone receptor isoform expression in luteal phase fallopian tube epithelium and high-grade serous carcinoma","year":2011,"lang":"en","type":"article","venue":"Endocrine Related Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; University of Toronto; Mount Sinai Hospital; Lunenfeld-Tanenbaum Research Institute","funders":"Institute of Gender and Health; Canadian Institutes of Health Research; University Health Network; U.S. Department of Defense","keywords":"Luteal phase; Follicular phase; Progesterone receptor; Serous carcinoma; Fallopian tube; Biology; Immunohistochemistry; Internal medicine; Andrology; Endocrinology; Molecular biology; Medicine; Estrogen receptor; Cancer; Ovarian cancer","score_opus":0.02399009151892472,"score_gpt":0.2851806287602314,"score_spread":0.2611905372413067,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2158435543","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99801147,0.0013288594,0.00018120749,0.000016404121,0.0000046908767,0.000008141006,0.00015019548,0.000011710646,0.00028731968],"genre_scores_gemma":[0.9986778,0.00038146047,0.00027925763,0.000021327696,0.000004659416,0.0000072795747,0.00027621645,0.000004671938,0.00034728233],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99983597,0.000023303444,0.000018415232,0.00003890723,0.000049598748,0.000033730255],"domain_scores_gemma":[0.9997837,0.000043920572,0.000063766114,0.000026160922,0.000036635713,0.000045942674],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022199137,0.00013950073,0.00024463297,0.0009336051,0.00025870992,0.00040954698,0.00013132712,0.0003353025,0.0010876801],"category_scores_gemma":[0.00058540213,0.0001599682,0.00018587204,0.0005131762,0.00024129722,0.00016384046,0.00019407745,0.00020811454,0.0002045469],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022037157,0.00005374273,0.3562054,0.00022892638,0.00008260478,0.0045734327,0.00065486605,0.00009888894,0.6249304,0.000072931005,0.00019511023,0.010700002],"study_design_scores_gemma":[0.000011905604,0.0001919092,0.9694586,0.000011574367,0.000030110883,0.0061335177,0.00028873427,0.00017963209,0.022493206,0.00004270291,0.0011520253,0.0000060951347],"about_ca_topic_score_codex":0.001304539,"about_ca_topic_score_gemma":0.0017111413,"teacher_disagreement_score":0.001304539,"about_ca_system_score_codex":0.00021704056,"about_ca_system_score_gemma":0.00014265857,"threshold_uncertainty_score":0.0036386251},"labels":[],"label_agreement":null},{"id":"W2159816324","doi":"10.1677/erc-07-0238","title":"Gonadotropin-stimulated epidermal growth factor receptor expression in human ovarian surface epithelial cells: involvement of cyclic AMP-dependent exchange protein activated by cAMP pathway","year":2008,"lang":"en","type":"article","venue":"Endocrine Related Cancer","topic":"Reproductive System and Pregnancy","field":"Immunology and Microbiology","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Canadian Institutes of Health Research; Child and Family Research Institute","keywords":"Epidermal growth factor; Internal medicine; Endocrinology; Cell biology; Receptor; Protein expression; Epidermal growth factor receptor; Chemistry; Biology; Medicine; Gene; Biochemistry","score_opus":0.01980460408551053,"score_gpt":0.2522318952140281,"score_spread":0.2324272911285176,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2159816324","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99406505,0.0027308292,0.0006964836,0.000104034625,0.000024056599,0.000027257905,0.00043614605,0.000020792386,0.0018952783],"genre_scores_gemma":[0.99441385,0.001973306,0.0007650225,0.00006768648,0.000011928997,0.00003421911,0.00083855103,0.00000369498,0.0018916567],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99993694,0.000007884682,0.0000046391237,0.000010334521,0.000020571553,0.000019610632],"domain_scores_gemma":[0.99997675,0.000004345776,0.000004218293,0.000004115228,0.0000043724644,0.000006164071],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006526318,0.00013276566,0.00014664675,0.00015757083,0.000104089886,0.00022801483,0.000064003885,0.00016363234,0.0010654324],"category_scores_gemma":[0.000056673147,0.000092358234,0.00022318854,0.00021693402,0.00013347193,0.00012088895,0.00007404347,0.00029957865,0.0002203894],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013772873,0.00002280917,0.0006059578,0.00005159766,0.000005697514,0.00019976558,0.00003299854,0.000019062029,0.997846,0.00007240331,0.00004248961,0.0009634065],"study_design_scores_gemma":[0.00007057714,0.00039422925,0.07513986,0.000014717375,0.0000389401,0.0019767382,0.000306127,0.0010879488,0.9144388,0.00012702068,0.00639358,0.000011522468],"about_ca_topic_score_codex":0.0013074783,"about_ca_topic_score_gemma":0.0011801454,"teacher_disagreement_score":0.0013074783,"about_ca_system_score_codex":0.00013629303,"about_ca_system_score_gemma":0.00016372208,"threshold_uncertainty_score":0.0035642385},"labels":[],"label_agreement":null},{"id":"W2161615846","doi":"10.1530/erc-13-0165","title":"GnRH agonists and the rapidly increasing use of combined androgen blockade in prostate cancer","year":2014,"lang":"en","type":"review","venue":"Endocrine Related Cancer","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":41,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Wilfrid Laurier University; Université du Québec","funders":"","keywords":"Enzalutamide; Prostate cancer; Antiandrogen; Blockade; Medicine; Androgen; Bicalutamide; Castration; Oncology; Prostate; Internal medicine; Metastasis; Androgen receptor; Cancer; Endocrinology; Hormone; Receptor","score_opus":0.039029580951642,"score_gpt":0.366636645280232,"score_spread":0.32760706432859,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2161615846","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0038133264,0.98598295,0.00044722442,0.0051614526,0.0009992829,0.000008959602,0.00003587377,0.000014166671,0.0035368192],"genre_scores_gemma":[0.043743894,0.9425202,0.0011623956,0.006091969,0.0042619887,0.000031418487,0.00010809508,0.000012956369,0.0020670532],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9995976,0.00013023811,0.00005022113,0.00005520654,0.00013592072,0.000030819097],"domain_scores_gemma":[0.99924916,0.0004438646,0.00012695118,0.000030176503,0.00008785922,0.00006187986],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011312191,0.00024978918,0.00056381884,0.00055476645,0.00013668556,0.0006355016,0.00041004622,0.00084751524,0.0017280969],"category_scores_gemma":[0.0013665148,0.00015383748,0.00034089526,0.0009952475,0.00071491656,0.00049920304,0.00048621395,0.0020403767,0.0005436813],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018866253,0.00029641206,0.0030340326,0.004506974,0.00023842811,0.0012163777,0.00017982999,0.0009479376,0.0047924123,0.019804906,0.02140798,0.9416882],"study_design_scores_gemma":[0.00078231766,0.0038989477,0.017877927,0.0019696578,0.0002702697,0.00760396,0.00019460003,0.0006325989,0.0031595456,0.010853557,0.95267284,0.0000838495],"about_ca_topic_score_codex":0.00089679833,"about_ca_topic_score_gemma":0.0014666687,"teacher_disagreement_score":0.0017280969,"about_ca_system_score_codex":0.0006928972,"about_ca_system_score_gemma":0.00082261243,"threshold_uncertainty_score":0.005982518},"labels":[],"label_agreement":null},{"id":"W2165778677","doi":"10.1677/erc-09-0113","title":"VP-128, a novel oestradiol-platinum(II) hybrid with selective anti-tumour activity towards hormone-dependent breast cancer cells in vivo","year":2009,"lang":"en","type":"article","venue":"Endocrine Related Cancer","topic":"Ferrocene Chemistry and Applications","field":"Chemistry","cited_by":37,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université du Québec à Trois-Rivières","funders":"Natural Sciences and Engineering Research Council of Canada; Fonds Québécois de la Recherche sur la Nature et les Technologies; Canadian Institutes of Health Research; Cancer Research Society","keywords":"In vivo; Cisplatin; Apoptosis; In vitro; Cancer research; Cancer cell; Breast cancer; Chemistry; Cancer; Biology; Internal medicine; Medicine; Chemotherapy; Biochemistry","score_opus":0.007695355261116825,"score_gpt":0.24644652225702884,"score_spread":0.238751166995912,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2165778677","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9849701,0.0040445426,0.0075425142,0.00010998638,0.00004735113,0.000112720336,0.0003314266,0.00013144228,0.0027099762],"genre_scores_gemma":[0.98836714,0.0013676018,0.0066756555,0.0000611102,0.000010524035,0.00005866299,0.00048701465,0.000029659577,0.002942648],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99993706,0.000011916899,0.000005701988,0.000018006289,0.000017678234,0.000009597127],"domain_scores_gemma":[0.9999585,0.000006823504,0.000012118914,0.000006127567,0.0000055050864,0.000010899032],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006924157,0.00024443757,0.00023711655,0.00013391404,0.00006482125,0.00020170587,0.00025061937,0.0002745057,0.00080870104],"category_scores_gemma":[0.00012363591,0.00012813276,0.00013574194,0.00013249274,0.00013477656,0.00023271723,0.00020231532,0.00031717174,0.0003073994],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007312311,0.000025827101,0.00010025683,0.0000653307,0.0000074404898,0.00006530977,0.000012396472,0.00019990277,0.9950009,0.000094224175,0.000052127765,0.004303175],"study_design_scores_gemma":[0.000036044126,0.000708779,0.0008164546,0.000005264155,0.00002066156,0.0008062084,0.000008659406,0.00046515235,0.99064064,0.000035081735,0.0064525097,0.000004580797],"about_ca_topic_score_codex":0.00013125064,"about_ca_topic_score_gemma":0.00014054899,"teacher_disagreement_score":0.00080870104,"about_ca_system_score_codex":0.00016404477,"about_ca_system_score_gemma":0.000088204964,"threshold_uncertainty_score":0.0027053952},"labels":[],"label_agreement":null},{"id":"W2165922343","doi":"10.1530/erc-15-0038","title":"X-linked acrogigantism syndrome: clinical profile and therapeutic responses","year":2015,"lang":"en","type":"article","venue":"Endocrine Related Cancer","topic":"Pituitary Gland Disorders and Treatments","field":"Medicine","cited_by":185,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Eunice Kennedy Shriver National Institute of Child Health and Human Development; National Institute of Child Health and Human Development; U.S. Department of Health and Human Services; National Cancer Institute; National Institutes of Health; National Institute of Neurological Disorders and Stroke; National Human Genome Research Institute","keywords":"Gigantism; Somatostatin; Medicine; Acromegaly; Internal medicine; Endocrinology; Gastroenterology; Hypopituitarism; Prolactin; Pathology; Hormone; Growth hormone","score_opus":0.05922207547736815,"score_gpt":0.3823451828277266,"score_spread":0.3231231073503585,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2165922343","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99779165,0.00054703694,0.000092280716,0.00007088057,0.000004090016,0.000014029195,0.00012609753,0.000007018301,0.00134689],"genre_scores_gemma":[0.9993919,0.000103164006,0.000058681715,0.000040288876,0.0000114383265,0.000010617605,0.00020298058,0.0000022076047,0.000178749],"study_design_codex":"observational","study_design_gemma":"case_report","domain_scores_codex":[0.99985015,0.00003150551,0.000020492897,0.00002868232,0.00003070802,0.000038407732],"domain_scores_gemma":[0.9995103,0.00013892872,0.00009894164,0.00001673541,0.000053955067,0.00018113085],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000174817,0.0002638529,0.00036310288,0.00028225142,0.00023461292,0.0002682257,0.00013982342,0.00037219195,0.00057660684],"category_scores_gemma":[0.00088227337,0.00006264726,0.00018243618,0.00030734547,0.00016304845,0.00015937458,0.00012328978,0.00029940245,0.00015632511],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0046151727,0.00048056425,0.85906506,0.000095844654,0.00010572,0.03978759,0.0006937213,0.0011882572,0.047058042,0.00019222965,0.0007169967,0.046000786],"study_design_scores_gemma":[0.00020407273,0.0033821464,0.9390799,0.000018817109,0.0000710178,0.052450243,0.00029548595,0.00080476055,0.0018913932,0.00018390566,0.0015911649,0.00002701487],"about_ca_topic_score_codex":0.0006244875,"about_ca_topic_score_gemma":0.00069353404,"teacher_disagreement_score":0.0006244875,"about_ca_system_score_codex":0.00021890478,"about_ca_system_score_gemma":0.00014149539,"threshold_uncertainty_score":0.0019289851},"labels":[],"label_agreement":null},{"id":"W2169734442","doi":"10.1530/erc-11-0326","title":"Oncostatin M suppresses oestrogen receptor-α expression and is associated with poor outcome in human breast cancer","year":2012,"lang":"en","type":"article","venue":"Endocrine Related Cancer","topic":"Cytokine Signaling Pathways and Interactions","field":"Medicine","cited_by":74,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; University of Manitoba; University of Victoria; BC Cancer Agency","funders":"BC Cancer Agency; Office of Defense Programs; BC Cancer Foundation; U.S. Department of Defense","keywords":"Oncostatin M; Breast cancer; Cancer research; Signal transduction; Cancer; Estrogen receptor; Internal medicine; Receptor; Cytokine; Biology; Medicine; Endocrinology; Interleukin 6; Cell biology","score_opus":0.023930661185169445,"score_gpt":0.33280238368534665,"score_spread":0.3088717225001772,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2169734442","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99862695,0.0006182873,0.00010392219,0.000028258719,0.00000826371,0.0000070319848,0.00024485533,0.000014913839,0.00034766394],"genre_scores_gemma":[0.9978198,0.00059749244,0.00012731891,0.000028783446,0.000008703996,0.000008814342,0.0010122304,0.0000034348086,0.00039347354],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99993,0.000012770204,0.000009059525,0.0000086104965,0.000019120354,0.000020507554],"domain_scores_gemma":[0.9998661,0.00002150553,0.000055811855,0.000014590694,0.000011333277,0.00003063655],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014258677,0.00011666108,0.00022616035,0.00021289749,0.0000839135,0.0001936429,0.00007956163,0.00008680704,0.0006178475],"category_scores_gemma":[0.000280043,0.00004887358,0.00016457024,0.00032777735,0.00011979433,0.000059205213,0.00016766936,0.00016335564,0.00013765333],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0063831466,0.00046101873,0.2280527,0.00031507015,0.00024575111,0.0012138495,0.00014124713,0.00046864885,0.7083427,0.00014522523,0.0017548265,0.05247592],"study_design_scores_gemma":[0.00013488138,0.0035963808,0.8823168,0.000018716937,0.00017363451,0.0035792233,0.00019929235,0.0008440843,0.102213405,0.000102110294,0.0068115974,0.000009783223],"about_ca_topic_score_codex":0.0005568654,"about_ca_topic_score_gemma":0.0008040817,"teacher_disagreement_score":0.0006178475,"about_ca_system_score_codex":0.00014942378,"about_ca_system_score_gemma":0.00015436248,"threshold_uncertainty_score":0.0020669699},"labels":[],"label_agreement":null},{"id":"W2171347556","doi":"10.1677/erc.0.0100561","title":"Deregulation of the IGF axis in cancer: epidemiological evidence and potential therapeutic interventions.","year":2003,"lang":"en","type":"review","venue":"Endocrine Related Cancer","topic":"Growth Hormone and Insulin-like Growth Factors","field":"Medicine","cited_by":97,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Cancer research; Insulin-like growth factor-binding protein; Prostate cancer; Cancer; Cell growth; Biology; Prostate; Receptor; Apoptosis; PI3K/AKT/mTOR pathway; Growth factor; Endocrinology; Internal medicine; Medicine; Signal transduction; Immunology; Cell biology; Insulin-like growth factor; Biochemistry","score_opus":0.13604043471661362,"score_gpt":0.4208137108266259,"score_spread":0.28477327611001224,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2171347556","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000054369953,0.9990006,0.000040223542,0.00023462132,0.00011951658,0.0000018789349,0.000005727917,0.0000030066699,0.000540107],"genre_scores_gemma":[0.00048620536,0.9987607,0.000094959,0.00015841881,0.0001475263,0.000003431882,0.0000106729485,4.6871443e-7,0.00033766983],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99983287,0.000039295483,0.00001830801,0.000025542666,0.00007071015,0.000013242896],"domain_scores_gemma":[0.9997526,0.00011115666,0.00003238566,0.00000891412,0.00006686605,0.000028019167],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005845761,0.00081627315,0.00113115,0.0021801465,0.00029184323,0.00079802965,0.00085300463,0.0014664116,0.00396234],"category_scores_gemma":[0.00064377027,0.00020916549,0.0003080416,0.0031068854,0.0005942599,0.0013903878,0.00055636297,0.0012416189,0.0021495803],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011195489,0.00008014702,0.00031872522,0.009169512,0.00007090361,0.0004302207,0.000059082962,0.00024195614,0.0010831174,0.0022256004,0.030254617,0.9559542],"study_design_scores_gemma":[0.00004548477,0.00015911911,0.002453412,0.0036922619,0.000090372756,0.0033377155,0.00013945204,0.00009121778,0.0003259928,0.0027701352,0.98687637,0.000018565079],"about_ca_topic_score_codex":0.0018831466,"about_ca_topic_score_gemma":0.0038850394,"teacher_disagreement_score":0.00396234,"about_ca_system_score_codex":0.00074170623,"about_ca_system_score_gemma":0.0010331485,"threshold_uncertainty_score":0.013255358},"labels":[],"label_agreement":null},{"id":"W2172078107","doi":"10.1530/erc-14-0267","title":"Elevated YKL40 is associated with advanced prostate cancer (PCa) and positively regulates invasion and migration of PCa cells","year":2014,"lang":"en","type":"article","venue":"Endocrine Related Cancer","topic":"Studies on Chitinases and Chitosanases","field":"Biochemistry, Genetics and Molecular Biology","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Queensland Government; Australian Government","keywords":"LNCaP; Prostate cancer; Gene knockdown; Cancer research; Metastasis; Androgen receptor; Angiogenesis; Biology; Prostate; Cancer; Cell culture; Medicine; Internal medicine","score_opus":0.004080062653689674,"score_gpt":0.22755207254140666,"score_spread":0.22347200988771698,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2172078107","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9895807,0.007309629,0.0011693677,0.000092254704,0.000022260921,0.000020326795,0.0007635699,0.00013145027,0.0009104835],"genre_scores_gemma":[0.99462575,0.0024334062,0.00055103394,0.000029662317,0.000019591092,0.000025959278,0.0007808339,0.00001338154,0.0015203634],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9999192,0.000009551959,0.0000044192307,0.000014359825,0.00003129268,0.000021158425],"domain_scores_gemma":[0.99986494,0.000009026931,0.00005535027,0.000005123441,0.000016041653,0.00004952815],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000073510186,0.0003748001,0.00032307868,0.0006064013,0.00025412466,0.00027766352,0.000109044144,0.0001840699,0.0018788466],"category_scores_gemma":[0.0001257997,0.00013144627,0.00026541066,0.00064051687,0.00023450734,0.000121223355,0.00025571053,0.0004546469,0.00033719206],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012311048,0.00009243638,0.035470966,0.00031620404,0.00010170795,0.0012303484,0.0001436057,0.00014615583,0.94979084,0.00016804604,0.0007740209,0.010534582],"study_design_scores_gemma":[0.000049981056,0.0008425429,0.84809947,0.000032489505,0.00017136619,0.008214998,0.00026138025,0.0009538407,0.12925409,0.0003203518,0.011750895,0.000048644222],"about_ca_topic_score_codex":0.0014507021,"about_ca_topic_score_gemma":0.0013160394,"teacher_disagreement_score":0.0018788466,"about_ca_system_score_codex":0.00019508062,"about_ca_system_score_gemma":0.00030697943,"threshold_uncertainty_score":0.006285429},"labels":[],"label_agreement":null},{"id":"W2173456805","doi":"10.1530/erc-15-0460","title":"Functional characterization of multiple DICER1 mutations in an adolescent","year":2015,"lang":"en","type":"letter","venue":"Endocrine Related Cancer","topic":"Congenital Diaphragmatic Hernia Studies","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital","funders":"Canadian Institutes of Health Research; Fonds de Recherche du Québec - Santé; University of Exeter; National Institute of General Medical Sciences; Alex's Lemonade Stand Foundation for Childhood Cancer","keywords":"Characterization (materials science); Genetics; Biology; Computer science; Nanotechnology; Materials science","score_opus":0.03718770911554439,"score_gpt":0.29822312635986026,"score_spread":0.2610354172443159,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2173456805","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92545897,0.005413643,0.0019336427,0.052889675,0.0016017624,0.000086051565,0.0005181928,0.000083526946,0.012014501],"genre_scores_gemma":[0.9854504,0.0015941451,0.0016325803,0.0076504364,0.0018165411,0.000018672,0.000120880446,0.00003281917,0.0016836611],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9994974,0.00007452438,0.00009293125,0.00013607026,0.00008970079,0.000109366396],"domain_scores_gemma":[0.9979055,0.0010616403,0.00023159504,0.000086255815,0.00021922377,0.0004957912],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00048509223,0.00060139754,0.00057003123,0.0009848112,0.00085733476,0.0007318252,0.0007816662,0.004100447,0.0015667456],"category_scores_gemma":[0.0039835186,0.00032100047,0.00062285084,0.0004149703,0.001014741,0.00086548354,0.00059434853,0.002322431,0.00038005732],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000064769134,0.000033089105,0.032236572,0.000049936087,0.000012911743,0.957162,0.00027105995,0.000117869415,0.0031326225,0.00054680655,0.0030763547,0.0032960493],"study_design_scores_gemma":[0.000018693308,0.000106206106,0.014241777,0.00005298329,0.00003521372,0.9773284,0.00031367366,0.0005391652,0.001969944,0.00042224544,0.004958301,0.000013344225],"about_ca_topic_score_codex":0.0015763553,"about_ca_topic_score_gemma":0.0018401808,"teacher_disagreement_score":0.004100447,"about_ca_system_score_codex":0.0006533291,"about_ca_system_score_gemma":0.0004554142,"threshold_uncertainty_score":0.005241275},"labels":[],"label_agreement":null},{"id":"W2175151668","doi":"10.1530/erc-15-0386","title":"CYP19A1 fine-mapping and Mendelian randomization: estradiol is causal for endometrial cancer","year":2015,"lang":"en","type":"article","venue":"Endocrine Related Cancer","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":72,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Cancer Institute; Medical Research Council; Canadian Institutes of Health Research; U.S. Public Health Service; Helse Vest; Hunter Medical Research Institute; National Health and Medical Research Council; Vincent Fairfax Family Foundation; Norges Forskningsråd; Kreftforeningen; Wellcome Trust; Cancer Research UK; Universitetet i Bergen; National Institute for Health and Care Research; Cancer Council Queensland; Haukeland Universitetssjukehus; Fred C. and Katherine B. Andersen Foundation; QIMR Berghofer Medical Research Institute; Francis Crick Institute; Mayo Foundation for Medical Education and Research; Cancer Council Tasmania; National Institutes of Health; Ovarian Cancer Research Fund; Breast Cancer Research Foundation","keywords":"Mendelian randomization; Endometrial cancer; Cancer; Randomization; Gynecology; Medicine; Oncology; Biology; Clinical trial; Internal medicine; Genetics; Gene","score_opus":0.02217251667561125,"score_gpt":0.30153985889802,"score_spread":0.2793673422224087,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2175151668","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9052085,0.0030236854,0.08382744,0.0010023887,0.00016084766,0.0002324252,0.0014021284,0.00046548902,0.004677095],"genre_scores_gemma":[0.9889347,0.00032649457,0.0094725005,0.00021828811,0.000058017376,0.0000938312,0.00028632037,0.00006022316,0.0005495878],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99077374,0.006228145,0.00026344493,0.001857263,0.0005909551,0.00028636956],"domain_scores_gemma":[0.98831266,0.008434142,0.0011375141,0.0016944192,0.00019675569,0.00022451763],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0072631873,0.0005575386,0.0010032882,0.00097218633,0.000591802,0.0007827481,0.0008879352,0.0006995388,0.005622675],"category_scores_gemma":[0.018822514,0.00035409493,0.0012163521,0.0013939284,0.00094837503,0.00037299434,0.0006158471,0.00051698956,0.00047395937],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011377496,0.00028975186,0.78302026,0.00053052703,0.008773692,0.007235025,0.0006392314,0.0089921765,0.04122244,0.03109953,0.003945429,0.10287454],"study_design_scores_gemma":[0.0030243115,0.0019162666,0.80366695,0.00019460045,0.006153606,0.011787001,0.00034015861,0.089346446,0.009949073,0.06251122,0.01095404,0.00015630964],"about_ca_topic_score_codex":0.0028646553,"about_ca_topic_score_gemma":0.0022480343,"teacher_disagreement_score":0.0072631873,"about_ca_system_score_codex":0.00029557614,"about_ca_system_score_gemma":0.00048595303,"threshold_uncertainty_score":0.038411856},"labels":[],"label_agreement":null},{"id":"W2202874374","doi":"10.1530/erc-15-0045","title":"Autotaxin is an inflammatory mediator and therapeutic target in thyroid cancer","year":2015,"lang":"en","type":"article","venue":"Endocrine Related Cancer","topic":"Sphingolipid Metabolism and Signaling","field":"Biochemistry, Genetics and Molecular Biology","cited_by":64,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Canadian Institutes of Health Research; University of Alberta","keywords":"Autotaxin; Mediator; Thyroid cancer; Thyroid; Medicine; Inflammation; Cancer research; Cancer; Internal medicine; Neuroscience; Oncology; Biology; Lysophosphatidic acid; Receptor","score_opus":0.01588283169369096,"score_gpt":0.2840353588239547,"score_spread":0.2681525271302637,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2202874374","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8614283,0.12439147,0.0044592787,0.0017556131,0.00023220397,0.00018001505,0.0003762734,0.00020527252,0.006971499],"genre_scores_gemma":[0.9660118,0.026681865,0.0031343212,0.00034466898,0.00008805389,0.00008175589,0.00035114097,0.000010351933,0.0032959643],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999367,0.000009721556,0.0000041543367,0.000008630055,0.000019770525,0.000021018257],"domain_scores_gemma":[0.9999559,0.0000061833475,0.000013091582,0.000003473277,0.000007254674,0.000014028365],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015223307,0.00017455283,0.00023433326,0.0002201888,0.00017793504,0.00031985887,0.00014400369,0.00031560505,0.0008131825],"category_scores_gemma":[0.00006789568,0.00007645928,0.00024615772,0.00023186342,0.00019970762,0.00016406542,0.00016545814,0.00064416183,0.00023528181],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00042410102,0.00015276572,0.0012839002,0.00043342498,0.000019959522,0.0003542532,0.000049618237,0.00032435387,0.9621455,0.0004606746,0.0006366168,0.033714734],"study_design_scores_gemma":[0.0003520535,0.0058792313,0.028396444,0.00017563511,0.00026185033,0.005377136,0.00018545565,0.0028678838,0.86140674,0.00084230996,0.09421662,0.000038586626],"about_ca_topic_score_codex":0.00068618025,"about_ca_topic_score_gemma":0.0024307661,"teacher_disagreement_score":0.0008131825,"about_ca_system_score_codex":0.0004661639,"about_ca_system_score_gemma":0.00055023335,"threshold_uncertainty_score":0.0033823252},"labels":[],"label_agreement":null},{"id":"W2231391297","doi":"10.1530/erc-15-0541","title":"Bilateral adrenalectomy in the 21st century: when to use it for hypercortisolism?","year":2016,"lang":"en","type":"review","venue":"Endocrine Related Cancer","topic":"Pituitary Gland Disorders and Treatments","field":"Medicine","cited_by":71,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Medicine; Adrenalectomy; Bilateral adrenalectomy; Therapeutic approach; Surgery; Cushing syndrome; Internal medicine; Disease","score_opus":0.04791771087209198,"score_gpt":0.3570622790869505,"score_spread":0.30914456821485853,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2231391297","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00018045129,0.9986504,0.00006485611,0.00041858063,0.000101500365,0.0000014604083,0.000007844062,0.0000031549544,0.0005717662],"genre_scores_gemma":[0.0014891819,0.99762183,0.00016210874,0.0002995882,0.00015762892,0.0000022410593,0.000016523565,0.0000012502588,0.00024958636],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99986184,0.000029746781,0.000026828528,0.000022420798,0.000046644403,0.000012577647],"domain_scores_gemma":[0.9998142,0.00009257842,0.000033024997,0.0000067100746,0.000036595244,0.000016872586],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003374744,0.00032619716,0.00079962244,0.0010631786,0.00020799313,0.0007286998,0.0004089838,0.00063348934,0.0034898957],"category_scores_gemma":[0.00063786446,0.00011520769,0.00038799507,0.0010691029,0.00047873968,0.0011112462,0.00038729518,0.0012855674,0.0009528184],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011250616,0.000046946265,0.00050540775,0.015688907,0.00011250166,0.00052488473,0.000101564874,0.00015946095,0.0014113245,0.0027235763,0.015051271,0.96356165],"study_design_scores_gemma":[0.000047587764,0.00019506332,0.0031859966,0.0093718255,0.0002724397,0.011434861,0.0002798524,0.00009013647,0.00071393425,0.004215641,0.97016215,0.000030462996],"about_ca_topic_score_codex":0.00091944984,"about_ca_topic_score_gemma":0.0026161438,"teacher_disagreement_score":0.0034898957,"about_ca_system_score_codex":0.00033044495,"about_ca_system_score_gemma":0.0007988206,"threshold_uncertainty_score":0.011674821},"labels":[],"label_agreement":null},{"id":"W2264528830","doi":"10.1530/erc-15-0383","title":"TGFβ signaling regulates epithelial–mesenchymal plasticity in ovarian cancer ascites-derived spheroids","year":2015,"lang":"en","type":"article","venue":"Endocrine Related Cancer","topic":"Cancer Cells and Metastasis","field":"Medicine","cited_by":94,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"London Health Sciences Foundation; Canadian Institutes of Health Research; Ovarian Cancer Canada","keywords":"Cancer research; Epithelial–mesenchymal transition; Spheroid; Ovarian cancer; Metastasis; Mesenchymal stem cell; Cancer cell; Cell migration; Biology; Signal transduction; Cell; Cell biology; Chemistry; Cancer; Cell culture","score_opus":0.03015247300578474,"score_gpt":0.30358537831464427,"score_spread":0.27343290530885955,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2264528830","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9937848,0.0009754412,0.0027000664,0.0000925751,0.000036149977,0.000048532926,0.0007596806,0.000097569384,0.0015052648],"genre_scores_gemma":[0.9947273,0.0005596389,0.001840628,0.000044704106,0.000007173184,0.000045915313,0.0010991767,0.000017551363,0.001657877],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99990726,0.000012962429,0.00001209504,0.000017323759,0.000029204431,0.000021180987],"domain_scores_gemma":[0.9999052,0.000017287595,0.00002565369,0.000011778979,0.000013930108,0.00002614066],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009321053,0.00018209919,0.00024794697,0.00018795775,0.00018732208,0.00027818687,0.00009765979,0.00015955811,0.0007210242],"category_scores_gemma":[0.000069113725,0.0001360379,0.00021732427,0.00018338127,0.00012032174,0.00015513776,0.00016166706,0.00037358454,0.00034671952],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000038858216,0.000018461831,0.0002549428,0.000015894768,0.000003191091,0.000053882188,0.00003250849,0.00008382479,0.9988906,0.000059301507,0.00007823321,0.00047030483],"study_design_scores_gemma":[0.000019054294,0.00018347148,0.014268908,0.000005843002,0.00001293674,0.00026072032,0.00009697263,0.0033075376,0.97777224,0.0000688236,0.0039969,0.000006646668],"about_ca_topic_score_codex":0.0013574143,"about_ca_topic_score_gemma":0.0021406156,"teacher_disagreement_score":0.0013574143,"about_ca_system_score_codex":0.00030539057,"about_ca_system_score_gemma":0.00021756081,"threshold_uncertainty_score":0.0026990771},"labels":[],"label_agreement":null},{"id":"W2279025682","doi":"10.1530/erc-15-0502","title":"Cdc42 and Rac1 activity is reduced in human pheochromocytoma and correlates with FARP1 and ARHGEF1 expression","year":2016,"lang":"en","type":"article","venue":"Endocrine Related Cancer","topic":"Microtubule and mitosis dynamics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Caprion (Canada)","funders":"Conseil Régional d'Alsace; Centre National de la Recherche Scientifique; Institut National de la Santé et de la Recherche Médicale; Ligue Contre le Cancer; Québec Consortium for Drug Discovery","keywords":"RAC1; CDC42; GTPase; Guanine nucleotide exchange factor; Gene knockdown; GTP'; Cell biology; Chemistry; Biology; Biochemistry; Signal transduction; Enzyme; Gene","score_opus":0.0048107735937042715,"score_gpt":0.24989023913491476,"score_spread":0.2450794655412105,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2279025682","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9983449,0.00070692145,0.00034132562,0.000029116118,0.000004891026,0.000003611593,0.00026297636,0.00002844677,0.0002777939],"genre_scores_gemma":[0.9982389,0.00031435024,0.00025461908,0.000015052736,0.0000045329116,0.000007905063,0.00030782362,0.000005099562,0.00085181004],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99986446,0.000007917974,0.000008964602,0.000044101882,0.000048140468,0.000026444339],"domain_scores_gemma":[0.9998517,0.000018507992,0.000061394734,0.000008332592,0.00001545849,0.000044502944],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006052302,0.00018785779,0.00019479994,0.000461475,0.00013189903,0.00021584216,0.00006885913,0.00020509351,0.0009089287],"category_scores_gemma":[0.00011559339,0.00012365301,0.00015096908,0.00022490218,0.00016454248,0.000081363774,0.00011153412,0.00027102872,0.00018960329],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003747989,0.000027279553,0.0074712983,0.00003224295,0.000020204447,0.0006105973,0.00004535153,0.000028503815,0.98973024,0.000023235334,0.000042984182,0.0015932462],"study_design_scores_gemma":[0.000019697134,0.0004422417,0.47477818,0.000005821351,0.000059826707,0.0068448423,0.00013556135,0.0005386643,0.51559055,0.00006603023,0.0015053822,0.000013218734],"about_ca_topic_score_codex":0.0011710994,"about_ca_topic_score_gemma":0.0010629552,"teacher_disagreement_score":0.0011710994,"about_ca_system_score_codex":0.00016226924,"about_ca_system_score_gemma":0.000115336734,"threshold_uncertainty_score":0.003040731},"labels":[],"label_agreement":null},{"id":"W2291987540","doi":"10.1530/erc-16-0082","title":"Somatic mosaicism underlies X-linked acrogigantism syndrome in sporadic male subjects","year":2016,"lang":"en","type":"article","venue":"Endocrine Related Cancer","topic":"Genomic variations and chromosomal abnormalities","field":"Biochemistry, Genetics and Molecular Biology","cited_by":90,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Children's Hospital","funders":"Baylor-Hopkins Center for Mendelian Genomics; National Institute of Neurological Disorders and Stroke; National Human Genome Research Institute; Johns Hopkins University","keywords":"Gigantism; Biology; Comparative genomic hybridization; Genetics; Gene duplication; Loss of heterozygosity; Somatic cell; Cytogenetics; Chromosome; Gene; Allele","score_opus":0.007570864529437352,"score_gpt":0.23462486353359419,"score_spread":0.22705399900415685,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2291987540","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99942505,0.000096934666,0.00016251548,0.00001193817,0.0000019618367,0.000005330649,0.00003685525,0.000012626331,0.00024683098],"genre_scores_gemma":[0.9996724,0.000040055264,0.0001254432,0.000008389124,0.000007267102,0.0000028227844,0.000044005945,0.000002310823,0.00009723674],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99982494,0.000025663816,0.000013579116,0.00006572988,0.000045615034,0.000024431245],"domain_scores_gemma":[0.9998325,0.000044343175,0.000068189926,0.000013028828,0.000011438546,0.000030420953],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015070314,0.00032649242,0.0001967555,0.00075997104,0.00030208015,0.00024231714,0.00012396373,0.00022527626,0.001792574],"category_scores_gemma":[0.00058927,0.00016245253,0.00012042068,0.00034218986,0.0002752773,0.00009930052,0.00022040156,0.00013465543,0.00017793251],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00035339265,0.0000519593,0.8438575,0.000028906414,0.00004312411,0.01617044,0.00061389204,0.00008433698,0.12807475,0.00014067059,0.00019421855,0.010386624],"study_design_scores_gemma":[0.00001692176,0.00030395345,0.9520104,0.000005846766,0.000033560154,0.041507404,0.0002276719,0.00031566728,0.0049204314,0.00008342459,0.0005672558,0.0000075852927],"about_ca_topic_score_codex":0.00079279364,"about_ca_topic_score_gemma":0.0009949537,"teacher_disagreement_score":0.001792574,"about_ca_system_score_codex":0.000096754266,"about_ca_system_score_gemma":0.00008196769,"threshold_uncertainty_score":0.0059967637},"labels":[],"label_agreement":null},{"id":"W2298325430","doi":"10.1530/erc-15-0105","title":"Estrogen regulates luminal progenitor cell differentiation through H19 gene expression","year":2015,"lang":"en","type":"article","venue":"Endocrine Related Cancer","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":39,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"Canadian Cancer Society Research Institute; Cure Brain Cancer Foundation; CancerCare Manitoba Foundation; University of Manitoba; Manitoba Health Research Council","keywords":"Progenitor cell; Estrogen receptor; Estrogen; Matrigel; Biology; Progenitor; Estrogen receptor alpha; Signal transduction; Cell biology; Estrogen receptor beta; Cancer research; Cellular differentiation; Endocrinology; Internal medicine; Stem cell; Breast cancer; Cancer; Angiogenesis; Medicine; Gene; Genetics","score_opus":0.010119038642521581,"score_gpt":0.2596078442966456,"score_spread":0.24948880565412399,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2298325430","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.990998,0.0025787617,0.0026101526,0.00011607869,0.000020530848,0.000020974072,0.00036361287,0.000062237064,0.0032296479],"genre_scores_gemma":[0.9885436,0.0029821137,0.0020464808,0.00007915636,0.000018849127,0.000021015574,0.00064296153,0.000022205297,0.0056436006],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999628,0.0000055654946,0.0000023846437,0.0000066640873,0.000010914505,0.000011600449],"domain_scores_gemma":[0.99996567,0.000006473621,0.000008390016,0.0000024594538,0.000005095052,0.00001189401],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000056839304,0.00013088956,0.0001015503,0.00014394081,0.000095935495,0.00020038092,0.000086741995,0.00009923824,0.00094228546],"category_scores_gemma":[0.00005785322,0.000085498665,0.00011388909,0.00008879935,0.00010442043,0.00009779342,0.0001150925,0.00022579127,0.0003359844],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010447828,0.000020108115,0.00072004716,0.000019693818,0.0000026155526,0.000069316084,0.00001637404,0.000035526646,0.9960228,0.00019194078,0.000071775445,0.0027252878],"study_design_scores_gemma":[0.000027114836,0.00026510895,0.030030943,0.000008819688,0.000018218943,0.00025996295,0.00007776778,0.0009817265,0.9591106,0.00017564293,0.009039927,0.000004181307],"about_ca_topic_score_codex":0.000520092,"about_ca_topic_score_gemma":0.0006928642,"teacher_disagreement_score":0.00094228546,"about_ca_system_score_codex":0.00014451581,"about_ca_system_score_gemma":0.00014699352,"threshold_uncertainty_score":0.0031522512},"labels":[],"label_agreement":null},{"id":"W2310360756","doi":"10.1530/erc-15-0042","title":"Autophagy in endocrine tumors","year":2015,"lang":"en","type":"review","venue":"Endocrine Related Cancer","topic":"Autophagy in Disease and Therapy","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital","funders":"","keywords":"Autophagy; Endocrine system; Biology; Context (archaeology); Cancer research; Cancer; Pancreas; Cell biology; Endocrinology; Hormone; Apoptosis; Biochemistry; Genetics","score_opus":0.059445931346016626,"score_gpt":0.42773020507760057,"score_spread":0.36828427373158396,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2310360756","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00017677927,0.9979786,0.00010210487,0.00021706763,0.0001273161,0.0000033055517,0.000021587553,0.0000080873915,0.0013650631],"genre_scores_gemma":[0.0015232957,0.99716336,0.00017033449,0.00016329388,0.00013401799,0.0000039770975,0.00004161935,0.0000014808769,0.0007986596],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99988186,0.000017869197,0.000022734226,0.000022389602,0.0000428341,0.000012264173],"domain_scores_gemma":[0.9998851,0.000039215585,0.000021427997,0.000004469312,0.00003624397,0.000013536242],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002747196,0.0005274676,0.0008497074,0.002039707,0.0003371723,0.0007766615,0.00037055966,0.00070958183,0.0033673695],"category_scores_gemma":[0.00039524082,0.00014770249,0.00045766003,0.0015270726,0.00034317517,0.0008108044,0.00066246727,0.0011260567,0.0014744069],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000620925,0.000039651368,0.00036280963,0.017196422,0.00007020492,0.0006739293,0.00013407618,0.00030606458,0.0026443275,0.004773183,0.040066674,0.9336706],"study_design_scores_gemma":[0.000009094497,0.00005575301,0.001288282,0.0038520496,0.00009015616,0.0055107283,0.00008211246,0.00006073024,0.0005708697,0.002615819,0.98584795,0.000016399581],"about_ca_topic_score_codex":0.001234334,"about_ca_topic_score_gemma":0.002186654,"teacher_disagreement_score":0.0033673695,"about_ca_system_score_codex":0.0005332827,"about_ca_system_score_gemma":0.00093792786,"threshold_uncertainty_score":0.01126498},"labels":[],"label_agreement":null},{"id":"W2313448551","doi":"10.1530/erc-12-0324","title":"Insulin resistance and cancer: the role of insulin and IGFs","year":2012,"lang":"en","type":"review","venue":"Endocrine Related Cancer","topic":"Metabolism, Diabetes, and Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":261,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Insulin resistance; Insulin; Insulin receptor; Carcinogenesis; Cancer; Biology; Immune system; Cell growth; Cancer research; Bioinformatics; Endocrinology; Immunology; Genetics","score_opus":0.013489286838058426,"score_gpt":0.2885564802797654,"score_spread":0.27506719344170694,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2313448551","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000079330675,0.9985071,0.00009952137,0.0002741782,0.00019579146,0.0000015309057,0.000006982914,0.0000057001257,0.0008298405],"genre_scores_gemma":[0.00062393514,0.9981207,0.00015251632,0.00015417761,0.00021436944,0.0000032734383,0.000014657247,0.0000011560999,0.00071517867],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99985623,0.000027165053,0.00001517594,0.000028219236,0.000055870576,0.000017267948],"domain_scores_gemma":[0.99984205,0.00005836655,0.000019984405,0.0000063305165,0.000047578502,0.000025646785],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003566242,0.0008786316,0.0011266088,0.0016732615,0.0003301716,0.00100149,0.0006635642,0.0011716188,0.0027387934],"category_scores_gemma":[0.00039652872,0.00021022157,0.00032255056,0.0023701796,0.00059294025,0.001252019,0.0007286668,0.001803818,0.0021222904],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008443106,0.00006417085,0.0002515689,0.006769624,0.00005974197,0.00031852224,0.00006762445,0.00032052104,0.0023586228,0.006140172,0.034209214,0.9493557],"study_design_scores_gemma":[0.000010235713,0.0000469968,0.0008065325,0.0011989214,0.00003073238,0.0015331601,0.00006418838,0.00004988667,0.0003466158,0.0028912583,0.99300766,0.000013916388],"about_ca_topic_score_codex":0.0010794598,"about_ca_topic_score_gemma":0.0013751639,"teacher_disagreement_score":0.0027387934,"about_ca_system_score_codex":0.00076875504,"about_ca_system_score_gemma":0.00092026714,"threshold_uncertainty_score":0.009162188},"labels":[],"label_agreement":null},{"id":"W2314780368","doi":"10.1530/erc-16-0013","title":"NG2 targets tumorigenic Rb inactivation in Pit1-lineage pituitary cells","year":2016,"lang":"en","type":"article","venue":"Endocrine Related Cancer","topic":"Pituitary Gland Disorders and Treatments","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"Canadian Institutes of Health Research","keywords":"Corticotropic cell; Biology; Immunohistochemistry; Internal medicine; Endocrinology; Anterior pituitary; Pituitary gland; Pituitary tumors; Prolactin; Cancer research; Hormone; Immunology; Medicine","score_opus":0.008880662768574877,"score_gpt":0.2697453911216173,"score_spread":0.2608647283530424,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2314780368","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99513197,0.00064286176,0.0016305187,0.00006401494,0.000017378172,0.000032721557,0.00054823305,0.00011904842,0.0018133251],"genre_scores_gemma":[0.99298733,0.00043269355,0.001239987,0.00003238048,0.0000052312894,0.000034448203,0.00068851415,0.000049451428,0.004529969],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998901,0.000011180314,0.000007413969,0.000022896034,0.000034793757,0.000033684628],"domain_scores_gemma":[0.9999119,0.000016335664,0.000024646477,0.0000139171225,0.00000613511,0.000027095824],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010527517,0.00036053488,0.0001887528,0.00023300563,0.00014060596,0.00026916794,0.0001968959,0.00028446017,0.001370349],"category_scores_gemma":[0.00009233278,0.00014955008,0.00020098692,0.00011050196,0.00024320805,0.00014184378,0.00022610817,0.00042572324,0.0004020312],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004721229,0.000008727142,0.00013611015,0.000013021696,0.0000017013913,0.00007622428,0.000011148567,0.000049398983,0.999126,0.000055843615,0.000022254637,0.00045248345],"study_design_scores_gemma":[0.000014474971,0.0001314412,0.0036218935,0.0000034693644,0.000009367874,0.00036968192,0.000029926521,0.0008674358,0.9926323,0.000027639393,0.0022894738,0.000002918607],"about_ca_topic_score_codex":0.0015558855,"about_ca_topic_score_gemma":0.0028881498,"teacher_disagreement_score":0.0015558855,"about_ca_system_score_codex":0.00028412841,"about_ca_system_score_gemma":0.0002301086,"threshold_uncertainty_score":0.004584253},"labels":[],"label_agreement":null},{"id":"W2324898736","doi":"10.1530/erc-14-0423","title":"The UGT1 locus is a determinant of prostate cancer recurrence after prostatectomy","year":2014,"lang":"en","type":"article","venue":"Endocrine Related Cancer","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Centre hospitalier de l'Université Laval; Centre hospitalier universitaire de Québec","funders":"Prostate Cancer Canada; Canadian Institutes of Health Research; Cancer Research Society","keywords":"Single-nucleotide polymorphism; Prostate cancer; Internal medicine; Haplotype; Proportional hazards model; Locus (genetics); Hazard ratio; Medicine; Oncology; Endocrinology; Biochemical recurrence; Allele; Glucuronosyltransferase; Prostatectomy; Genotype; Genetics; Biology; Cancer; Gene","score_opus":0.0027862196196356053,"score_gpt":0.250667759555955,"score_spread":0.2478815399363194,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2324898736","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99881136,0.00059882307,0.00013593848,0.000044736273,0.0000045453485,0.0000026173632,0.000070637034,0.000010846641,0.00032052372],"genre_scores_gemma":[0.9997123,0.00006771452,0.000030374827,0.000006083726,0.000009372971,9.145649e-7,0.000056435434,0.0000022814168,0.000114567934],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99975866,0.00007796395,0.000012662059,0.000059149676,0.000053662236,0.000037994385],"domain_scores_gemma":[0.9986291,0.00034447393,0.0005961144,0.00011777771,0.00007976934,0.00023285275],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036633646,0.00019006613,0.00025069728,0.00030491373,0.00021814117,0.00034814444,0.0002730911,0.00027779225,0.0017959832],"category_scores_gemma":[0.002005807,0.00014873392,0.00030861745,0.0004008082,0.00028917412,0.00014764194,0.00023317298,0.00049586577,0.00023180396],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034871782,0.000015605132,0.9942986,0.0000101890355,0.00006377057,0.00015146022,0.000035312358,0.00009287469,0.0014198902,0.000020735895,0.00007791353,0.0034649263],"study_design_scores_gemma":[0.0000021462831,0.000055625533,0.99913365,0.0000015808713,0.00002427753,0.00038332216,0.000014461039,0.00017097454,0.00012277953,0.0000167636,0.000072753835,0.0000016725618],"about_ca_topic_score_codex":0.002953635,"about_ca_topic_score_gemma":0.0020882913,"teacher_disagreement_score":0.002953635,"about_ca_system_score_codex":0.00013651102,"about_ca_system_score_gemma":0.00018272012,"threshold_uncertainty_score":0.006008148},"labels":[],"label_agreement":null},{"id":"W2325704466","doi":"10.1530/erc-14-0232","title":"The kinome associated with estrogen receptor-positive status in human breast cancer","year":2014,"lang":"en","type":"review","venue":"Endocrine Related Cancer","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; CancerCare Manitoba","funders":"Canadian Cancer Society Research Institute; Canadian Institutes of Health Research; Cure Brain Cancer Foundation","keywords":"Kinome; Breast cancer; Kinase; Estrogen receptor; Bioinformatics; Computational biology; Estrogen receptor alpha; Biology; Cancer research; Medicine; Cancer; Oncology; Internal medicine; Genetics","score_opus":0.007334814083471788,"score_gpt":0.2987326748477516,"score_spread":0.2913978607642798,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2325704466","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00015189755,0.99869233,0.00009534814,0.00014954917,0.00005956222,0.000003382023,0.00002962654,0.0000056645085,0.00081261265],"genre_scores_gemma":[0.0009033915,0.9984659,0.00010806454,0.00007015496,0.000044996992,0.0000034538132,0.000038329512,7.7657126e-7,0.000364983],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998629,0.000022134584,0.00002432532,0.000027740834,0.0000508918,0.000012000898],"domain_scores_gemma":[0.9997495,0.00011018721,0.000051620907,0.000006921254,0.00006112662,0.000020705756],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036992395,0.00056027726,0.0010494081,0.002914112,0.00025771116,0.0008326303,0.000598361,0.00080532086,0.0034509087],"category_scores_gemma":[0.0006396927,0.00022550384,0.000419868,0.002566941,0.0003768805,0.0010302833,0.00060926634,0.00087138143,0.0016879854],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007035211,0.00003905671,0.00038117284,0.0227167,0.000108405635,0.00027233013,0.00006471184,0.00032119866,0.0014835302,0.002614524,0.01768062,0.95424736],"study_design_scores_gemma":[0.000013031363,0.00008792308,0.00246504,0.0060426984,0.0002432624,0.003548038,0.00010791605,0.00009700359,0.00076557987,0.002630395,0.9839692,0.000029860481],"about_ca_topic_score_codex":0.0012909429,"about_ca_topic_score_gemma":0.0020465974,"teacher_disagreement_score":0.0034509087,"about_ca_system_score_codex":0.0006111032,"about_ca_system_score_gemma":0.0009416277,"threshold_uncertainty_score":0.011544406},"labels":[],"label_agreement":null},{"id":"W2509895884","doi":"10.1530/erc-16-0297","title":"BRCA2 functions: from DNA repair to replication fork stabilization","year":2016,"lang":"en","type":"review","venue":"Endocrine Related Cancer","topic":"DNA Repair Mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":87,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital; Université Laval; Hôtel-Dieu de Québec","funders":"Natural Sciences and Engineering Research Council of Canada; Jewish General Hospital; Canadian Institutes of Health Research; Cancer Research Society","keywords":"Genome instability; Biology; Fanconi anemia; DNA repair; RAD51; Homologous recombination; Genetics; Chromosome instability; Telomere; BRCA2 Protein; DNA replication; Cancer research; DNA re-replication; DNA damage; Gene; Mutation; DNA; Chromosome; Eukaryotic DNA replication; Germline mutation","score_opus":0.02034789958555874,"score_gpt":0.3258856017428809,"score_spread":0.3055377021573222,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2509895884","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00020258003,0.9975521,0.00018699853,0.00032483158,0.00016414508,0.0000033842173,0.00002139344,0.000013217727,0.0015313638],"genre_scores_gemma":[0.0014359341,0.99694794,0.00015238943,0.00016040243,0.000121387035,0.0000042597385,0.000042025356,0.0000022574313,0.0011333643],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99988675,0.00001654733,0.000013985585,0.000024914507,0.00003982333,0.000017996677],"domain_scores_gemma":[0.999882,0.00003276334,0.00002250557,0.0000046217747,0.000035632234,0.000022458871],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032495375,0.000769334,0.0008140819,0.0015415958,0.0002949338,0.00089257484,0.0007747639,0.00081150274,0.0026830647],"category_scores_gemma":[0.00033055333,0.00020636678,0.00032895003,0.0012560525,0.0005409512,0.00094197894,0.00064232637,0.001399221,0.0019146476],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007693663,0.000046774254,0.00025278688,0.008657873,0.00005937298,0.00022947163,0.000065650485,0.0003537512,0.005263512,0.0044326847,0.029589515,0.9509717],"study_design_scores_gemma":[0.000008464458,0.000048598275,0.00058386574,0.00089774915,0.0000405789,0.0010649421,0.000031908145,0.000059822807,0.0012772079,0.0016264565,0.9943498,0.000010531125],"about_ca_topic_score_codex":0.0008572114,"about_ca_topic_score_gemma":0.0012886561,"teacher_disagreement_score":0.0026830647,"about_ca_system_score_codex":0.00068863924,"about_ca_system_score_gemma":0.0008453876,"threshold_uncertainty_score":0.008975804},"labels":[],"label_agreement":null},{"id":"W2522136113","doi":"10.1530/erc-16-0354","title":"BRCA2: a grown-up cancer susceptibility gene","year":2016,"lang":"en","type":"editorial","venue":"Endocrine Related Cancer","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Cancer; Gene; Biology; Genetics; Oncology; Medicine; Computational biology; Cancer research","score_opus":0.007848481268727153,"score_gpt":0.30912316152798375,"score_spread":0.3012746802592566,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2522136113","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00005721091,0.013324212,0.00019408784,0.04326451,0.941753,0.00001624371,0.000049246886,0.000047506375,0.0012941281],"genre_scores_gemma":[0.00036073016,0.006197792,0.00010933067,0.01915434,0.9667632,0.000018285247,0.000032259395,0.000016800559,0.007347174],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99706155,0.0005644698,0.00043719632,0.0003804892,0.0013217845,0.00023446692],"domain_scores_gemma":[0.99112964,0.0037630908,0.0008403011,0.00030433646,0.002336066,0.0016266012],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0052663023,0.0038454344,0.0033024268,0.0030042657,0.0021020002,0.0057608224,0.003314183,0.017538594,0.008541463],"category_scores_gemma":[0.014056402,0.0014529327,0.0025707716,0.0010217981,0.00253559,0.0038634182,0.00218252,0.023825832,0.007011799],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006434204,0.00001538438,0.000055617,0.00023057444,0.00002572338,0.0003995953,0.000008666639,0.00003794092,0.00012246943,0.0003464263,0.9907933,0.007899993],"study_design_scores_gemma":[0.00010765815,0.00005872304,0.0004254954,0.00037270473,0.00010526529,0.0011541048,0.000028860573,0.0001873706,0.00023143471,0.0011350528,0.99616724,0.000026066891],"about_ca_topic_score_codex":0.0011459711,"about_ca_topic_score_gemma":0.0030632243,"teacher_disagreement_score":0.017538594,"about_ca_system_score_codex":0.002962657,"about_ca_system_score_gemma":0.0019025457,"threshold_uncertainty_score":0.02857405},"labels":[],"label_agreement":null},{"id":"W2528213995","doi":"10.1530/erc-16-0329","title":"mTOR inhibitors response and mTOR pathway in pancreatic neuroendocrine tumors","year":2016,"lang":"en","type":"article","venue":"Endocrine Related Cancer","topic":"Neuroendocrine Tumor Research Advances","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pancreas Centre (Canada)","funders":"","keywords":"Everolimus; PI3K/AKT/mTOR pathway; Protein kinase B; Neuroendocrine tumors; Immunohistochemistry; Medicine; In vivo; Cancer research; Internal medicine; Pharmacology; Apoptosis; Oncology; Biology; Biotechnology; Biochemistry","score_opus":0.01351555454926406,"score_gpt":0.2978357769380235,"score_spread":0.2843202223887594,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2528213995","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99450594,0.0041135233,0.00024309421,0.00007624529,0.000010880657,0.000013704855,0.00013858438,0.000013388811,0.00088462076],"genre_scores_gemma":[0.9984939,0.00077015255,0.00015428055,0.000039560757,0.000008903306,0.000013845318,0.00016594406,0.0000025179256,0.00035093253],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9998764,0.00003958139,0.000017028615,0.000024107954,0.000025065152,0.000017897752],"domain_scores_gemma":[0.9998374,0.00006612574,0.000040689614,0.00001033095,0.00001753754,0.000027969641],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023653421,0.00014110183,0.00027419653,0.000266818,0.00010659829,0.00030725612,0.000080930586,0.00023622904,0.00084968156],"category_scores_gemma":[0.00031006994,0.000054367545,0.00019668949,0.00017043603,0.000115419905,0.00018092302,0.00009485554,0.000308361,0.00013737532],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0130656315,0.00082509895,0.16880071,0.0005864349,0.0002789963,0.0022015118,0.00016839756,0.001533651,0.6972425,0.000229628,0.0007773506,0.114290096],"study_design_scores_gemma":[0.00017714272,0.009853861,0.7920728,0.000036810703,0.00029415038,0.0067792125,0.00033868206,0.003432392,0.18018094,0.00026526747,0.006549923,0.000018944553],"about_ca_topic_score_codex":0.0002318159,"about_ca_topic_score_gemma":0.00038804853,"teacher_disagreement_score":0.00084968156,"about_ca_system_score_codex":0.00018974328,"about_ca_system_score_gemma":0.00011843553,"threshold_uncertainty_score":0.002842486},"labels":[],"label_agreement":null},{"id":"W2552944256","doi":"10.1530/erc-16-0393","title":"Differential roles of RET isoforms in medullary and papillary thyroid carcinomas","year":2016,"lang":"en","type":"article","venue":"Endocrine Related Cancer","topic":"Thyroid Cancer Diagnosis and Treatment","field":"Medicine","cited_by":45,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; St. Paul's Hospital; Canada's Michael Smith Genome Sciences Centre; University of British Columbia; Queen's University","funders":"Queen's University; Canadian Institutes of Health Research; Cancer Research Society","keywords":"Cancer research; Thyroid carcinoma; Biology; Anoikis; Receptor tyrosine kinase; Proto-Oncogene Proteins c-ret; Tyrosine kinase; Cell biology; Cancer cell; Endocrinology; Thyroid; Cancer; Signal transduction; Receptor","score_opus":0.007796352522564408,"score_gpt":0.2553965774551967,"score_spread":0.2476002249326323,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2552944256","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9966008,0.0014321737,0.00042883988,0.000024003419,0.000005997233,0.000008174918,0.00013038733,0.000020626652,0.0013490804],"genre_scores_gemma":[0.9982849,0.0004247266,0.00020174311,0.00001616094,0.000006741754,0.000007607564,0.00016133292,0.000008491345,0.0008883019],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9997391,0.000021250093,0.00002754791,0.000062986874,0.00008984356,0.000059309332],"domain_scores_gemma":[0.99979776,0.000033507105,0.000053877968,0.000019148974,0.00004243599,0.00005332223],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002396512,0.00020036487,0.00020509878,0.00066811027,0.00026719275,0.00046738927,0.00021064795,0.0002700947,0.0009683799],"category_scores_gemma":[0.00032710057,0.00016601599,0.00029567143,0.00032022895,0.00026273486,0.00024129028,0.0003154736,0.00018150755,0.00022773149],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006016319,0.000019190771,0.03603942,0.00010392079,0.00003830766,0.0014837062,0.00033269974,0.000075089636,0.95418864,0.00043328336,0.000091631184,0.006592461],"study_design_scores_gemma":[0.00004314323,0.00059301616,0.7740843,0.000040010596,0.00025719914,0.019345272,0.0011056329,0.0009383223,0.19480777,0.0005710911,0.0081666345,0.00004756558],"about_ca_topic_score_codex":0.0018045007,"about_ca_topic_score_gemma":0.0024840909,"teacher_disagreement_score":0.0018045007,"about_ca_system_score_codex":0.00034384846,"about_ca_system_score_gemma":0.0002982478,"threshold_uncertainty_score":0.0035879612},"labels":[],"label_agreement":null},{"id":"W2564132902","doi":"10.1530/erc-16-0419","title":"Progressive epigenetic dysregulation in neuroendocrine tumour liver metastases","year":2017,"lang":"en","type":"letter","venue":"Endocrine Related Cancer","topic":"Neuroendocrine Tumor Research Advances","field":"Medicine","cited_by":53,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"Medical Research Council; University College London Hospitals NHS Foundation Trust; National Institute for Health and Care Research; Cancer Research UK; Wellcome Trust","keywords":"Epigenetics; Neuroendocrine carcinoma; Neuroendocrine tumour; Medicine; Cancer research; Oncology; Internal medicine; Biology; Pathology; Carcinoma; Genetics; Gene","score_opus":0.029450846015961395,"score_gpt":0.3454542594050315,"score_spread":0.3160034133890701,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2564132902","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.024558607,0.019649044,0.0011244146,0.9178331,0.02149309,0.00003760612,0.0002898615,0.00014462443,0.014869652],"genre_scores_gemma":[0.32594407,0.028815972,0.0020855088,0.47524825,0.1415484,0.0001165165,0.00031050775,0.00007763945,0.025853185],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.99974674,0.00007029776,0.00002796444,0.00003142424,0.0000780127,0.000045418736],"domain_scores_gemma":[0.9990939,0.00049796054,0.00008257177,0.000054962547,0.00014334822,0.00012731248],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005212093,0.00018225396,0.00046599822,0.0002636834,0.0005833663,0.0008067695,0.00033183684,0.004729179,0.0028583042],"category_scores_gemma":[0.0036037075,0.0001327325,0.00030363153,0.0002451777,0.0006429186,0.00067174213,0.00047776435,0.0049847737,0.0011716171],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005625197,0.000111235226,0.013820724,0.00040170236,0.00006265233,0.086524986,0.000295624,0.00063154416,0.008938087,0.008208314,0.71325654,0.16718611],"study_design_scores_gemma":[0.00038474475,0.00032729463,0.0140053565,0.00042897274,0.00014111621,0.101266794,0.0007449067,0.0030161245,0.007042103,0.023092378,0.8494817,0.00006859225],"about_ca_topic_score_codex":0.00064416736,"about_ca_topic_score_gemma":0.001194771,"teacher_disagreement_score":0.004729179,"about_ca_system_score_codex":0.0009456222,"about_ca_system_score_gemma":0.0005318249,"threshold_uncertainty_score":0.0095620155},"labels":[],"label_agreement":null},{"id":"W2583082560","doi":"10.1530/erc-16-0496","title":"Pituitary acromegaly: not one disease","year":2017,"lang":"en","type":"letter","venue":"Endocrine Related Cancer","topic":"Pituitary Gland Disorders and Treatments","field":"Medicine","cited_by":45,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Acromegaly; Risk stratification; Pituitary tumors; Epigenetics; Pituitary adenoma; Disease; Medicine; Bioinformatics; Broad spectrum; Adenoma; Pathology; Neuroscience; Biology; Internal medicine; Genetics; Growth hormone; Gene","score_opus":0.02703821333650549,"score_gpt":0.3045985027313428,"score_spread":0.27756028939483735,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2583082560","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.008715733,0.05088212,0.0007701946,0.9077427,0.017821034,0.00001877926,0.00008879687,0.000104934574,0.013855717],"genre_scores_gemma":[0.19454424,0.086079106,0.0020287845,0.51593935,0.1898318,0.000059229267,0.0001529465,0.00008391845,0.011280665],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9992611,0.00023488444,0.0000783136,0.000104321036,0.00020593843,0.00011548728],"domain_scores_gemma":[0.9975248,0.001242753,0.00024944858,0.00014411527,0.00036257884,0.00047632618],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007746034,0.00053862156,0.0011767296,0.0005615363,0.0014260943,0.001474466,0.00075044483,0.007960948,0.0026216828],"category_scores_gemma":[0.007301192,0.00028015647,0.0005161434,0.00046848346,0.002332002,0.0026097752,0.0010598318,0.012056874,0.0023739845],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026418266,0.00009255121,0.010915389,0.0008626984,0.00013230547,0.2569805,0.00061378605,0.00046663912,0.0022266863,0.021636292,0.576403,0.12940589],"study_design_scores_gemma":[0.00015543107,0.0001274283,0.004203847,0.0010700071,0.00007672413,0.5722835,0.00081154774,0.00091971864,0.00059145933,0.04037289,0.37929574,0.00009184104],"about_ca_topic_score_codex":0.0014628321,"about_ca_topic_score_gemma":0.0030004135,"teacher_disagreement_score":0.007960948,"about_ca_system_score_codex":0.0022062883,"about_ca_system_score_gemma":0.0013725191,"threshold_uncertainty_score":0.016007781},"labels":[],"label_agreement":null},{"id":"W2592270240","doi":"10.1530/erc-17-0004","title":"From pituitary adenoma to pituitary neuroendocrine tumor (PitNET): an International Pituitary Pathology Club proposal","year":2017,"lang":"en","type":"article","venue":"Endocrine Related Cancer","topic":"Pituitary Gland Disorders and Treatments","field":"Medicine","cited_by":352,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"Ipsen; Università degli Studi di Torino; Kanazawa Medical University; Università degli Studi dell'Aquila; Université de Lyon; Hospices Civils de Lyon","keywords":"Pituitary tumors; Pituitary adenoma; Neuroendocrine tumors; Adenoma; Pathology; Anterior pituitary; Medicine; Hormone; Internal medicine","score_opus":0.014553462301906121,"score_gpt":0.3212345771739681,"score_spread":0.30668111487206196,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2592270240","genre_codex":"commentary","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.021216888,0.04451681,0.053773645,0.503782,0.20867832,0.0005862801,0.00042689897,0.000667697,0.16635142],"genre_scores_gemma":[0.28283256,0.074276984,0.07118048,0.24016245,0.25956544,0.0019442651,0.0015921806,0.000736817,0.06770888],"study_design_codex":"not_applicable","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.99650747,0.00070575834,0.00057344924,0.000508886,0.0012177107,0.00048666843],"domain_scores_gemma":[0.993519,0.0013057085,0.0005477267,0.0003300738,0.0026982995,0.0015990876],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0055068266,0.0009241438,0.0009794707,0.0048796763,0.0026652592,0.004372445,0.0025470462,0.0051876623,0.0026223175],"category_scores_gemma":[0.008657542,0.00031109416,0.0010352125,0.003797678,0.010705957,0.005440854,0.0036701737,0.009702079,0.0018491511],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017622123,0.00030466367,0.015101563,0.00083123264,0.000043951448,0.0064275786,0.0028990312,0.00086428074,0.0019211653,0.24163114,0.42506644,0.3047327],"study_design_scores_gemma":[0.00007362351,0.00021908851,0.0060243686,0.0007743207,0.000068026166,0.014685709,0.0016526656,0.0013045873,0.00045736754,0.059225194,0.915429,0.00008609455],"about_ca_topic_score_codex":0.0028019473,"about_ca_topic_score_gemma":0.004689882,"teacher_disagreement_score":0.0055068266,"about_ca_system_score_codex":0.0023183357,"about_ca_system_score_gemma":0.007821019,"threshold_uncertainty_score":0.029123247},"labels":[],"label_agreement":null},{"id":"W2618996609","doi":"10.1530/erc-17-0131","title":"Loss-of-function mutations in the CABLES1 gene are a novel cause of Cushing’s disease","year":2017,"lang":"en","type":"article","venue":"Endocrine Related Cancer","topic":"Pituitary Gland Disorders and Treatments","field":"Medicine","cited_by":89,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Clinical Research Institute","funders":"Canadian Institutes of Health Research; National Institutes of Health; Université Paris Descartes","keywords":"Germline; Biology; Missense mutation; Germline mutation; Cancer research; Pituitary tumors; Mutation; Gene; Cell cycle; Copy-number variation; Cyclin E; Genetics; Endocrinology; Internal medicine; Molecular biology; Cyclin D1; Medicine; Genome","score_opus":0.030825204639808222,"score_gpt":0.3205431530728196,"score_spread":0.2897179484330114,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2618996609","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.999244,0.00023964942,0.00017665552,0.000024681487,0.000006370152,0.000005241013,0.00010225598,0.00000919623,0.00019216802],"genre_scores_gemma":[0.99950206,0.0001071013,0.0001481218,0.000013674547,0.000015229606,0.000002674173,0.00010493927,0.0000040986683,0.000102142796],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999757,0.000026310268,0.000029513154,0.00008034651,0.00007043236,0.000036408444],"domain_scores_gemma":[0.9995844,0.00014898647,0.00014458207,0.000017793269,0.000022609147,0.000081630766],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014828658,0.0007584925,0.00032039083,0.0012445481,0.00038216892,0.0003065086,0.0003699857,0.00061322784,0.0015299094],"category_scores_gemma":[0.00080162095,0.00026896247,0.0002150632,0.00063182216,0.0005143459,0.00015395416,0.0002874934,0.00027180326,0.00020604787],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001977317,0.00022082044,0.5029495,0.00027076108,0.00032461257,0.20352793,0.0017092559,0.0008592359,0.26243964,0.0005787971,0.0011445154,0.02399768],"study_design_scores_gemma":[0.0001317919,0.00044504378,0.7278575,0.000049139322,0.00017696644,0.24634025,0.0003681711,0.0013920829,0.019999325,0.00021435044,0.0029787882,0.000046633846],"about_ca_topic_score_codex":0.00097327103,"about_ca_topic_score_gemma":0.0009574599,"teacher_disagreement_score":0.0015299094,"about_ca_system_score_codex":0.00024612347,"about_ca_system_score_gemma":0.0001221386,"threshold_uncertainty_score":0.0051180124},"labels":[],"label_agreement":null},{"id":"W2735522662","doi":"10.1530/erc-17-0209","title":"A comprehensive review on MEN2B","year":2017,"lang":"en","type":"review","venue":"Endocrine Related Cancer","topic":"Radiomics and Machine Learning in Medical Imaging","field":"Medicine","cited_by":97,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Computer science","score_opus":0.09907016582732375,"score_gpt":0.4699450566218236,"score_spread":0.37087489079449987,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2735522662","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000117000905,0.99828076,0.00007272668,0.00031520368,0.00018667828,0.0000052197274,0.00008000407,0.0000076007746,0.0009347249],"genre_scores_gemma":[0.0006825361,0.9981018,0.00017832308,0.00025317087,0.00018830072,0.0000074165496,0.00012992423,0.0000022332279,0.0004562892],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.999703,0.000055434215,0.00008799532,0.00005042089,0.00008335839,0.000019838724],"domain_scores_gemma":[0.9993235,0.00039501805,0.000104929924,0.000015732592,0.0001225373,0.000038194652],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00058301754,0.00073454424,0.0012186848,0.003933959,0.00031411948,0.0009745614,0.0007663366,0.0007688902,0.0093438905],"category_scores_gemma":[0.0020660087,0.00025658947,0.00091816694,0.0035063212,0.00027308537,0.0009978788,0.00056932855,0.0009909704,0.0024087285],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010018868,0.000047832065,0.00055532093,0.077325344,0.00035109467,0.0004985837,0.00016008975,0.0004046468,0.0010260484,0.0024018285,0.08333093,0.8337982],"study_design_scores_gemma":[0.000014666547,0.000058285194,0.0014109237,0.017781297,0.0003697168,0.0025202795,0.00006167538,0.00005588728,0.00021322725,0.00091360125,0.9765805,0.000019820725],"about_ca_topic_score_codex":0.001899803,"about_ca_topic_score_gemma":0.0030160777,"teacher_disagreement_score":0.0093438905,"about_ca_system_score_codex":0.0005632315,"about_ca_system_score_gemma":0.002001116,"threshold_uncertainty_score":0.031258404},"labels":[],"label_agreement":null},{"id":"W2748863347","doi":"10.1530/erc-17-0251","title":"Medical ovariectomy in menopausal breast cancer patients with high testosterone levels: a further step toward tailored therapy","year":2017,"lang":"en","type":"article","venue":"Endocrine Related Cancer","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; McMaster University Medical Centre","funders":"ArcelorMittal","keywords":"Medicine; Breast cancer; Internal medicine; Androgen receptor; Estrogen; Testosterone (patch); Endocrinology; Androgen; Oncology; Estrogen receptor; Cancer; Hormone; Prostate cancer","score_opus":0.008230355450572038,"score_gpt":0.26481141155503457,"score_spread":0.2565810561044625,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2748863347","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.63257647,0.26098543,0.017298264,0.057308942,0.0017648676,0.0005086674,0.00027052863,0.00028650658,0.029000316],"genre_scores_gemma":[0.91980886,0.054260205,0.012094729,0.0060972506,0.0033312342,0.00018323415,0.00028920177,0.000024776178,0.003910492],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9999356,0.000023979415,0.0000072524936,0.0000071165196,0.000012584119,0.000013397155],"domain_scores_gemma":[0.9998822,0.000039364528,0.00002238993,0.000007561334,0.000011825192,0.000036673617],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027851993,0.00016866947,0.00038736552,0.00032030806,0.00017475401,0.00033780857,0.00020838458,0.00036172246,0.0014079309],"category_scores_gemma":[0.00053090864,0.00006430066,0.00032825925,0.00016875024,0.0001567556,0.00031096785,0.0002557266,0.0005400494,0.00020727092],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0037983656,0.0015680315,0.07500419,0.0013195727,0.00022654714,0.0035391261,0.00021478056,0.0015469674,0.023059027,0.0027211946,0.00814132,0.87886083],"study_design_scores_gemma":[0.003939457,0.013122897,0.6273288,0.002722037,0.0015004158,0.03264046,0.0016571708,0.00712862,0.018880839,0.024657805,0.2662444,0.00017705532],"about_ca_topic_score_codex":0.00035509045,"about_ca_topic_score_gemma":0.000784866,"teacher_disagreement_score":0.0014079309,"about_ca_system_score_codex":0.00021677915,"about_ca_system_score_gemma":0.0005644479,"threshold_uncertainty_score":0.004709959},"labels":[],"label_agreement":null},{"id":"W2750836859","doi":"10.1530/erc-17-0266","title":"Looking beyond the thyroid: advances in the understanding of pheochromocytoma and hyperparathyroidism phenotypes in MEN2 and of non-MEN2 familial forms","year":2017,"lang":"en","type":"review","venue":"Endocrine Related Cancer","topic":"Adrenal and Paraganglionic Tumors","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Penetrance; Pheochromocytoma; Multiple endocrine neoplasia type 2; Medicine; Parathyroidectomy; Disease; Phenotype; Mutation; Germline mutation; Internal medicine; Genetics; Biology; Gene","score_opus":0.04421730752026238,"score_gpt":0.36869530282173,"score_spread":0.32447799530146765,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2750836859","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0010041187,0.99594325,0.00035378107,0.0017230326,0.00021592632,0.0000018000553,0.000016672982,0.0000072130733,0.00073423353],"genre_scores_gemma":[0.01030013,0.98441434,0.00078190624,0.0018239603,0.0020536499,0.0000070246138,0.000062993844,0.000007641314,0.00054833],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99961793,0.00008445995,0.00007936752,0.00007888585,0.0000996971,0.000039548337],"domain_scores_gemma":[0.9987552,0.00083913613,0.00014543917,0.000034223216,0.00015998555,0.00006590101],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001035405,0.00046437766,0.0014301573,0.002346818,0.00025676787,0.0011537547,0.0006672827,0.0011496006,0.0013096406],"category_scores_gemma":[0.0014502724,0.0002668043,0.0007566293,0.0015361528,0.0010718722,0.0027304916,0.0008195774,0.0020101585,0.00045067052],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003432155,0.00008037745,0.008477877,0.021008601,0.0003363666,0.0072168233,0.001588491,0.0006788617,0.009401904,0.012704033,0.017660543,0.9205028],"study_design_scores_gemma":[0.000034641773,0.00037841804,0.026061594,0.008528872,0.0006003802,0.06843499,0.0017038252,0.0005502711,0.001997251,0.02030269,0.8712665,0.00014040533],"about_ca_topic_score_codex":0.0019334218,"about_ca_topic_score_gemma":0.0027482389,"teacher_disagreement_score":0.002346818,"about_ca_system_score_codex":0.0007836206,"about_ca_system_score_gemma":0.001021096,"threshold_uncertainty_score":0.0056856275},"labels":[],"label_agreement":null},{"id":"W2755822411","doi":"10.1530/erc-17-0316","title":"Immune responses in the thyroid cancer microenvironment: making immunotherapy a possible mission","year":2017,"lang":"en","type":"review","venue":"Endocrine Related Cancer","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":36,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Guelph","funders":"OVC Pet Trust; Canadian Institutes of Health Research; Terry Fox Research Institute; Ministry of Agriculture, Food and Rural Affairs; Natural Sciences and Engineering Research Council of Canada; Ontario Ministry of Agriculture, Food and Rural Affairs","keywords":"Immunotherapy; Immune system; Tumor microenvironment; Cancer immunotherapy; Thyroid cancer; Cancer; Medicine; Immunology; Internal medicine","score_opus":0.050254521916592194,"score_gpt":0.3710253973340803,"score_spread":0.3207708754174881,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2755822411","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00008778959,0.9979336,0.00013071085,0.00063027587,0.0004969091,0.0000020171633,0.000007134905,0.000006401478,0.00070512097],"genre_scores_gemma":[0.00086061156,0.9974045,0.00015553826,0.00042381254,0.00048793628,0.0000041623875,0.000016378266,0.0000015201131,0.00064557506],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99980134,0.000040497445,0.000022359229,0.000025741892,0.000080614634,0.000029500196],"domain_scores_gemma":[0.9996984,0.00013245126,0.00003411112,0.000010539998,0.000087800276,0.000036719368],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005471913,0.0006368707,0.00094182236,0.001301377,0.00032755337,0.0010611033,0.00064740935,0.0014579083,0.0023444279],"category_scores_gemma":[0.00072234124,0.00020103752,0.00038683502,0.0010311705,0.00059542916,0.0016537115,0.00077413995,0.0022759128,0.001381266],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000796257,0.00006120299,0.00026964038,0.014235058,0.0000665092,0.00029672324,0.00012785273,0.00043971388,0.0046443352,0.010076801,0.064087,0.90561545],"study_design_scores_gemma":[0.0000072563016,0.000059364364,0.00041910232,0.001985429,0.000034253844,0.0010415149,0.000080904705,0.00006943536,0.00052719424,0.0037622284,0.9920021,0.000011253892],"about_ca_topic_score_codex":0.0005476893,"about_ca_topic_score_gemma":0.0009612619,"teacher_disagreement_score":0.0023444279,"about_ca_system_score_codex":0.0006734546,"about_ca_system_score_gemma":0.001132269,"threshold_uncertainty_score":0.007842898},"labels":[],"label_agreement":null},{"id":"W2763295416","doi":"10.1530/erc-17-0377","title":"Dose–response effects of exercise on insulin among colon cancer survivors","year":2017,"lang":"en","type":"article","venue":"Endocrine Related Cancer","topic":"Cancer survivorship and care","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"National Center for Advancing Translational Sciences; National Center for Research Resources; National Cancer Institute; National Institutes of Health; National Institute of Diabetes and Digestive and Kidney Diseases; University of Pennsylvania","keywords":"Medicine; Insulin resistance; Aerobic exercise; Colorectal cancer; Insulin; Internal medicine; Cancer; Endocrinology; Gastroenterology","score_opus":0.010464477358873792,"score_gpt":0.30381474723005564,"score_spread":0.29335026987118185,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2763295416","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9992692,0.00037190586,0.00004571262,0.00003075,0.000013228892,0.000032720567,0.000037642294,0.0000039808624,0.00019489092],"genre_scores_gemma":[0.9991559,0.00022327848,0.00014366342,0.000060809747,0.000014016339,0.000052190524,0.00009912762,0.0000014430839,0.0002495964],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99961203,0.00020993776,0.000034394052,0.000053492917,0.000045976725,0.00004414873],"domain_scores_gemma":[0.9993742,0.00024281858,0.00017512316,0.00008323821,0.0000361171,0.00008850375],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006265252,0.00016411189,0.00034678695,0.0001725176,0.00011392091,0.00022346388,0.00013962224,0.00035638595,0.0010532691],"category_scores_gemma":[0.0013405208,0.00019182487,0.0005889735,0.00020141165,0.00016805014,0.0001362638,0.00022257376,0.00043375697,0.00010566831],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.41691872,0.01913288,0.39713207,0.000570073,0.0035346462,0.00013019783,0.0003527956,0.0020095336,0.044346016,0.00011598083,0.00069420965,0.11506283],"study_design_scores_gemma":[0.0051329336,0.08141385,0.9080807,0.00002382504,0.0006769017,0.00006579101,0.00011520164,0.0009610521,0.0028318786,0.000110775865,0.00056867703,0.000018394734],"about_ca_topic_score_codex":0.00054145395,"about_ca_topic_score_gemma":0.0011308446,"teacher_disagreement_score":0.0010532691,"about_ca_system_score_codex":0.00015043051,"about_ca_system_score_gemma":0.0001358362,"threshold_uncertainty_score":0.0035235286},"labels":[],"label_agreement":null},{"id":"W2774064635","doi":"10.1530/erc-17-0366","title":"Receptor activities of persistent pollutant serum mixtures and breast cancer risk","year":2017,"lang":"en","type":"article","venue":"Endocrine Related Cancer","topic":"Per- and polyfluoroalkyl substances research","field":"Environmental Science","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Breast cancer; Aryl hydrocarbon receptor; Internal medicine; Estrogen receptor; Androgen receptor; Cancer; Pollutant; Receptor; Hormone; Medicine; Physiology; Endocrinology; Oncology; Chemistry; Gene; Transcription factor; Biochemistry; Organic chemistry","score_opus":0.00932906123112882,"score_gpt":0.27697832576651116,"score_spread":0.26764926453538235,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2774064635","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9943336,0.0041377274,0.0004821739,0.000037627506,0.0000082197275,0.00000978529,0.00032947885,0.000011678021,0.000649823],"genre_scores_gemma":[0.9978485,0.0009814857,0.00032712944,0.000019890824,0.000009377033,0.0000108347795,0.00032007243,0.0000025158809,0.000480078],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999366,0.00017231515,0.000043067655,0.00014587159,0.00022164712,0.000051120016],"domain_scores_gemma":[0.99951303,0.00012697198,0.00017016837,0.000045432553,0.00010329455,0.00004115346],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005906234,0.00028201146,0.0003115566,0.00088497985,0.00014760872,0.0004888209,0.00020099554,0.00030173073,0.0013658402],"category_scores_gemma":[0.00096357585,0.00020213732,0.00031277502,0.0006093877,0.00018754422,0.00018071628,0.00036173058,0.00020338391,0.00020473187],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013681643,0.00010949433,0.8749571,0.00019329452,0.0007856617,0.00013960958,0.000143654,0.00019393467,0.10523726,0.00007900296,0.00009126538,0.016701577],"study_design_scores_gemma":[0.000008614339,0.00060004933,0.9834683,0.000018661867,0.00043382385,0.00077385124,0.00014586566,0.000409676,0.013185351,0.00008554605,0.0008631782,0.0000070522337],"about_ca_topic_score_codex":0.0024424829,"about_ca_topic_score_gemma":0.0032392056,"teacher_disagreement_score":0.0024424829,"about_ca_system_score_codex":0.0002306373,"about_ca_system_score_gemma":0.00022375915,"threshold_uncertainty_score":0.004856527},"labels":[],"label_agreement":null},{"id":"W2782939356","doi":"10.1530/erc-17-0509","title":"DICER1 gene mutations in endocrine tumors","year":2018,"lang":"en","type":"review","venue":"Endocrine Related Cancer","topic":"Congenital Diaphragmatic Hernia Studies","field":"Medicine","cited_by":41,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital; McGill University Health Centre; St. Michael's Hospital","funders":"","keywords":"Endocrine system; Pancreas; Endocrine gland; Gene mutation; Gene; Cancer research; Biology; Thyroid; Mutation; Medicine; Internal medicine; Endocrinology; Hormone; Genetics","score_opus":0.0442906480848622,"score_gpt":0.3826765592906455,"score_spread":0.33838591120578326,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2782939356","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00034351108,0.9979741,0.00010170711,0.00023379957,0.00014531877,0.00000381127,0.000036542595,0.000006897357,0.0011542988],"genre_scores_gemma":[0.0021984614,0.9966635,0.00022905435,0.00019937154,0.00015389924,0.000004094987,0.000057580874,0.0000017183769,0.00049223995],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99983025,0.000022905104,0.000045256926,0.000029593728,0.000056886834,0.00001502374],"domain_scores_gemma":[0.9996123,0.00021618263,0.00006486053,0.000009529831,0.000074501106,0.000022777964],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029211995,0.00050030416,0.0006442622,0.003766777,0.0002919142,0.00049388665,0.0004350475,0.0005484382,0.0031836957],"category_scores_gemma":[0.0010499061,0.00017609312,0.00034299266,0.002366044,0.0002565748,0.00076747005,0.0005106133,0.0006463062,0.00072489725],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000060461676,0.000025988498,0.0012998204,0.032365687,0.00015754624,0.0029016775,0.00022763551,0.0003711293,0.0028406829,0.0023796668,0.041056782,0.9163129],"study_design_scores_gemma":[0.000011923238,0.000054957163,0.003821618,0.011397884,0.0003475164,0.032454856,0.00017205878,0.00006935566,0.0009604661,0.0018400236,0.9488461,0.00002329533],"about_ca_topic_score_codex":0.00091872347,"about_ca_topic_score_gemma":0.0013979352,"teacher_disagreement_score":0.003766777,"about_ca_system_score_codex":0.00037211835,"about_ca_system_score_gemma":0.00088840025,"threshold_uncertainty_score":0.010650516},"labels":[],"label_agreement":null},{"id":"W2783442236","doi":"10.1530/erc-17-0493","title":"Sex steroids in the tumor microenvironment and prostate cancer progression","year":2018,"lang":"en","type":"review","venue":"Endocrine Related Cancer","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"Prostate Cancer Canada; Movember Foundation","keywords":"Prostate cancer; Tumor microenvironment; Prostate; Context (archaeology); Medicine; Cancer; Tumor progression; Androgen; Sex steroid; Oncology; Testosterone (patch); Cancer research; Internal medicine; Biology; Steroid; Hormone","score_opus":0.03428621551525527,"score_gpt":0.3960438199909786,"score_spread":0.3617576044757233,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2783442236","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00012919815,0.99837375,0.000073179086,0.00035324565,0.00015140619,0.0000031738896,0.000023559245,0.0000064146807,0.00088604906],"genre_scores_gemma":[0.00096804334,0.9980484,0.0000907429,0.0001342639,0.00015471759,0.0000032956407,0.000029466986,0.0000012045821,0.00056978606],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997874,0.000044114757,0.000032081593,0.00003075732,0.00008393687,0.000021730692],"domain_scores_gemma":[0.99971205,0.00012564944,0.000046218516,0.000008978275,0.000082010374,0.000025025685],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00043037883,0.00052502076,0.0008776744,0.002016123,0.00032051027,0.0010297868,0.0005500855,0.000849703,0.0045373803],"category_scores_gemma":[0.0007122651,0.00018041636,0.0004524006,0.0017391011,0.00041888552,0.00081827544,0.0005849651,0.0014234905,0.0018476389],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007890047,0.00006373902,0.00046622084,0.015766988,0.00010261613,0.00028624697,0.00010227847,0.00035363776,0.001703273,0.0050737304,0.0308581,0.9451442],"study_design_scores_gemma":[0.000007920536,0.000055707977,0.000992817,0.0026942166,0.00006334915,0.001362547,0.000066672066,0.00004627987,0.00041825316,0.0019522676,0.99232787,0.000012078757],"about_ca_topic_score_codex":0.0013782858,"about_ca_topic_score_gemma":0.0024523162,"teacher_disagreement_score":0.0045373803,"about_ca_system_score_codex":0.00054511917,"about_ca_system_score_gemma":0.0012748276,"threshold_uncertainty_score":0.015179038},"labels":[],"label_agreement":null},{"id":"W2784118723","doi":"10.1530/erc-17-0488","title":"The evolving clinical, genetic and therapeutic landscape of multiple endocrine neoplasia type 2","year":2018,"lang":"en","type":"editorial","venue":"Endocrine Related Cancer","topic":"Neuroendocrine Tumor Research Advances","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Multiple endocrine neoplasia type 2; Multiple endocrine neoplasia; Endocrine system; Biology; Evolutionary biology; Computational biology; Medicine; Genetics; Internal medicine; Mutation; Gene; Hormone; Germline mutation","score_opus":0.020021790533924017,"score_gpt":0.36836582583155236,"score_spread":0.34834403529762836,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2784118723","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000076483935,0.023584792,0.000182723,0.049044997,0.9259211,0.000008964304,0.00003123748,0.00004006541,0.0011096797],"genre_scores_gemma":[0.00048181333,0.012071605,0.000115471164,0.015049081,0.96955174,0.000007656173,0.000014449934,0.000013546005,0.0026946415],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99760866,0.00056761,0.00036285873,0.00028553535,0.00099032,0.00018510172],"domain_scores_gemma":[0.9838795,0.009265159,0.0008776658,0.0003055834,0.004054982,0.0016170557],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005439605,0.002044199,0.002375592,0.0021606106,0.0014766222,0.0048068413,0.0021694365,0.008511472,0.0057632457],"category_scores_gemma":[0.019150455,0.00064802077,0.0012434822,0.00086531125,0.0019589374,0.0037665195,0.0012652394,0.0151256,0.003108757],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005003146,0.000016666143,0.00008061892,0.00042715686,0.000023475362,0.00029909972,0.000022863645,0.000048290665,0.00011459712,0.0006732299,0.9784128,0.019831141],"study_design_scores_gemma":[0.000047901904,0.000039302373,0.00031234382,0.00055520167,0.000064310945,0.0008856158,0.00006459443,0.00015425512,0.00013764777,0.0013080473,0.9964097,0.000020979065],"about_ca_topic_score_codex":0.0008222324,"about_ca_topic_score_gemma":0.0026738618,"teacher_disagreement_score":0.008511472,"about_ca_system_score_codex":0.0021627005,"about_ca_system_score_gemma":0.0019973484,"threshold_uncertainty_score":0.028767765},"labels":[],"label_agreement":null},{"id":"W2790570326","doi":"10.1530/erc-18-0015","title":"65 YEARS OF THE DOUBLE HELIX: Treatment of pituitary tumors with temozolomide: an update","year":2018,"lang":"en","type":"review","venue":"Endocrine Related Cancer","topic":"Pituitary Gland Disorders and Treatments","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"","keywords":"Temozolomide; Medicine; Pituitary tumors; Anaplastic astrocytoma; Oncology; Internal medicine; Glioblastoma; Adjuvant; Adjuvant therapy; Pituitary adenoma; Astrocytoma; Melanoma; Cancer research; Chemotherapy; Adenoma","score_opus":0.03173571722439277,"score_gpt":0.338364168976728,"score_spread":0.3066284517523352,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2790570326","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00009213753,0.9985769,0.00004857729,0.00038055266,0.00024917192,0.0000024171813,0.00001957916,0.0000037551065,0.00062704185],"genre_scores_gemma":[0.0005729813,0.9983833,0.0001053184,0.0003388446,0.00027191534,0.0000028771028,0.000033528184,0.0000013168342,0.0002899909],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99981374,0.000034048488,0.00004776305,0.00003073227,0.00005750455,0.00001630074],"domain_scores_gemma":[0.9994413,0.00030932837,0.000093541596,0.000011295225,0.000111757916,0.000032765958],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00047594775,0.00062986393,0.0009354103,0.0022693283,0.00026786356,0.0009871292,0.00063860836,0.0009561199,0.004409638],"category_scores_gemma":[0.0011830854,0.00020252954,0.0006319694,0.0018890899,0.00036156492,0.0015947622,0.0005619753,0.0015455429,0.001194994],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000084834894,0.000051051233,0.00035662216,0.028046647,0.00012976614,0.00036583273,0.000108928085,0.00022489078,0.0006452231,0.0024754133,0.042475723,0.925035],"study_design_scores_gemma":[0.000015392776,0.00006589614,0.0009273648,0.0107028885,0.00024166738,0.0027986625,0.00008911829,0.00005861819,0.00018381754,0.0013044993,0.98359686,0.000015227758],"about_ca_topic_score_codex":0.0013369273,"about_ca_topic_score_gemma":0.0026650133,"teacher_disagreement_score":0.004409638,"about_ca_system_score_codex":0.0005178482,"about_ca_system_score_gemma":0.001179366,"threshold_uncertainty_score":0.014751732},"labels":[],"label_agreement":null},{"id":"W2800029808","doi":"10.1530/erc-18-0141","title":"65 YEARS OF THE DOUBLE HELIX: Exploiting insights on the RET receptor for personalized cancer medicine","year":2018,"lang":"en","type":"review","venue":"Endocrine Related Cancer","topic":"Neuroendocrine Tumor Research Advances","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Medicine; Disease; Cancer; Precision medicine; Receptor tyrosine kinase; Repurposing; Cancer research; Bioinformatics; Targeted therapy; Personalized medicine; Multiple endocrine neoplasia type 2; Medullary thyroid cancer; Thyroid cancer; Internal medicine; Receptor; Mutation; Biology; Gene; Pathology; Genetics; Germline mutation","score_opus":0.11340842744004513,"score_gpt":0.42436261938153297,"score_spread":0.3109541919414878,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2800029808","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0001004142,0.9971102,0.00015299514,0.0010490161,0.00040946197,0.000003269669,0.000013104007,0.000008239387,0.0011532593],"genre_scores_gemma":[0.00079572684,0.99731123,0.00018499553,0.00053873745,0.0003640125,0.000004139846,0.000022304837,0.000002071551,0.0007767555],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998011,0.000043802833,0.000025554376,0.000028389893,0.00007943417,0.000021898753],"domain_scores_gemma":[0.9995577,0.0002349302,0.000038212493,0.000016618176,0.00011185581,0.000040609197],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00070478534,0.0005427708,0.00081186317,0.001958284,0.000289967,0.00088616915,0.000610126,0.001027994,0.0037253455],"category_scores_gemma":[0.0009946413,0.00018700743,0.00050399353,0.0012115459,0.00056219177,0.001700622,0.0007573233,0.0025562479,0.0020373138],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007746252,0.000059133563,0.00022342795,0.008815077,0.00008520383,0.0002509578,0.0000937538,0.00032900105,0.0015388305,0.010984722,0.057372157,0.92017037],"study_design_scores_gemma":[0.000008676848,0.00004373652,0.00030367906,0.0016610433,0.00003692438,0.0007134853,0.000041006453,0.00005602865,0.00021631944,0.0030641148,0.99384475,0.000010240435],"about_ca_topic_score_codex":0.00079562375,"about_ca_topic_score_gemma":0.0016937638,"teacher_disagreement_score":0.0037253455,"about_ca_system_score_codex":0.0006830833,"about_ca_system_score_gemma":0.00087119546,"threshold_uncertainty_score":0.012462556},"labels":[],"label_agreement":null},{"id":"W2802716398","doi":"10.1530/erc-18-0100","title":"Preventive medicine of von Hippel–Lindau disease-associated pancreatic neuroendocrine tumors","year":2018,"lang":"en","type":"article","venue":"Endocrine Related Cancer","topic":"Neuroendocrine Tumor Research Advances","field":"Medicine","cited_by":67,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Mount Sinai Hospital; Princess Margaret Cancer Centre; University Health Network","funders":"Cleveland Clinic","keywords":"Von Hippel–Lindau disease; Neuroendocrine tumors; Medicine; Disease; Internal medicine; Pathology","score_opus":0.017657227347211223,"score_gpt":0.33661801883928955,"score_spread":0.31896079149207834,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2802716398","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.867581,0.09592709,0.001162828,0.019538756,0.00066516374,0.00005314858,0.0007734493,0.000081671606,0.014216809],"genre_scores_gemma":[0.9791479,0.017962864,0.0005874755,0.000895785,0.00036440583,0.000023344659,0.00018148974,0.0000039489883,0.0008327138],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99962866,0.00017591036,0.000025194475,0.000039622642,0.000077345765,0.00005331997],"domain_scores_gemma":[0.99948573,0.00013653754,0.00014594934,0.000024202873,0.00007227434,0.00013516926],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008110204,0.00020504012,0.00030285094,0.0008435923,0.000381172,0.00056430267,0.0002386195,0.00048683953,0.001509052],"category_scores_gemma":[0.0020620164,0.00013102306,0.00034738454,0.00050055934,0.00017864667,0.0003340301,0.0003266867,0.0005501589,0.00012292834],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003875587,0.0007774802,0.88103384,0.0003363436,0.00032667792,0.00028050426,0.00022032385,0.00023795033,0.0005247401,0.0009013493,0.0052086613,0.10976456],"study_design_scores_gemma":[0.00008225472,0.00065028237,0.9852446,0.00051622716,0.0004303892,0.00051382586,0.00033309177,0.0009031472,0.0002910593,0.0014323981,0.009589356,0.00001331975],"about_ca_topic_score_codex":0.0072212955,"about_ca_topic_score_gemma":0.0090478305,"teacher_disagreement_score":0.0072212955,"about_ca_system_score_codex":0.00057277747,"about_ca_system_score_gemma":0.000847332,"threshold_uncertainty_score":0.0143585205},"labels":[],"label_agreement":null},{"id":"W2848247105","doi":"10.1530/erc-18-0283","title":"65 YEARS OF THE DOUBLE HELIX: It’s all in the DNA: understanding and managing endocrine neoplasms","year":2018,"lang":"en","type":"editorial","venue":"Endocrine Related Cancer","topic":"Cancer-related molecular mechanisms research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Endocrine system; Helix (gastropod); DNA; Computational biology; Cancer research; Medicine; Computer science; Biology; Internal medicine; Genetics; Paleontology; Hormone","score_opus":0.02583665657043695,"score_gpt":0.3223109654274844,"score_spread":0.29647430885704745,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2848247105","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000031169042,0.019966474,0.00012809836,0.059616763,0.9195177,0.00000794476,0.000025245961,0.000029355371,0.0006772933],"genre_scores_gemma":[0.00034309895,0.009032358,0.00008448858,0.026417496,0.96035415,0.000009767046,0.000010921843,0.0000144381875,0.003733308],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99631375,0.0009643699,0.0005068758,0.00047417366,0.0014686772,0.0002720931],"domain_scores_gemma":[0.9826561,0.00983361,0.0009391997,0.00039846692,0.0040308735,0.0021416673],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0067715854,0.0033693626,0.003193761,0.0022745337,0.0023743776,0.006126572,0.003064049,0.016541839,0.0069302386],"category_scores_gemma":[0.023374198,0.0009673499,0.0020331203,0.0009062704,0.0032082056,0.0060974695,0.0019277197,0.029138217,0.0049237837],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000043628097,0.000014734829,0.000028341681,0.0002601782,0.000021919412,0.00014571227,0.000028111253,0.000025684989,0.00006329293,0.0006360201,0.9909197,0.007812631],"study_design_scores_gemma":[0.000047679223,0.00003657238,0.00015009481,0.0004514788,0.00004544055,0.0003870845,0.0000637135,0.000080826045,0.00010303223,0.0017976158,0.99681586,0.000020605992],"about_ca_topic_score_codex":0.0016403791,"about_ca_topic_score_gemma":0.004236837,"teacher_disagreement_score":0.016541839,"about_ca_system_score_codex":0.0028216466,"about_ca_system_score_gemma":0.0027783595,"threshold_uncertainty_score":0.03581196},"labels":[],"label_agreement":null},{"id":"W2870052481","doi":"10.1530/erc-18-0160","title":"65 YEARS OF THE DOUBLE HELIX: Endocrine tumour syndromes in children and adolescents","year":2018,"lang":"en","type":"review","venue":"Endocrine Related Cancer","topic":"Neuroendocrine Tumor Research Advances","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; Jewish General Hospital; University of Toronto; Hospital for Sick Children","funders":"Canadian Institutes of Health Research; Fondation du cancer des Cèdres; Children's Hospital Foundation; Fondation de l'Hôpital de Montréal pour enfants; National Institutes of Health; Pediatric Oncology Group of Ontario","keywords":"GNAS complex locus; Medullary thyroid cancer; Endocrine system; Medicine; Disease; MEN1; Bioinformatics; Genetic testing; Cancer; Precision medicine; Thyroid cancer; Biology; Genetics; Internal medicine; Gene; Pathology; Hormone","score_opus":0.02644096254670851,"score_gpt":0.35937220213488075,"score_spread":0.3329312395881722,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2870052481","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0007279474,0.9921063,0.00018262822,0.0013932532,0.0007082181,0.0000064692886,0.00006259654,0.000017925453,0.004794655],"genre_scores_gemma":[0.005478478,0.99102014,0.00021101009,0.0008234054,0.00051902514,0.0000058365463,0.00010726278,0.000003850007,0.0018311025],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998896,0.000018201596,0.000017501316,0.000017584447,0.000039075876,0.000017956252],"domain_scores_gemma":[0.99981433,0.000084445615,0.00003247788,0.0000048179595,0.000041107058,0.00002287948],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019281474,0.00043319,0.00047555682,0.0011488261,0.00028691508,0.0004294487,0.00030527034,0.0006525198,0.0034805653],"category_scores_gemma":[0.0007456097,0.00011877687,0.00030574686,0.0010212954,0.00033732824,0.00058569905,0.00046488098,0.0013139786,0.0012476749],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000078961035,0.000037189122,0.0032849973,0.006821821,0.00007610196,0.0047019077,0.0002583912,0.00030471166,0.000993623,0.0058393963,0.09702098,0.8805819],"study_design_scores_gemma":[0.0000134403845,0.00003538045,0.0050180177,0.005367327,0.00009393147,0.03720155,0.0002422052,0.00005070065,0.00030207474,0.0022520444,0.9494071,0.00001626814],"about_ca_topic_score_codex":0.001604407,"about_ca_topic_score_gemma":0.0026513718,"teacher_disagreement_score":0.0034805653,"about_ca_system_score_codex":0.0003600916,"about_ca_system_score_gemma":0.0006816426,"threshold_uncertainty_score":0.011643589},"labels":[],"label_agreement":null},{"id":"W2883001605","doi":"10.1530/erc-18-0244","title":"Evaluating gastroenteropancreatic neuroendocrine tumors through microRNA sequencing","year":2018,"lang":"en","type":"article","venue":"Endocrine Related Cancer","topic":"Neuroendocrine Tumor Research Advances","field":"Medicine","cited_by":50,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"Southeastern Ontario Academic Medical Organization","keywords":"microRNA; Neuroendocrine tumors; Biology; Classifier (UML); Preprocessor; Computational biology; Artificial intelligence; Computer science; Genetics","score_opus":0.05979104104869274,"score_gpt":0.4035878385768374,"score_spread":0.3437967975281446,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2883001605","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9163434,0.0011652886,0.077548206,0.00009769617,0.000026565649,0.00017961809,0.002319922,0.00063480536,0.0016844802],"genre_scores_gemma":[0.8749657,0.00068307034,0.119324386,0.00013100861,0.00001712478,0.00020985169,0.003453988,0.00009460507,0.001120201],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9996094,0.00006618719,0.000052223528,0.00013005435,0.00010409926,0.000038020207],"domain_scores_gemma":[0.99934477,0.00029044543,0.00010238447,0.000045309127,0.00017614877,0.000040920502],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00087434566,0.00032419717,0.0003975916,0.00096955284,0.00016812723,0.00066506123,0.00023643003,0.0003972652,0.00046969968],"category_scores_gemma":[0.0020161911,0.00019046834,0.000352839,0.00039450076,0.00014507041,0.0002849534,0.00031269275,0.00030181644,0.00041090438],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010980684,0.00012083008,0.20871001,0.0002757924,0.00018016668,0.00092866074,0.00028917904,0.009876977,0.6050423,0.0004608393,0.001186097,0.17183107],"study_design_scores_gemma":[0.000045945693,0.00065956806,0.23496564,0.00010598369,0.00031537193,0.0027737278,0.00036296976,0.25236985,0.49756914,0.0015756517,0.009166226,0.00008987772],"about_ca_topic_score_codex":0.0008162615,"about_ca_topic_score_gemma":0.001383968,"teacher_disagreement_score":0.00096955284,"about_ca_system_score_codex":0.0002255335,"about_ca_system_score_gemma":0.00023851762,"threshold_uncertainty_score":0.004624009},"labels":[],"label_agreement":null},{"id":"W2896060946","doi":"10.1530/erc-18-0226","title":"Neuroendocrine differentiation of prostate cancer leads to PSMA suppression","year":2018,"lang":"en","type":"article","venue":"Endocrine Related Cancer","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":181,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; University of British Columbia; University of Windsor","funders":"Academy of Medical Sciences; Korea Health Industry Development Institute; National Institute for Health and Care Research; Cancer Research UK; Government of Ontario","keywords":"Somatostatin receptor 2; Prostate cancer; Cancer research; Enzalutamide; Somatostatin receptor; Neuroendocrine differentiation; Biology; Neuroendocrine tumors; Cell biology; Cancer; Molecular biology; Medicine; Internal medicine; Endocrinology; Somatostatin; Androgen receptor","score_opus":0.019242059246432963,"score_gpt":0.34537987315157886,"score_spread":0.3261378139051459,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2896060946","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9967038,0.0010905531,0.0009250105,0.00004526659,0.000010909624,0.000012644237,0.00027113967,0.00005387304,0.00088680536],"genre_scores_gemma":[0.99695706,0.0006550017,0.00036122042,0.000034581597,0.0000029868017,0.000008153093,0.00039238346,0.000009084389,0.0015795826],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9999417,0.000007133183,0.000004247209,0.000015940292,0.000019325389,0.000011557492],"domain_scores_gemma":[0.99993837,0.000009344955,0.00001556445,0.000009861047,0.000008884424,0.00001787585],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000053322598,0.00016978222,0.00013988408,0.00017012382,0.00010921045,0.00022328028,0.0000688923,0.00012512962,0.0010207561],"category_scores_gemma":[0.00008602657,0.000096089396,0.00016739733,0.00012687428,0.00013504375,0.00008236235,0.0001425434,0.00030830633,0.0002804066],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007970396,0.000012256442,0.002143973,0.000022806493,0.000006332772,0.00025197212,0.00001852276,0.000039645292,0.99572325,0.000037221645,0.000047844296,0.0016165895],"study_design_scores_gemma":[0.000014898555,0.00061444123,0.09957854,0.0000070654196,0.000034974615,0.0047769635,0.000109464396,0.0008499724,0.88743085,0.00009716255,0.006477689,0.000007954266],"about_ca_topic_score_codex":0.00085823634,"about_ca_topic_score_gemma":0.0014463678,"teacher_disagreement_score":0.0010207561,"about_ca_system_score_codex":0.00018664084,"about_ca_system_score_gemma":0.0001550724,"threshold_uncertainty_score":0.0034148097},"labels":[],"label_agreement":null},{"id":"W2908714764","doi":"10.1530/erc-18-0523","title":"Prolactin modulates TNBC aggressive phenotype limiting tumorigenesis","year":2019,"lang":"en","type":"article","venue":"Endocrine Related Cancer","topic":"Growth Hormone and Insulin-like Growth Factors","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"Canadian Institutes of Health Research","keywords":"Limiting; Carcinogenesis; Prolactin; Phenotype; Cancer research; Medicine; Biology; Internal medicine; Cancer; Genetics; Gene; Hormone; Engineering","score_opus":0.009550721519378361,"score_gpt":0.2621290981097536,"score_spread":0.25257837659037524,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2908714764","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9933891,0.002973912,0.00082229153,0.0002054986,0.000050802028,0.000014655003,0.00029213005,0.00008766417,0.0021639625],"genre_scores_gemma":[0.99692637,0.0010844911,0.00024900833,0.000056029683,0.000008694644,0.000010008867,0.000154883,0.000009410112,0.0015011512],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99992085,0.000019146037,0.00000512361,0.000010637985,0.00001680036,0.000027472339],"domain_scores_gemma":[0.9999497,0.000007344178,0.000012290741,0.000004935484,0.000006075736,0.000019691486],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000066384484,0.00015076682,0.00013787809,0.00011354166,0.00010515417,0.00029643744,0.000074290234,0.00013730867,0.0011150653],"category_scores_gemma":[0.00009756661,0.000072522314,0.00010926888,0.000086258464,0.00015058478,0.00009518037,0.00012817333,0.000413746,0.00024380331],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002850688,0.00003391769,0.00040170123,0.000027173852,0.0000029718576,0.000059470945,0.000016419554,0.000024804185,0.9966704,0.00005359135,0.00007648195,0.002347987],"study_design_scores_gemma":[0.000049683582,0.001417598,0.024659654,0.000008849883,0.000038961327,0.00051612256,0.00014467057,0.00071383687,0.9622134,0.00009475421,0.010132856,0.000009712514],"about_ca_topic_score_codex":0.0006341194,"about_ca_topic_score_gemma":0.0011706933,"teacher_disagreement_score":0.0011150653,"about_ca_system_score_codex":0.00018661005,"about_ca_system_score_gemma":0.00018073645,"threshold_uncertainty_score":0.0037302375},"labels":[],"label_agreement":null},{"id":"W2910743083","doi":"10.1530/erc-18-0465","title":"Roles of the HOXA10 gene during castrate-resistant prostate cancer progression","year":2019,"lang":"en","type":"article","venue":"Endocrine Related Cancer","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Canadian Institutes of Health Research","keywords":"Prostate cancer; Downregulation and upregulation; Biology; Transcriptome; Transcription factor; Cancer research; LNCaP; Gene expression; Androgen receptor; Gene; Prostate; Cancer; Genetics","score_opus":0.010206905508999772,"score_gpt":0.31775176286825046,"score_spread":0.3075448573592507,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2910743083","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99384034,0.0024908984,0.0015896249,0.00007747427,0.000023456942,0.000015522275,0.00062459835,0.00007722214,0.0012609884],"genre_scores_gemma":[0.9958074,0.0007133174,0.00053539325,0.000040023613,0.0000065933395,0.000016622922,0.00060084846,0.000013862295,0.0022658037],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998976,0.00001736125,0.000004689221,0.000022839657,0.000030600084,0.000026945774],"domain_scores_gemma":[0.9998976,0.000013140262,0.00003335104,0.000007576725,0.000016092095,0.000032239994],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011974761,0.00019864204,0.00018352925,0.0003779583,0.00018237218,0.00034319906,0.00011285138,0.0001648058,0.0012849909],"category_scores_gemma":[0.00011952527,0.00013914178,0.00021716226,0.00018577653,0.00021340416,0.000100385885,0.00020777313,0.00037303616,0.00023914952],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00040542486,0.00002486468,0.0053086453,0.000048642534,0.000012003094,0.00013540505,0.00006759391,0.00013609989,0.98965037,0.00013513079,0.000107525346,0.0039682076],"study_design_scores_gemma":[0.00003417223,0.0007216728,0.41880828,0.000036027905,0.000079693906,0.0012892635,0.00044291353,0.002233472,0.5674649,0.00025656953,0.008605728,0.000027296022],"about_ca_topic_score_codex":0.0019860608,"about_ca_topic_score_gemma":0.0023128309,"teacher_disagreement_score":0.0019860608,"about_ca_system_score_codex":0.00030142078,"about_ca_system_score_gemma":0.00025136097,"threshold_uncertainty_score":0.004298687},"labels":[],"label_agreement":null},{"id":"W2915015126","doi":"10.1530/erc-18-0332","title":"Genomic profiling of NETs: a comprehensive analysis of the RADIANT trials","year":2019,"lang":"en","type":"article","venue":"Endocrine Related Cancer","topic":"Neuroendocrine Tumor Research Advances","field":"Medicine","cited_by":46,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"Novartis Pharmaceuticals Corporation","keywords":"Chromosome instability; Internal medicine; Oncology; Genome instability; Clinical trial; Biomarker; Medicine; Neuroendocrine tumors; Multivariate analysis; Biology; Genetics; Chromosome; Gene","score_opus":0.03917875316243985,"score_gpt":0.3686049822565779,"score_spread":0.32942622909413805,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2915015126","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96697134,0.023498135,0.0019486262,0.0008244199,0.000029450932,0.00012617551,0.0046270336,0.000038613704,0.0019361965],"genre_scores_gemma":[0.985316,0.0047512604,0.0021563927,0.00057062664,0.00005228423,0.0001138579,0.006601639,0.000020826525,0.00041711947],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985423,0.00065218157,0.00015699312,0.00025699436,0.00033043386,0.000061097664],"domain_scores_gemma":[0.99768174,0.00077521655,0.00085466704,0.00022753591,0.00027285126,0.00018796748],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0029493496,0.00019882698,0.0006465221,0.00071607204,0.00016000956,0.0006432591,0.00021941861,0.0002218479,0.00069154846],"category_scores_gemma":[0.003128304,0.000104218794,0.00040487808,0.0013800445,0.00024322172,0.00030383686,0.0005262227,0.00028000135,0.00014007081],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0062340894,0.00016805831,0.69894046,0.0008983927,0.0022851233,0.00045525224,0.00031092245,0.0028329797,0.04233508,0.00042431278,0.0037644573,0.2413508],"study_design_scores_gemma":[0.00014006601,0.0017571374,0.9780573,0.00009222251,0.0008526394,0.0010900267,0.00010875455,0.0007697888,0.0036737968,0.00040348648,0.013034272,0.00002043118],"about_ca_topic_score_codex":0.000470203,"about_ca_topic_score_gemma":0.0017604966,"teacher_disagreement_score":0.0029493496,"about_ca_system_score_codex":0.00036643932,"about_ca_system_score_gemma":0.00047607845,"threshold_uncertainty_score":0.01559782},"labels":[],"label_agreement":null},{"id":"W2991511894","doi":"10.1530/erc-19-0258","title":"Photodynamic therapy enables tumor-specific ablation in preclinical models of thyroid cancer","year":2019,"lang":"en","type":"article","venue":"Endocrine Related Cancer","topic":"Thyroid Cancer Diagnosis and Treatment","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"Canadian Cancer Society Research Institute; Terry Fox Research Institute; Princess Margaret Cancer Foundation","keywords":"Medicine; Thyroid cancer; Photodynamic therapy; Thyroid; Cancer; Malignancy; Thyroid carcinoma; Ablation; Pathology; Cancer research; Oncology; Internal medicine; Surgery; Chemistry","score_opus":0.027580300683800515,"score_gpt":0.32287675943587335,"score_spread":0.29529645875207283,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2991511894","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9605103,0.005219552,0.02488726,0.0003822309,0.00016962785,0.00046604418,0.0017820579,0.0005841413,0.0059988364],"genre_scores_gemma":[0.9780465,0.0026912543,0.011829893,0.00011809433,0.000019634674,0.000549748,0.0010599995,0.00006355789,0.0056213373],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9996991,0.000031902116,0.000029956751,0.000076559714,0.00008753005,0.00007507447],"domain_scores_gemma":[0.99988115,0.000022733993,0.000028672543,0.00001757201,0.000023182649,0.000026699508],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00054820563,0.00048231753,0.0003780206,0.0003770866,0.00026208136,0.00033622343,0.0005074104,0.00067802216,0.0011800375],"category_scores_gemma":[0.00016996637,0.00027613263,0.00049199944,0.0002665818,0.00028883162,0.00030116513,0.00025621252,0.0011186252,0.00027973717],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013622918,0.00012007277,0.00008987761,0.0001150931,0.000009874406,0.000063641244,0.000052966843,0.00045517448,0.99725133,0.00025854493,0.0001863624,0.0012608991],"study_design_scores_gemma":[0.0000420103,0.0014530484,0.00069859356,0.000011366348,0.00003757495,0.00015842202,0.000029813436,0.002876523,0.99000996,0.00008424731,0.004587872,0.000010600807],"about_ca_topic_score_codex":0.0036323867,"about_ca_topic_score_gemma":0.0054539284,"teacher_disagreement_score":0.0036323867,"about_ca_system_score_codex":0.00071634364,"about_ca_system_score_gemma":0.0006183426,"threshold_uncertainty_score":0.007222533},"labels":[],"label_agreement":null},{"id":"W2994033895","doi":"10.1530/erc-19-0420","title":"The epigenetic and transcriptional landscape of neuroendocrine prostate cancer","year":2019,"lang":"en","type":"review","venue":"Endocrine Related Cancer","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":93,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"National Health and Medical Research Council; Canadian Institutes of Health Research; Medical Research Council; Prostate Cancer Foundation","keywords":"Epigenetics; Reprogramming; Biology; Prostate cancer; Epigenome; Lineage (genetic); Cancer research; DNA methylation; Phenotype; Cancer; Transcription factor; Genetics; Gene; Gene expression","score_opus":0.043541312039840095,"score_gpt":0.37492675142322535,"score_spread":0.33138543938338527,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2994033895","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0002104155,0.99759537,0.0001438326,0.00040485128,0.00018264573,0.000002640289,0.000028846078,0.0000089127525,0.0014225021],"genre_scores_gemma":[0.0010416798,0.9976109,0.00010299637,0.00020962661,0.00013776851,0.0000031692969,0.00003683631,0.0000013309882,0.00085555593],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9999254,0.000013225517,0.000009298057,0.000013824843,0.000029225801,0.000009029156],"domain_scores_gemma":[0.999902,0.00003951655,0.00001460762,0.00000349737,0.00002809775,0.000012126946],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002294052,0.00041906608,0.00062903244,0.00089833426,0.00020208395,0.0006423689,0.00037160623,0.0005590117,0.0028737288],"category_scores_gemma":[0.00028099696,0.00013270516,0.00022569657,0.00087671995,0.0002944031,0.0006398597,0.0005146972,0.0010676719,0.0013750931],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000047116133,0.000029723255,0.00026779823,0.010695037,0.000064989516,0.00023978624,0.00009235772,0.00035848355,0.0049941516,0.005348972,0.029727638,0.948134],"study_design_scores_gemma":[0.000004030733,0.000039772243,0.0007782587,0.0012227526,0.00004089469,0.0009966034,0.00004287791,0.00005493334,0.0006088058,0.001664438,0.9945372,0.00000944153],"about_ca_topic_score_codex":0.0008921964,"about_ca_topic_score_gemma":0.0023012946,"teacher_disagreement_score":0.0028737288,"about_ca_system_score_codex":0.00043082275,"about_ca_system_score_gemma":0.00072556315,"threshold_uncertainty_score":0.009613574},"labels":[],"label_agreement":null},{"id":"W29986924","doi":"10.1530/erc-18-0160","title":"Reply to Todres, Stephenson and Jones","year":2017,"lang":"en","type":"article","venue":"Endocrine Related Cancer","topic":"Pituitary Gland Disorders and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Canadian Institutes of Health Research","keywords":"History","score_opus":0.01701823401570567,"score_gpt":0.3198969860869099,"score_spread":0.30287875207120424,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W29986924","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00009165179,0.007853574,0.000096523894,0.8762892,0.11470539,0.000012579457,0.000073358286,0.000033139135,0.0008446061],"genre_scores_gemma":[0.0009036312,0.0066512804,0.00017254114,0.90448534,0.08339565,0.00003341139,0.000047275054,0.00003193371,0.004278951],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99591404,0.0009053374,0.0005445878,0.0007266529,0.0015346156,0.00037472154],"domain_scores_gemma":[0.9832556,0.0071268813,0.000776234,0.00054976164,0.0058561014,0.002435439],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0062248223,0.001484521,0.0024037368,0.0014319883,0.0027230072,0.004712669,0.0036870611,0.027888408,0.0088306535],"category_scores_gemma":[0.039963257,0.0010480563,0.0016550708,0.0010697738,0.004109055,0.009087175,0.002889481,0.051978793,0.010595469],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000015989352,0.000007869293,0.000054050022,0.000061700695,0.000006152328,0.00011994816,0.000035833902,0.000010946517,0.000020904523,0.0004596535,0.99645114,0.002755781],"study_design_scores_gemma":[0.000035739427,0.000025995656,0.0003913974,0.00036860473,0.00001803191,0.0009663506,0.00031787506,0.00005876997,0.00010897733,0.0022153598,0.9954366,0.000056315417],"about_ca_topic_score_codex":0.005371139,"about_ca_topic_score_gemma":0.007806993,"teacher_disagreement_score":0.027888408,"about_ca_system_score_codex":0.0030160975,"about_ca_system_score_gemma":0.005486651,"threshold_uncertainty_score":0.03292042},"labels":[],"label_agreement":null},{"id":"W2998813768","doi":"10.1530/erc-19-0448","title":"Effects of epigenetic pathway inhibitors on corticotroph tumour AtT20 cells","year":2020,"lang":"en","type":"article","venue":"Endocrine Related Cancer","topic":"Protein Degradation and Inhibitors","field":"Biochemistry, Genetics and Molecular Biology","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Ministero dello Sviluppo Economico; Fundação de Amparo à Pesquisa do Estado de São Paulo; Ontario Ministry of Economic Development and Innovation; Medical Research Council; Ontario Genomics Institute; European Federation of Pharmaceutical Industries and Associations; Novartis Pharma; Wellcome Trust; Genome Canada; Ontario Genomics; Pfizer","keywords":"Somatostatin receptor 2; Propidium iodide; Corticotropic cell; Apoptosis; Molecular biology; Cell cycle; Flow cytometry; Somatostatin; Adrenocorticotropic hormone; Cancer research; Biology; Somatostatin receptor; Chemistry; Endocrinology; Biochemistry; Hormone; Anterior pituitary","score_opus":0.005619348997792304,"score_gpt":0.22123994661301688,"score_spread":0.21562059761522456,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2998813768","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98809916,0.0059212116,0.0016951949,0.0001306063,0.00010718595,0.00007857808,0.000935454,0.00010958955,0.0029230902],"genre_scores_gemma":[0.9866317,0.0045931335,0.0023993538,0.00013481951,0.000030073948,0.00014224548,0.0018303522,0.000025550975,0.004212736],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998367,0.00002258634,0.0000150457745,0.000033911478,0.00005562906,0.00003611363],"domain_scores_gemma":[0.999905,0.00003117083,0.000018297285,0.00001095451,0.000015575422,0.000018915822],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014836309,0.00040529453,0.0004168947,0.00026270153,0.00017092557,0.00022482392,0.0001444125,0.0002462866,0.0019480971],"category_scores_gemma":[0.00010480279,0.0000963724,0.00036602715,0.0002254473,0.00014883578,0.00013639222,0.0001358774,0.000609445,0.00039263998],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019378439,0.00007294891,0.00011391193,0.00006486508,0.00000913255,0.000050562336,0.000020261738,0.00007124057,0.9973617,0.00003867048,0.000057862464,0.0019450287],"study_design_scores_gemma":[0.000046192814,0.001647256,0.004627234,0.000008730503,0.00003070483,0.00022820689,0.000038300743,0.0005341959,0.98910856,0.000026625095,0.003698468,0.000005504196],"about_ca_topic_score_codex":0.00058291643,"about_ca_topic_score_gemma":0.0015896887,"teacher_disagreement_score":0.0019480971,"about_ca_system_score_codex":0.00016733189,"about_ca_system_score_gemma":0.0001664803,"threshold_uncertainty_score":0.006516993},"labels":[],"label_agreement":null},{"id":"W3005995778","doi":"10.1530/erc-19-0417","title":"Thyroid dysfunction and cancer incidence: a systematic review and meta-analysis","year":2020,"lang":"en","type":"review","venue":"Endocrine Related Cancer","topic":"Thyroid Cancer Diagnosis and Treatment","field":"Medicine","cited_by":92,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Thyroid cancer; Meta-analysis; Internal medicine; Cochrane Library; Incidence (geometry); Relative risk; Prostate cancer; Oncology; Breast cancer; Publication bias; Cancer; Confounding; Gynecology; Confidence interval","score_opus":0.051508940819235995,"score_gpt":0.3708871010082483,"score_spread":0.3193781601890123,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3005995778","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0017130849,0.99669456,0.00037600324,0.00019250062,0.0001326685,0.00016573524,0.0005424551,0.0000141403125,0.00016887164],"genre_scores_gemma":[0.08768536,0.90656585,0.0020187078,0.0012725246,0.00034554058,0.0008659284,0.0009173355,0.000029835066,0.00029881127],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99049103,0.0043329424,0.00272809,0.0010411697,0.00105858,0.0003482042],"domain_scores_gemma":[0.98169476,0.013794138,0.00254876,0.0005496018,0.0012341271,0.00017865824],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.012471504,0.0027719329,0.015975485,0.007031734,0.00065918633,0.0032957979,0.0018564686,0.0020927438,0.004071541],"category_scores_gemma":[0.03326112,0.0015395295,0.037542056,0.0089237485,0.00063227094,0.0016662016,0.0014227626,0.0020572904,0.0003549759],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00092436624,0.00001812018,0.0046550785,0.5157054,0.46492717,0.0001432172,0.00007339597,0.00045922556,0.00017823174,0.00015296786,0.0009157656,0.01184702],"study_design_scores_gemma":[0.00035893658,0.00012513933,0.0037451147,0.044660915,0.947793,0.00016516216,0.000036514262,0.00013035073,0.00009954613,0.00022434608,0.0026386876,0.000022249184],"about_ca_topic_score_codex":0.009885207,"about_ca_topic_score_gemma":0.024525909,"teacher_disagreement_score":0.015975485,"about_ca_system_score_codex":0.002837434,"about_ca_system_score_gemma":0.0048457794,"threshold_uncertainty_score":0.065956354},"labels":[],"label_agreement":null},{"id":"W3014356214","doi":"10.1530/erc-19-0463","title":"Pulmonary and overall healthcare utilization after childhood and young adult thyroid cancer","year":2020,"lang":"en","type":"article","venue":"Endocrine Related Cancer","topic":"Thyroid Cancer Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Hospital for Sick Children; The Scarborough Hospital; Public Health Ontario; University of Toronto; Pediatric Oncology Group","funders":"Pediatric Oncology Group of Ontario; Government of Ontario; Ontario Ministry of Health and Long-Term Care; Ontario Institute for Cancer Research; Cancer Care Ontario","keywords":"Childhood cancer; Medicine; Thyroid cancer; Health care; Pediatrics; Cancer; Intensive care medicine; Oncology; Internal medicine; Political science","score_opus":0.015543057188599545,"score_gpt":0.28242053054796673,"score_spread":0.2668774733593672,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3014356214","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99673575,0.0012346815,0.000025239664,0.000094332136,0.0000039965694,0.000004600484,0.0013589866,0.0000032998391,0.0005389437],"genre_scores_gemma":[0.99830014,0.00063916546,0.00002946183,0.00002750936,0.0000048775228,0.0000038414532,0.0009011194,0.0000010117932,0.000092771785],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995276,0.00007343833,0.000057306195,0.00006775174,0.00014967738,0.00012432475],"domain_scores_gemma":[0.99892706,0.000093622024,0.00065190106,0.00003504283,0.00011836784,0.00017399792],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032485925,0.00011727352,0.0001699445,0.00067481823,0.00023703405,0.00045029237,0.00030305257,0.0002232869,0.0007875733],"category_scores_gemma":[0.001523346,0.000111593705,0.00042279536,0.001272064,0.00021874475,0.00024124222,0.0004118416,0.0002936199,0.00008574361],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000007267655,0.000003370095,0.999086,0.0000069534735,0.000017182429,0.000030842744,0.00002896449,0.00001888766,0.00002158407,0.0000064338315,0.00006301281,0.00070944405],"study_design_scores_gemma":[4.798379e-7,0.0000083453015,0.999706,0.000005716049,0.000007092434,0.00007458943,0.00007193054,0.000034940324,0.000009419994,0.0000025824693,0.00007816189,6.7122505e-7],"about_ca_topic_score_codex":0.1794239,"about_ca_topic_score_gemma":0.27348095,"teacher_disagreement_score":0.1794239,"about_ca_system_score_codex":0.0014611495,"about_ca_system_score_gemma":0.0010750659,"threshold_uncertainty_score":0.35675907},"labels":[],"label_agreement":null},{"id":"W3032997756","doi":"10.1530/erc-20-0201","title":"HEREDITARY ENDOCRINE TUMOURS: CURRENT STATE-OF-THE-ART AND RESEARCH OPPORTUNITIES: History of the multiple endocrine neoplasia workshops and overview of MEN2019","year":2020,"lang":"en","type":"editorial","venue":"Endocrine Related Cancer","topic":"Neuroendocrine Tumor Research Advances","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Pheochromocytoma; Multiple endocrine neoplasia; MEN1; Medicine; Multiple endocrine neoplasia type 2; Thyroid carcinoma; Endocrine system; Cancer; Thyroid cancer; Thyroid; Internal medicine; Hormone; Biology; Gene; Germline mutation; Genetics","score_opus":0.09646010021006984,"score_gpt":0.38087666160831646,"score_spread":0.2844165613982466,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3032997756","genre_codex":"review","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00066839805,0.8326589,0.00038194185,0.105542496,0.05087883,0.000014746552,0.000074767995,0.00004553304,0.009734313],"genre_scores_gemma":[0.00499586,0.8941271,0.0006677553,0.033621196,0.05002046,0.00004005806,0.0001822831,0.000058717396,0.016286662],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9984995,0.00051844283,0.00016523578,0.00015827667,0.00046649823,0.00019209537],"domain_scores_gemma":[0.9937983,0.0027552522,0.00038320303,0.0001145385,0.0013490419,0.001599621],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005284556,0.00069817447,0.0007227875,0.0025305336,0.0012173848,0.0039983047,0.0011667018,0.003486733,0.009048468],"category_scores_gemma":[0.008548484,0.00050910964,0.0006671558,0.002477595,0.0017488577,0.0045405175,0.0025364596,0.0054536415,0.002497457],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012236954,0.00009856985,0.0008451836,0.001921875,0.000023329658,0.0004248979,0.00054767926,0.00014466478,0.00031042643,0.006120006,0.696515,0.2929261],"study_design_scores_gemma":[0.00000540113,0.000032709635,0.00060898584,0.0014932068,0.000009337871,0.00039160877,0.0002854062,0.000018434388,0.00005946467,0.00080325635,0.99628204,0.000010137458],"about_ca_topic_score_codex":0.0035500152,"about_ca_topic_score_gemma":0.010090277,"teacher_disagreement_score":0.009048468,"about_ca_system_score_codex":0.0031017943,"about_ca_system_score_gemma":0.003251437,"threshold_uncertainty_score":0.0302701},"labels":[],"label_agreement":null},{"id":"W3037336826","doi":"10.1530/erc-20-0135","title":"Tyrosine kinase inhibitor therapy and metabolic remodelling in papillary thyroid cancer","year":2020,"lang":"en","type":"article","venue":"Endocrine Related Cancer","topic":"Thyroid Cancer Diagnosis and Treatment","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Alberta","funders":"Canadian Institutes of Health Research","keywords":"Papillary thyroid cancer; Tyrosine kinase; Tyrosine-kinase inhibitor; Cancer research; Thyroid cancer; Medicine; Tyrosine; Cancer; Oncology; Internal medicine; Biology; Endocrinology; Receptor; Biochemistry","score_opus":0.030049953456722983,"score_gpt":0.287824498911565,"score_spread":0.257774545454842,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3037336826","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98662007,0.010180856,0.00045790747,0.00012243206,0.000012295315,0.00001871782,0.00014879157,0.000027024389,0.0024118652],"genre_scores_gemma":[0.9960969,0.0023967868,0.00024963182,0.000059187725,0.0000052692153,0.000013426303,0.0001870951,0.0000052565824,0.0009864867],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9999397,0.000011636301,0.0000024093613,0.00000910685,0.000021958027,0.000015209285],"domain_scores_gemma":[0.99996114,0.000009476721,0.000012489508,0.0000029360845,0.000005309747,0.000008513036],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014263028,0.00012073699,0.00021934228,0.00012547337,0.00013300095,0.0002907066,0.00010971282,0.00022533533,0.00091554574],"category_scores_gemma":[0.00010409842,0.00008989398,0.00023924622,0.00021863445,0.00014804273,0.0001366036,0.000096823205,0.00029767252,0.000118873184],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016401613,0.00012439687,0.01441683,0.00019215693,0.000052944953,0.0006681374,0.00008203999,0.00048436303,0.95825696,0.00021140004,0.00027601543,0.023594655],"study_design_scores_gemma":[0.00017496536,0.0084597515,0.49259657,0.000040247054,0.00032170743,0.009706935,0.0004839066,0.0037905984,0.45580125,0.00067218224,0.02791368,0.00003817622],"about_ca_topic_score_codex":0.0026012843,"about_ca_topic_score_gemma":0.0040536197,"teacher_disagreement_score":0.0026012843,"about_ca_system_score_codex":0.0006960489,"about_ca_system_score_gemma":0.00038935454,"threshold_uncertainty_score":0.0051722527},"labels":[],"label_agreement":null},{"id":"W3091526633","doi":"10.1530/erc-20-0297","title":"Adiponectin receptor activation inhibits prostate cancer xenograft growth","year":2020,"lang":"en","type":"article","venue":"Endocrine Related Cancer","topic":"Adipokines, Inflammation, and Metabolic Diseases","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"National Health and Medical Research Council; State Government of Victoria; Prostate Cancer Foundation of Australia; Society for Endocrinology; Movember Foundation; Australian Government; Prostate Cancer Foundation","keywords":"Adiponectin; Adiponectin receptor 1; LNCaP; Prostate cancer; Adipokine; Cancer research; Endocrinology; Internal medicine; Medicine; Cancer; Biology; Insulin resistance; Insulin","score_opus":0.014645533151671823,"score_gpt":0.27615078193587606,"score_spread":0.2615052487842042,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3091526633","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97834694,0.006955646,0.00363541,0.00055474683,0.0003543653,0.00013077962,0.0023965132,0.0005923397,0.007033319],"genre_scores_gemma":[0.9851747,0.0026932338,0.0012901094,0.00016870954,0.000021786493,0.00007560153,0.0018405966,0.000030816784,0.008704398],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998087,0.000026948826,0.000015054539,0.000036420195,0.00005733724,0.000055579305],"domain_scores_gemma":[0.9999167,0.000016135526,0.000018089639,0.0000134491565,0.000009465309,0.000026237167],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018115586,0.0004779509,0.00034726402,0.00029919986,0.00012362884,0.00030543946,0.00030415508,0.00031424646,0.0026922608],"category_scores_gemma":[0.00010078019,0.00020326955,0.00039109198,0.0002595905,0.00019033527,0.0001759676,0.00016351115,0.0012555197,0.0006967006],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013404555,0.0010602348,0.00033339602,0.00023332487,0.000048798345,0.00010833894,0.000086428976,0.000757448,0.9828439,0.00044512594,0.0017505751,0.010992054],"study_design_scores_gemma":[0.00024400576,0.011753011,0.0067459717,0.00002840924,0.000073060284,0.0005349461,0.00010446198,0.0047518983,0.9602112,0.0001744742,0.015354969,0.000023573388],"about_ca_topic_score_codex":0.0023967149,"about_ca_topic_score_gemma":0.0031272096,"teacher_disagreement_score":0.0026922608,"about_ca_system_score_codex":0.00034994935,"about_ca_system_score_gemma":0.000438691,"threshold_uncertainty_score":0.0090065},"labels":[],"label_agreement":null},{"id":"W3126018719","doi":"10.1530/erc-20-0382","title":"Spartalizumab in metastatic, well/poorly differentiated neuroendocrine neoplasms","year":2021,"lang":"en","type":"article","venue":"Endocrine Related Cancer","topic":"Neuroendocrine Tumor Research Advances","field":"Medicine","cited_by":106,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Nausea; Neuroendocrine tumors; Internal medicine; Clinical endpoint; Gastroenterology; Confidence interval; Oncology; Clinical trial","score_opus":0.02156480544578787,"score_gpt":0.3332527958309429,"score_spread":0.31168799038515504,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3126018719","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9961492,0.0032406647,0.00012202942,0.00008473926,0.000017517763,0.00005772376,0.00005586717,0.000008658288,0.0002635783],"genre_scores_gemma":[0.99819046,0.0011513482,0.00020292323,0.00011535089,0.00002179748,0.000034150675,0.0001306024,0.0000016672424,0.0001516943],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9998006,0.0000988537,0.000016374239,0.000029932831,0.000029964049,0.000024346966],"domain_scores_gemma":[0.9997211,0.00006266113,0.000060238614,0.000015135532,0.000020094009,0.00012070707],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009099355,0.00034262205,0.00074425165,0.00015926505,0.00010153916,0.00031307602,0.00021005908,0.00026415725,0.00029405975],"category_scores_gemma":[0.00048176362,0.00015745818,0.00044044942,0.0001481492,0.00027777976,0.0002996709,0.00020954038,0.00056576915,0.00007113137],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.19810565,0.0103077255,0.1974524,0.0019962497,0.0017851252,0.003294701,0.0004678835,0.009000648,0.22053665,0.00068274885,0.0035263093,0.35284394],"study_design_scores_gemma":[0.09369688,0.5788861,0.27196056,0.00018423398,0.0013536907,0.005974487,0.00036794564,0.010500972,0.026208818,0.00080048136,0.010003126,0.000062685926],"about_ca_topic_score_codex":0.0005150624,"about_ca_topic_score_gemma":0.0026900289,"teacher_disagreement_score":0.0009099355,"about_ca_system_score_codex":0.00043976997,"about_ca_system_score_gemma":0.00053347234,"threshold_uncertainty_score":0.0048123},"labels":[],"label_agreement":null},{"id":"W3134335774","doi":"10.1530/erc-20-0504","title":"KLF5 and NFYA factors as novel regulators of prostate cancer cell metabolism","year":2021,"lang":"en","type":"article","venue":"Endocrine Related Cancer","topic":"Kruppel-like factors research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Centre hospitalier de l'Université Laval","funders":"Canadian Institutes of Health Research","keywords":"Gene knockdown; Biology; Cell growth; Prostate cancer; Transcription factor; Cancer research; Cell; Androgen receptor; Cell biology; Gene; Cancer; Genetics","score_opus":0.008863425710436808,"score_gpt":0.28919489979411445,"score_spread":0.28033147408367765,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3134335774","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9490564,0.026556501,0.01748705,0.00025939653,0.00007603253,0.00004736548,0.0022772527,0.00033104597,0.003908817],"genre_scores_gemma":[0.9892517,0.0026682208,0.003805459,0.00012873388,0.000020246049,0.000021882826,0.0015655002,0.00002368231,0.002514522],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998511,0.000019596744,0.000012328384,0.000047699104,0.000038733157,0.00003059163],"domain_scores_gemma":[0.99987316,0.00001700383,0.00004746147,0.000008623871,0.00001968369,0.000034032983],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021468867,0.00031653437,0.00024520204,0.00027850826,0.00018046799,0.00042658587,0.00014860279,0.0002090094,0.0011294252],"category_scores_gemma":[0.00015441078,0.00010560526,0.00035820113,0.00017191266,0.0001735943,0.0002990858,0.00024397888,0.00030112808,0.00025469565],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003701187,0.00002398408,0.009832592,0.0002446215,0.000045240635,0.0002638024,0.00007157859,0.00043786276,0.9747584,0.0007770179,0.00026189603,0.012912962],"study_design_scores_gemma":[0.00006326104,0.0005941938,0.21798317,0.00018106391,0.00026503758,0.002819461,0.00039466502,0.006950965,0.71900797,0.0012905042,0.05036945,0.000080231854],"about_ca_topic_score_codex":0.00071297714,"about_ca_topic_score_gemma":0.001153392,"teacher_disagreement_score":0.0011294252,"about_ca_system_score_codex":0.0003451237,"about_ca_system_score_gemma":0.00024706815,"threshold_uncertainty_score":0.0037782788},"labels":[],"label_agreement":null},{"id":"W3149820296","doi":"10.1530/erc-20-0496","title":"Incident atrial fibrillation in patients with differentiated thyroid cancer: a meta-analysis","year":2021,"lang":"en","type":"review","venue":"Endocrine Related Cancer","topic":"Thyroid Cancer Diagnosis and Treatment","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"National Institute for Health and Care Research","keywords":"Atrial fibrillation; Thyroid cancer; Meta-analysis; Medicine; Internal medicine; Thyroid; Cancer; Oncology; Cardiology","score_opus":0.047142731222190336,"score_gpt":0.3537511047315806,"score_spread":0.3066083735093903,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3149820296","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.021508537,0.9749663,0.0013085272,0.0002758393,0.00027573487,0.00018972358,0.0009805586,0.000057064906,0.00043775863],"genre_scores_gemma":[0.56106436,0.42989513,0.003130525,0.0013288518,0.00052299805,0.00089825597,0.0023160751,0.00007648177,0.00076736056],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99372876,0.0029712373,0.00158204,0.0009491611,0.000490426,0.0002783392],"domain_scores_gemma":[0.98800254,0.008721848,0.001403974,0.00069001276,0.0009683513,0.00021322786],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009449501,0.0025716273,0.013783192,0.0035870892,0.0006889763,0.0033459347,0.0016678111,0.0022275608,0.002969098],"category_scores_gemma":[0.020676995,0.0014764969,0.060589727,0.0044598123,0.00048093198,0.0013353735,0.0012708948,0.0021656374,0.00035469444],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0030186889,0.000024665973,0.00836316,0.0599492,0.9225493,0.00015045622,0.00004752881,0.00078279455,0.00021118025,0.00007517192,0.00041741456,0.004410324],"study_design_scores_gemma":[0.00039509355,0.00012449244,0.0037782353,0.0025451228,0.99211264,0.000074808915,0.000018416511,0.00023996131,0.000058683756,0.00010773367,0.0005298206,0.00001490223],"about_ca_topic_score_codex":0.006937124,"about_ca_topic_score_gemma":0.010668519,"teacher_disagreement_score":0.013783192,"about_ca_system_score_codex":0.0016891356,"about_ca_system_score_gemma":0.0017120709,"threshold_uncertainty_score":0.049974322},"labels":[],"label_agreement":null},{"id":"W3162319908","doi":"10.1530/erc-21-0030","title":"A pilot study of everolimus and radiation for neuroendocrine liver metastases","year":2021,"lang":"en","type":"article","venue":"Endocrine Related Cancer","topic":"Neuroendocrine Tumor Research Advances","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Everolimus; Medicine; Neuroendocrine tumors; Tolerability; Radiation therapy; Oncology; Internal medicine; Progression-free survival; Response Evaluation Criteria in Solid Tumors; Urology; Phases of clinical research; Toxicity; Chemotherapy; Adverse effect","score_opus":0.03787095804094056,"score_gpt":0.34970388152816295,"score_spread":0.3118329234872224,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3162319908","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99361044,0.0005551366,0.0007511144,0.0001482515,0.00008314451,0.0035062765,0.00031246987,0.000045651243,0.000987495],"genre_scores_gemma":[0.98760325,0.0008656376,0.0023315225,0.00036209525,0.00026512353,0.0057781483,0.0009063486,0.000029726612,0.0018581729],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9986714,0.0007738302,0.0000698971,0.00019264877,0.00009127984,0.00020098187],"domain_scores_gemma":[0.9982058,0.0005414786,0.00014913557,0.0002376949,0.00009349699,0.0007724478],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002948427,0.0017335898,0.001994536,0.0005350765,0.00060372293,0.00061709416,0.0011507482,0.0012364892,0.0043284306],"category_scores_gemma":[0.0015040488,0.00069054705,0.0017874549,0.0005443863,0.0014810828,0.0008381315,0.00066490343,0.002478367,0.00090007874],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.5234923,0.3042231,0.010835004,0.00077016826,0.0014449251,0.0017884678,0.0007194957,0.0024409348,0.09463063,0.00033171102,0.0011227158,0.05820044],"study_design_scores_gemma":[0.042084593,0.95159847,0.0038161324,0.000005974378,0.00012821578,0.00019809381,0.000031145115,0.00015650215,0.0014693291,0.000040616625,0.00046301848,0.000007930541],"about_ca_topic_score_codex":0.0012970954,"about_ca_topic_score_gemma":0.0015030539,"teacher_disagreement_score":0.0043284306,"about_ca_system_score_codex":0.0004628879,"about_ca_system_score_gemma":0.001980088,"threshold_uncertainty_score":0.015592992},"labels":[],"label_agreement":null},{"id":"W3169559325","doi":"10.1530/erc-21-0116","title":"Targeting androgen receptor signaling: a historical perspective","year":2021,"lang":"en","type":"review","venue":"Endocrine Related Cancer","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Canadian Institutes of Health Research; Terry Fox Research Institute; Prostate Cancer Canada; Prostate Cancer Foundation","keywords":"Prostate cancer; Medicine; Androgen deprivation therapy; Cancer; Disease; Hormonal therapy; Oncology; Prostate; Internal medicine; Androgen; Hormone","score_opus":0.05901755478858615,"score_gpt":0.3948831400957289,"score_spread":0.3358655853071427,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3169559325","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00005733794,0.9974686,0.000041932493,0.00074827543,0.000681773,0.0000012130238,0.000007026588,0.000002668516,0.0009912864],"genre_scores_gemma":[0.0006684216,0.99711007,0.00004691606,0.0010691304,0.00075353816,0.0000025770241,0.000009605756,0.0000013230399,0.00033831777],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9996898,0.00007649828,0.00003969072,0.000059022706,0.00009842171,0.000036506965],"domain_scores_gemma":[0.9992132,0.00046132872,0.000057676127,0.000020777727,0.00019188484,0.000055061668],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00093857246,0.0008203447,0.0010560323,0.0029723987,0.00049623265,0.0016145994,0.000907436,0.0017384241,0.002676812],"category_scores_gemma":[0.0017202998,0.00035733616,0.00055519753,0.0027470957,0.00111178,0.0029051115,0.00083552446,0.0040998184,0.0017661655],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016231589,0.00011367334,0.00035183964,0.02370993,0.00009030191,0.0009530641,0.00042926244,0.00046861687,0.0015402937,0.02889225,0.14350484,0.7997836],"study_design_scores_gemma":[0.0000068142217,0.00005019351,0.0003436479,0.0042750053,0.000033169334,0.0015023792,0.00008696281,0.000031123323,0.00012003993,0.0029250893,0.9906116,0.000014025626],"about_ca_topic_score_codex":0.0020244247,"about_ca_topic_score_gemma":0.0033347872,"teacher_disagreement_score":0.0029723987,"about_ca_system_score_codex":0.001145934,"about_ca_system_score_gemma":0.0014960613,"threshold_uncertainty_score":0.008954823},"labels":[],"label_agreement":null},{"id":"W3170594626","doi":"10.1530/erc-21-0098","title":"Androgen receptor signaling inhibitors: post-chemotherapy, pre-chemotherapy and now in castration-sensitive prostate cancer","year":2021,"lang":"en","type":"review","venue":"Endocrine Related Cancer","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Terry Fox Foundation; National Cancer Institute; Dan L. Duncan Cancer Center, Baylor College of Medicine; Adrienne Helis Malvin Medical Research Foundation; Prostate Cancer Foundation","keywords":"Enzalutamide; Bicalutamide; Prostate cancer; Androgen receptor; Medicine; Flutamide; Abiraterone acetate; Cyproterone acetate; Androgen; Oncology; Internal medicine; Androgen deprivation therapy; Antiandrogen; Cancer; Pharmacology; Hormone","score_opus":0.02342480583172414,"score_gpt":0.3628771149748778,"score_spread":0.33945230914315366,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3170594626","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.012723151,0.97202253,0.0005405632,0.0070028105,0.001543177,0.000022698658,0.00011346992,0.0000433089,0.0059883646],"genre_scores_gemma":[0.11999515,0.85932255,0.0012086954,0.008397614,0.0029176949,0.000042636937,0.0004863562,0.000024148663,0.007605171],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.9998337,0.00002872258,0.000022184084,0.00003249614,0.000052922092,0.000029964784],"domain_scores_gemma":[0.9997062,0.00007291092,0.000055330027,0.000015574466,0.000075592645,0.00007445647],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00066192384,0.0002750079,0.0006113362,0.00039128194,0.00022259328,0.00095364486,0.00034054165,0.0004473879,0.002154277],"category_scores_gemma":[0.0007248382,0.00010386233,0.0002671436,0.0006129129,0.00042435253,0.0010517165,0.00031337107,0.0017627882,0.0006983149],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014190656,0.00025805656,0.0027942301,0.0022554433,0.0000659626,0.00035700286,0.000110314126,0.00023714751,0.0035163201,0.0041041607,0.016598526,0.96828383],"study_design_scores_gemma":[0.0003872249,0.0038671466,0.020449325,0.0019604634,0.00035973292,0.004777649,0.00020598216,0.0004399112,0.004999525,0.004639644,0.9578532,0.000060312817],"about_ca_topic_score_codex":0.0007048062,"about_ca_topic_score_gemma":0.0030129177,"teacher_disagreement_score":0.002154277,"about_ca_system_score_codex":0.0005214891,"about_ca_system_score_gemma":0.000728098,"threshold_uncertainty_score":0.0072067976},"labels":[],"label_agreement":null},{"id":"W3174319659","doi":"10.1530/erc-21-0192","title":"Celebrating the 80th anniversary of hormone ablation for prostate cancer","year":2021,"lang":"en","type":"article","venue":"Endocrine Related Cancer","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"U.S. Department of Veterans Affairs","keywords":"Prostate cancer; Medicine; Androgen; Cancer; Disease; Radiation therapy; Prostate; Ablation; Oncology; Endocrine system; Internal medicine; Hormone; Cancer research; Bioinformatics; Biology","score_opus":0.020317115866904788,"score_gpt":0.3338556181193614,"score_spread":0.3135385022524566,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3174319659","genre_codex":"editorial","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00061012496,0.2573068,0.0006994086,0.07798905,0.6480329,0.00003456089,0.00021699125,0.00022451152,0.014885713],"genre_scores_gemma":[0.0042632017,0.21941966,0.0006292041,0.037605785,0.6648894,0.000052207815,0.00030673764,0.00018000888,0.072653785],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99892896,0.00017621274,0.000083227394,0.00014272946,0.00052349456,0.00014531569],"domain_scores_gemma":[0.99689937,0.0008272845,0.0003083166,0.00011084176,0.00092784106,0.00092635385],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013913414,0.001049848,0.0010780735,0.0013681888,0.0010093374,0.003567884,0.0011020047,0.0025858101,0.020344857],"category_scores_gemma":[0.004105246,0.00033102007,0.0007770279,0.0007571046,0.00090613303,0.0025753484,0.0015785444,0.005420973,0.01215812],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007260139,0.000022435546,0.00008581261,0.00039314394,0.000015088449,0.000074440264,0.000033348053,0.000033534045,0.00031701487,0.00091878953,0.95220554,0.04582829],"study_design_scores_gemma":[0.0000060587777,0.00003955008,0.00025686307,0.00014028474,0.000011219617,0.0001365409,0.000027688324,0.000017941502,0.00012271729,0.00041736494,0.9988176,0.0000061134765],"about_ca_topic_score_codex":0.00057773833,"about_ca_topic_score_gemma":0.001985289,"teacher_disagreement_score":0.020344857,"about_ca_system_score_codex":0.0011110853,"about_ca_system_score_gemma":0.0011011101,"threshold_uncertainty_score":0.06806034},"labels":[],"label_agreement":null},{"id":"W4200075526","doi":"10.1530/erc-21-0107","title":"Serum markers, obesity and prostate cancer risk: results from the prostate cancer prevention trial","year":2021,"lang":"en","type":"article","venue":"Endocrine Related Cancer","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"National Cancer Institute; National Institutes of Health","keywords":"Prostate cancer; Finasteride; Obesity; Prostate; Cancer; Testosterone (patch); Odds ratio; PCA3","score_opus":0.013507635379501035,"score_gpt":0.2949682247587653,"score_spread":0.2814605893792642,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4200075526","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.87550294,0.10494893,0.0012486603,0.0036554786,0.00060013647,0.000499496,0.007961803,0.000100880614,0.005481631],"genre_scores_gemma":[0.976828,0.0126752,0.0009512898,0.0010744302,0.0004858634,0.0003889143,0.0055592936,0.00002610924,0.0020109958],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9985057,0.00094375404,0.000081511345,0.00016884696,0.00022662627,0.000073594776],"domain_scores_gemma":[0.9982504,0.00064485567,0.0005694553,0.00010958783,0.000113433736,0.0003122376],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0026240367,0.0005229092,0.0011107351,0.00033275617,0.00020859948,0.000686579,0.00034951023,0.00070624135,0.00273714],"category_scores_gemma":[0.0047819847,0.00025838503,0.0013640099,0.00073079026,0.00024515318,0.0004407602,0.00035032805,0.0013159034,0.00020450282],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.66984177,0.0023271372,0.19579881,0.004741805,0.027601171,0.0001696393,0.00010751284,0.0013193538,0.0019011399,0.00072759413,0.013262539,0.08220155],"study_design_scores_gemma":[0.23265204,0.025653893,0.6650678,0.00089966186,0.053654768,0.00070417556,0.00010904409,0.0027148426,0.0014737766,0.0021661173,0.014797133,0.00010671006],"about_ca_topic_score_codex":0.0014519375,"about_ca_topic_score_gemma":0.0019519653,"teacher_disagreement_score":0.00273714,"about_ca_system_score_codex":0.00030544645,"about_ca_system_score_gemma":0.00074937684,"threshold_uncertainty_score":0.013877392},"labels":[],"label_agreement":null},{"id":"W4308699314","doi":"10.1530/erc-22-0229","title":"Mitochondrial dynamics and oxidative phosphorylation as critical targets in cancer","year":2022,"lang":"en","type":"article","venue":"Endocrine Related Cancer","topic":"Mitochondrial Function and Pathology","field":"Biochemistry, Genetics and Molecular Biology","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"Natural Sciences and Engineering Research Council of Canada; Queen's University","keywords":"Mitochondrion; Oxidative phosphorylation; Cancer cell; mitochondrial fusion; Biology; Cell biology; Mitochondrial fission; Cancer; Phosphorylation; Computational biology; Cancer research; Biochemistry; Mitochondrial DNA; Gene; Genetics","score_opus":0.007867019348182926,"score_gpt":0.2878778467394413,"score_spread":0.2800108273912584,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4308699314","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.18474047,0.78013635,0.009013838,0.0124879,0.0005058603,0.000044434415,0.00019690153,0.000144091,0.012730135],"genre_scores_gemma":[0.69193774,0.29997277,0.0026821978,0.001008006,0.00035122302,0.00003321907,0.0001506033,0.0000200804,0.0038442262],"study_design_codex":"bench_or_experimental","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.9998938,0.000023303659,0.000007292763,0.000018357065,0.000035523943,0.000021801341],"domain_scores_gemma":[0.9998921,0.000020770914,0.000032981963,0.0000065627532,0.000018694687,0.000028859155],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029792264,0.00028067647,0.00031180945,0.00042913872,0.0003159877,0.00073910295,0.000286581,0.00072132936,0.0008362457],"category_scores_gemma":[0.00021777833,0.00010447581,0.00012822625,0.0004129077,0.00064449373,0.00090523047,0.00056335446,0.0007840332,0.00020479277],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011647058,0.00019055513,0.0044927355,0.0034074537,0.00008398051,0.0023017728,0.00073813705,0.0029509226,0.693223,0.07271086,0.0058272067,0.21290882],"study_design_scores_gemma":[0.000094951414,0.0014821701,0.04001136,0.00076857087,0.00015304716,0.009201616,0.0012591388,0.003996104,0.4703419,0.0945582,0.37800518,0.00012777999],"about_ca_topic_score_codex":0.00036021587,"about_ca_topic_score_gemma":0.0006210157,"teacher_disagreement_score":0.00085676555,"about_ca_system_score_codex":0.00085676555,"about_ca_system_score_gemma":0.0003535387,"threshold_uncertainty_score":0.006216347},"labels":[],"label_agreement":null},{"id":"W4309886630","doi":"10.1530/erc-22-0293","title":"The 2022 WHO classification of thyroid tumors: novel concepts in nomenclature and grading","year":2022,"lang":"en","type":"review","venue":"Endocrine Related Cancer","topic":"Thyroid Cancer Diagnosis and Treatment","field":"Medicine","cited_by":180,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Thyroid; Pathology; Thyroid nodules; Thyroid carcinoma; Thyroid neoplasm; Medicine; Thyroid cancer; Internal medicine","score_opus":0.04526580672888172,"score_gpt":0.37450418120894097,"score_spread":0.32923837448005927,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4309886630","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.01273873,0.57142806,0.13324964,0.08291523,0.07159827,0.00260574,0.0150490645,0.002390614,0.10802468],"genre_scores_gemma":[0.078511536,0.44802108,0.29551926,0.026541533,0.038848188,0.004115689,0.053322513,0.0017226244,0.053397633],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99446505,0.00133431,0.0010402583,0.00039698137,0.002349004,0.0004143461],"domain_scores_gemma":[0.99109393,0.0009891188,0.00083891005,0.00040160972,0.006003084,0.0006733257],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0071599036,0.001178204,0.0012981324,0.007757923,0.0010495746,0.0035089282,0.00243186,0.001631886,0.004204002],"category_scores_gemma":[0.011509728,0.00036557906,0.0012686616,0.007703834,0.002296842,0.0025964442,0.0020880557,0.0038891118,0.005330481],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010565151,0.000035646794,0.0073497477,0.0012232932,0.000076656965,0.00049370725,0.0006345315,0.0007549504,0.001986421,0.023958972,0.45309648,0.5102839],"study_design_scores_gemma":[0.000023175906,0.00006135984,0.0060790204,0.0011397799,0.000050364077,0.002132163,0.0002985967,0.0005545639,0.0003257841,0.009231073,0.980034,0.00007010989],"about_ca_topic_score_codex":0.022646043,"about_ca_topic_score_gemma":0.016396932,"teacher_disagreement_score":0.022646043,"about_ca_system_score_codex":0.0049294573,"about_ca_system_score_gemma":0.014345072,"threshold_uncertainty_score":0.045028448},"labels":[],"label_agreement":null},{"id":"W4313857372","doi":"10.1530/erc-22-0287","title":"Diagnosis and management of parathyroid carcinoma: a state-of-the-art review","year":2023,"lang":"en","type":"review","venue":"Endocrine Related Cancer","topic":"Parathyroid Disorders and Treatments","field":"Medicine","cited_by":71,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"National Institute for Health and Care Research","keywords":"Parathyroid carcinoma; Medicine; Primary hyperparathyroidism; Internal medicine; General surgery; Intensive care medicine","score_opus":0.05336146601300389,"score_gpt":0.37879065425612735,"score_spread":0.32542918824312345,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4313857372","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00007231616,0.99963963,0.000018417657,0.00012656431,0.000046972324,0.000007588667,0.000018072005,0.000001362027,0.00006894628],"genre_scores_gemma":[0.0008419814,0.99881846,0.00007334419,0.00014003251,0.000066163324,0.000013328033,0.000026269256,8.2500753e-7,0.00001959733],"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","domain_scores_codex":[0.9970367,0.0007114784,0.0011833527,0.00029307607,0.0006595702,0.00011594981],"domain_scores_gemma":[0.9819333,0.01369606,0.0027061685,0.00017037983,0.0012947873,0.00019934966],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0037455752,0.0010616133,0.005057651,0.008210047,0.00049268367,0.00286752,0.002013679,0.0019979912,0.0038931465],"category_scores_gemma":[0.014435201,0.00073587324,0.0031477339,0.00986147,0.00093750714,0.0024499192,0.0011888609,0.0012251479,0.0005337353],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016185535,0.00003730207,0.00056836114,0.7077698,0.0017129963,0.00023399507,0.0002574518,0.00016714104,0.00025982907,0.000570689,0.008486306,0.27977437],"study_design_scores_gemma":[0.0000893967,0.00019768397,0.0037210565,0.8073048,0.014126441,0.0019390895,0.00045479694,0.00012456896,0.00021404677,0.0010178107,0.17076194,0.000048394202],"about_ca_topic_score_codex":0.0036089402,"about_ca_topic_score_gemma":0.0076407096,"teacher_disagreement_score":0.008210047,"about_ca_system_score_codex":0.002205562,"about_ca_system_score_gemma":0.006789909,"threshold_uncertainty_score":0.01980871},"labels":[],"label_agreement":null},{"id":"W4360607662","doi":"10.1530/erc-22-0348","title":"Diffuse sclerosing variant papillary thyroid carcinoma has worse survival than classic papillary thyroid carcinoma: a meta-analysis","year":2023,"lang":"en","type":"review","venue":"Endocrine Related Cancer","topic":"Thyroid Cancer Diagnosis and Treatment","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Thyroid carcinoma; Internal medicine; Odds ratio; Meta-analysis; Thyroid cancer; Thyroid; Oncology; Carcinoma; Papillary thyroid cancer; Gastroenterology","score_opus":0.16672749847227097,"score_gpt":0.3536910852552722,"score_spread":0.18696358678300123,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4360607662","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.037268844,0.95794034,0.0010300054,0.00050130003,0.0003218727,0.00019078368,0.0019757666,0.0000496951,0.0007213717],"genre_scores_gemma":[0.74488187,0.24711126,0.001681391,0.0014142478,0.00046823133,0.0007314186,0.002634428,0.000078687495,0.0009985359],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.993887,0.0023439864,0.0016828912,0.0011717144,0.00060606847,0.00030833913],"domain_scores_gemma":[0.9871322,0.008953223,0.0018283387,0.00069562154,0.001069795,0.00032084747],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0081511,0.0021951946,0.010749914,0.0032891317,0.0007965458,0.0031037868,0.001609853,0.0022072785,0.004233352],"category_scores_gemma":[0.017587146,0.0012335647,0.045024224,0.0046373317,0.0005624399,0.0013784793,0.0014969783,0.001998907,0.00033844713],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0033936505,0.000027286738,0.035216346,0.08799471,0.86627495,0.00022823365,0.00010382021,0.0006377615,0.0003000756,0.00010985466,0.00069080497,0.005022527],"study_design_scores_gemma":[0.00035527532,0.00015490736,0.013780402,0.0036873326,0.98036,0.00011546967,0.0000433079,0.0002613398,0.00008280057,0.00015981795,0.0009774569,0.000021918679],"about_ca_topic_score_codex":0.008747253,"about_ca_topic_score_gemma":0.015823811,"teacher_disagreement_score":0.010749914,"about_ca_system_score_codex":0.0015999875,"about_ca_system_score_gemma":0.0018636954,"threshold_uncertainty_score":0.04310763},"labels":[],"label_agreement":null},{"id":"W4362601741","doi":"10.1530/erc-22-0226","title":"Practical considerations when providing palliative care to patients with neuroendocrine tumors in the context of routine disease management or hospice care","year":2023,"lang":"en","type":"review","venue":"Endocrine Related Cancer","topic":"Neuroendocrine Tumor Research Advances","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre; University of Calgary","funders":"","keywords":"Palliative care; Medicine; Context (archaeology); Multidisciplinary approach; Disease; Quality of life (healthcare); Disease management; Multidisciplinary team; Nursing; Hospice care; Family medicine; Intensive care medicine; Internal medicine","score_opus":0.07454472902699458,"score_gpt":0.41855732914249794,"score_spread":0.3440126001155034,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4362601741","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00032601212,0.95398915,0.00062882353,0.0359304,0.0039712028,0.000036606856,0.00002945671,0.000020883694,0.0050674453],"genre_scores_gemma":[0.0038280815,0.97633547,0.0027281686,0.0130017055,0.002831306,0.000053412296,0.00005260829,0.00001009951,0.0011590715],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9970367,0.0016865692,0.00042041688,0.00011686858,0.0005998758,0.00013956944],"domain_scores_gemma":[0.991871,0.005916784,0.000746955,0.00012265758,0.0010639033,0.00027867383],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004980769,0.00044901745,0.0010686402,0.0011259806,0.00078181777,0.002746854,0.0011311366,0.0029758122,0.0034112404],"category_scores_gemma":[0.012884556,0.00025293007,0.0007772371,0.0010953763,0.0010383129,0.005086517,0.0015021841,0.004673193,0.0014385496],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000735315,0.000055463683,0.00045758113,0.023369065,0.000105078674,0.0015502832,0.001276762,0.0002582864,0.0005020477,0.0064634476,0.1748959,0.79099256],"study_design_scores_gemma":[0.000027403026,0.00004979592,0.0006636611,0.02665723,0.00009276807,0.004197624,0.0014145288,0.000053196374,0.00014273118,0.00601419,0.96065396,0.000032914413],"about_ca_topic_score_codex":0.0012424564,"about_ca_topic_score_gemma":0.00597572,"teacher_disagreement_score":0.004980769,"about_ca_system_score_codex":0.0007765401,"about_ca_system_score_gemma":0.003804691,"threshold_uncertainty_score":0.02634114},"labels":[],"label_agreement":null},{"id":"W4365135500","doi":"10.1530/erc-22-0249","title":"African American vs Caucasian race/ethnicity in adrenocortical carcinoma patients","year":2023,"lang":"en","type":"article","venue":"Endocrine Related Cancer","topic":"Adrenal and Paraganglionic Tumors","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; Université de Montréal","funders":"","keywords":"Medicine; Demography; Poisson regression; Ethnic group; Internal medicine; Hazard ratio; Incidence (geometry); Epidemiology; Race (biology); Propensity score matching; Proportional hazards model; Oncology; Population; Confidence interval; Biology","score_opus":0.01270307319737803,"score_gpt":0.29984659443119366,"score_spread":0.28714352123381565,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4365135500","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9989662,0.00030461908,0.00007726106,0.000071865245,0.00000832222,0.0000037139916,0.00011557692,0.0000016375675,0.0004508444],"genre_scores_gemma":[0.99971324,0.000075820244,0.000031712163,0.000036394147,0.00001004512,0.0000031026968,0.00007112769,0.0000011707741,0.000057440615],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99963427,0.00013451854,0.000024895726,0.000074358366,0.00005438727,0.000077555975],"domain_scores_gemma":[0.9994443,0.00015350414,0.0002330586,0.000041182157,0.000030851745,0.00009709882],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005857713,0.00010871606,0.00025367705,0.000463485,0.0004188817,0.00044563517,0.00013421918,0.00026088345,0.0020034725],"category_scores_gemma":[0.0017244025,0.00010663458,0.00032885317,0.00059796596,0.00017363534,0.00025445365,0.00025627823,0.0002948444,0.00018821385],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022256435,0.000023621878,0.99708635,0.0000061311257,0.000036720157,0.00013526905,0.00008237591,0.000024778003,0.00022310093,0.00006660878,0.00011204619,0.0019804179],"study_design_scores_gemma":[0.000016285088,0.00011342892,0.9972223,0.000014550449,0.00006954447,0.00080518995,0.00041963803,0.00043351427,0.00012413625,0.00022036047,0.0005548861,0.000006220821],"about_ca_topic_score_codex":0.00183736,"about_ca_topic_score_gemma":0.00231117,"teacher_disagreement_score":0.0020034725,"about_ca_system_score_codex":0.0001337711,"about_ca_system_score_gemma":0.0002012479,"threshold_uncertainty_score":0.0067022443},"labels":[],"label_agreement":null},{"id":"W4376609289","doi":"10.1530/erc-22-0206","title":"Expert Consensus Practice Recommendations of the North American Neuroendocrine Tumor Society for the management of high grade gastroenteropancreatic and gynecologic neuroendocrine neoplasms","year":2023,"lang":"en","type":"article","venue":"Endocrine Related Cancer","topic":"Neuroendocrine Tumor Research Advances","field":"Medicine","cited_by":42,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre; University of Ottawa","funders":"","keywords":"Neuroendocrine tumors; Medicine; Pancreas; Disease; Neuroendocrine differentiation; Best practice; Pathology; Intensive care medicine; General surgery; Internal medicine; Oncology; Cancer; Management","score_opus":0.022998890176887065,"score_gpt":0.3362417012474677,"score_spread":0.31324281107058066,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4376609289","genre_codex":"commentary","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0043545426,0.05225096,0.04417297,0.77844,0.049740322,0.005328155,0.002435934,0.0007723879,0.06250477],"genre_scores_gemma":[0.06694667,0.13682212,0.45256406,0.23229893,0.03022323,0.012735761,0.014607502,0.00068970723,0.053111997],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9666072,0.01333142,0.007953015,0.0015591434,0.008772833,0.0017764515],"domain_scores_gemma":[0.8508545,0.021430446,0.010346082,0.002757662,0.1035852,0.011026216],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.046103712,0.0015839806,0.0022326834,0.0073597273,0.0033038352,0.0046263724,0.007576639,0.01423947,0.008354325],"category_scores_gemma":[0.113354914,0.0010513669,0.0046651005,0.004185222,0.002315698,0.004542339,0.005218598,0.014698999,0.007984984],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009615584,0.00020921764,0.0028940472,0.0028973941,0.00015522876,0.00100683,0.0010665802,0.0012442075,0.00069700857,0.005806649,0.7675666,0.21636003],"study_design_scores_gemma":[0.0002676278,0.00014395628,0.0039396263,0.018400982,0.00035218926,0.0021379835,0.0018013398,0.0019035095,0.000737904,0.017789068,0.95233107,0.00019492354],"about_ca_topic_score_codex":0.012564026,"about_ca_topic_score_gemma":0.017471496,"teacher_disagreement_score":0.046103712,"about_ca_system_score_codex":0.0061431704,"about_ca_system_score_gemma":0.03417813,"threshold_uncertainty_score":0.2438227},"labels":[],"label_agreement":null},{"id":"W4376619961","doi":"10.1530/erc-22-0337","title":"Second primary cancers and survival among neuroendocrine tumor patients","year":2023,"lang":"en","type":"article","venue":"Endocrine Related Cancer","topic":"Neuroendocrine Tumor Research Advances","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre; University of Toronto","funders":"","keywords":"Medicine; Internal medicine; Hazard ratio; Neuroendocrine tumors; Gastroenterology; Proportional hazards model; Cohort; Epidemiology; Pancreatic cancer; Cohort study; Population; Oncology; Cancer; Confidence interval","score_opus":0.012630497469520243,"score_gpt":0.29481861033033996,"score_spread":0.28218811286081974,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4376619961","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.998009,0.0007650595,0.00007146875,0.00005972195,0.00001226028,0.0000029003702,0.0005732895,0.000006230266,0.0005001364],"genre_scores_gemma":[0.9989832,0.0002057624,0.000022759808,0.00002705569,0.000011656377,0.0000029605324,0.0005789331,0.0000021156677,0.00016543269],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99976605,0.000030392834,0.000021987298,0.000081566766,0.00004584942,0.00005412035],"domain_scores_gemma":[0.99904543,0.00014683207,0.0004158328,0.00008331612,0.00008799642,0.00022054047],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002937375,0.00014196298,0.0003477575,0.00042344455,0.00021822707,0.00053150154,0.00016677138,0.00028886218,0.0019252202],"category_scores_gemma":[0.0015932826,0.00015783188,0.00054643373,0.00063418195,0.00014493505,0.00035275207,0.00036282468,0.00059356925,0.00022036649],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000071181224,0.000007894743,0.9986563,0.0000066801667,0.00003997968,0.000100814475,0.000016102773,0.000047006335,0.00010458672,0.000007960595,0.000101956546,0.0008396601],"study_design_scores_gemma":[0.000007229167,0.00006733182,0.9983814,0.00000779954,0.00003499237,0.0008792255,0.00005119273,0.00018654029,0.00006292347,0.000033513734,0.00028397352,0.000004019966],"about_ca_topic_score_codex":0.0030895597,"about_ca_topic_score_gemma":0.004722552,"teacher_disagreement_score":0.0030895597,"about_ca_system_score_codex":0.0003224605,"about_ca_system_score_gemma":0.00030212133,"threshold_uncertainty_score":0.0064405203},"labels":[],"label_agreement":null},{"id":"W4386705026","doi":"10.1530/erc-22-0301","title":"A phase II study of bevacizumab and temsirolimus in advanced extra-pancreatic neuroendocrine tumors","year":2023,"lang":"en","type":"article","venue":"Endocrine Related Cancer","topic":"Neuroendocrine Tumor Research Advances","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"National Cancer Institute; Genentech; Pfizer; Eli Lilly and Company","keywords":"Temsirolimus; Bevacizumab; Medicine; Discontinuation; Adverse effect; Internal medicine; Regimen; Phases of clinical research; Clinical endpoint; Gastroenterology; Progression-free survival; Oncology; Surgery; Toxicity; Chemotherapy; Clinical trial","score_opus":0.023715393067750237,"score_gpt":0.3639791544733013,"score_spread":0.3402637614055511,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386705026","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9937868,0.0027280557,0.0008095505,0.00026408635,0.00010815801,0.001387338,0.00022023323,0.000045932575,0.0006499173],"genre_scores_gemma":[0.9900468,0.0019292025,0.0033171677,0.0006516963,0.0002001109,0.0017033875,0.0012175778,0.000019624442,0.0009143533],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.999292,0.00041760158,0.000046534005,0.00009166555,0.00007222685,0.00007987536],"domain_scores_gemma":[0.9992151,0.00013627998,0.0001223862,0.00004441616,0.000045327793,0.00043644872],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002239766,0.00096056616,0.0021458992,0.00034632557,0.00027651014,0.00058947137,0.00060207257,0.0006895764,0.0011757733],"category_scores_gemma":[0.00074435095,0.0005233223,0.000868031,0.00036725067,0.0005334007,0.00051087013,0.00032381288,0.002264361,0.0003169789],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.48480085,0.12043838,0.018508269,0.0011504637,0.0026360322,0.00075484056,0.00036689173,0.0030762358,0.15596244,0.00035800855,0.0027603535,0.20918712],"study_design_scores_gemma":[0.456182,0.51970214,0.013349433,0.000028729564,0.0005629746,0.0004449482,0.00004172758,0.0018894318,0.0050103934,0.00011028217,0.002649817,0.000028125934],"about_ca_topic_score_codex":0.0005785688,"about_ca_topic_score_gemma":0.002053854,"teacher_disagreement_score":0.002239766,"about_ca_system_score_codex":0.0005351647,"about_ca_system_score_gemma":0.0015260624,"threshold_uncertainty_score":0.011845171},"labels":[],"label_agreement":null},{"id":"W4387392976","doi":"10.1530/erc-23-0010","title":"Semaphorin 3C promotes de novo steroidogenesis in prostate cancer cells","year":2023,"lang":"en","type":"article","venue":"Endocrine Related Cancer","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Zymeworks (Canada); Vancouver General Hospital; University of British Columbia","funders":"Terry Fox Research Institute; Terry Fox Foundation; Michael Smith Health Research BC; Prostate Cancer Canada; Cancer Research Society; National Cancer Institute; National Institutes of Health; Prostate Cancer Foundation; U.S. Department of Defense","keywords":"Prostate cancer; Semaphorin; Androgen; LNCaP; Androgen receptor; Androgen deprivation therapy; Endocrinology; Internal medicine; Cancer research; Biology; Enzalutamide; Downregulation and upregulation; Cancer; Medicine; Hormone; Receptor; Biochemistry; Gene","score_opus":0.02375680841031348,"score_gpt":0.34380338944090805,"score_spread":0.3200465810305946,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387392976","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9911006,0.0034349223,0.0015209393,0.00017703358,0.00005445376,0.00003342013,0.00043569613,0.00014968209,0.003093232],"genre_scores_gemma":[0.9947743,0.0012955588,0.000892687,0.00008933516,0.000009636914,0.000022602162,0.0005242764,0.000014139474,0.002377488],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99990964,0.000012968766,0.0000061472083,0.00001172292,0.000033582517,0.0000258004],"domain_scores_gemma":[0.9999578,0.0000066263656,0.0000076131796,0.000006507056,0.000005518886,0.000015951922],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007376235,0.00020367114,0.00024121003,0.00020402916,0.00015832402,0.00019116428,0.00009777067,0.0001681673,0.0008368986],"category_scores_gemma":[0.000049823695,0.00009655196,0.000250541,0.00021081853,0.00014946438,0.00006195063,0.00012598853,0.000534675,0.00025155253],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006728709,0.00003956619,0.0001918129,0.000029823857,0.00000571728,0.000032001513,0.000008815336,0.00005949736,0.99802256,0.00006502504,0.00007297051,0.0014048014],"study_design_scores_gemma":[0.000027083972,0.00041327262,0.009265704,0.000004871896,0.00001991748,0.00029593654,0.000023372015,0.0008681099,0.9842681,0.000057214143,0.0047510783,0.000005237924],"about_ca_topic_score_codex":0.0016580035,"about_ca_topic_score_gemma":0.003518428,"teacher_disagreement_score":0.0016580035,"about_ca_system_score_codex":0.00030527034,"about_ca_system_score_gemma":0.00047209352,"threshold_uncertainty_score":0.003296733},"labels":[],"label_agreement":null},{"id":"W4391887860","doi":"10.1530/erc-23-0353","title":"Multivariable model versus AJCC staging system: cancer-specific survival predictions in adrenocortical carcinoma","year":2024,"lang":"en","type":"article","venue":"Endocrine Related Cancer","topic":"Adrenal and Paraganglionic Tumors","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Adrenocortical carcinoma; Oncology; Cancer; Medicine; Internal medicine","score_opus":0.03631211611585243,"score_gpt":0.3257969445742213,"score_spread":0.28948482845836887,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391887860","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.78782946,0.00094114605,0.2039665,0.0012789775,0.00014405866,0.00014987389,0.0025798667,0.0009453442,0.0021648165],"genre_scores_gemma":[0.98358744,0.00012594798,0.014623938,0.00009079032,0.000052396386,0.00005602227,0.00095551903,0.000034533285,0.0004733822],"study_design_codex":"simulation_or_modeling","study_design_gemma":"observational","domain_scores_codex":[0.99934405,0.000353292,0.00003563875,0.00013037356,0.00009054756,0.00004609565],"domain_scores_gemma":[0.99870753,0.0008504473,0.00012316616,0.0000765285,0.00018886189,0.000053493262],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018100671,0.00044814573,0.0005499424,0.0006178398,0.00016861722,0.00072845886,0.0006108126,0.00030163868,0.0011622659],"category_scores_gemma":[0.0048718587,0.00014895348,0.0007292917,0.00050900073,0.00010214428,0.000311382,0.00054245506,0.00060451264,0.0002364848],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001107639,0.00030483355,0.26332653,0.00012307252,0.0006691679,0.0002678827,0.00013262438,0.6240774,0.0018424201,0.0025999895,0.0031567034,0.10239175],"study_design_scores_gemma":[0.00004628744,0.00024239956,0.015828878,0.000011796134,0.00010751811,0.00013131613,0.000021518206,0.98055124,0.00033070566,0.0018424289,0.0008691415,0.000016691374],"about_ca_topic_score_codex":0.008355534,"about_ca_topic_score_gemma":0.0055881864,"teacher_disagreement_score":0.008355534,"about_ca_system_score_codex":0.00048223985,"about_ca_system_score_gemma":0.0009815323,"threshold_uncertainty_score":0.016613781},"labels":[],"label_agreement":null},{"id":"W4395038817","doi":"10.1530/erc-23-0349","title":"Patient-reported burden associated with pheochromocytoma/paraganglioma diagnosis","year":2024,"lang":"en","type":"article","venue":"Endocrine Related Cancer","topic":"Pituitary Gland Disorders and Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Brock University","funders":"","keywords":"Medicine; Pheochromocytoma; Paraganglioma; Quality of life (healthcare); Disease burden; Disease; Neuroendocrine tumors; Intensive care medicine; Internal medicine; Pediatrics; Pathology; Nursing","score_opus":0.011350009008176983,"score_gpt":0.2763131222083702,"score_spread":0.26496311320019317,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4395038817","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9938198,0.00069991156,0.00007629987,0.0012705759,0.00003531,0.000023659826,0.0013873696,0.000008050219,0.0026789622],"genre_scores_gemma":[0.9987978,0.00033320824,0.00007633663,0.00012786734,0.000028989096,0.000009505463,0.0004643206,0.00000154105,0.0001604639],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99821293,0.00066134345,0.000323619,0.00017850375,0.00032896645,0.0002945674],"domain_scores_gemma":[0.9900287,0.0027171094,0.0042758486,0.00021092505,0.00087355584,0.0018938358],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00148658,0.00012092584,0.00037752884,0.00091379404,0.00056146644,0.00083919876,0.00030909033,0.00038791206,0.0035492023],"category_scores_gemma":[0.013746962,0.00012789838,0.000466536,0.0010999312,0.00034627737,0.0008556047,0.0013044768,0.0008435156,0.0002655357],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006247689,0.000040937954,0.99161047,0.00006651416,0.00006491329,0.00022418216,0.0009278924,0.00013767448,0.00007225913,0.000044481487,0.0010873616,0.005660715],"study_design_scores_gemma":[0.0000055094847,0.000113207236,0.9944991,0.00006275996,0.000030542422,0.0006635543,0.0030181932,0.00029532477,0.000043985074,0.00004625771,0.0012015967,0.000020130998],"about_ca_topic_score_codex":0.0077027874,"about_ca_topic_score_gemma":0.009318919,"teacher_disagreement_score":0.0077027874,"about_ca_system_score_codex":0.0007793401,"about_ca_system_score_gemma":0.00055895763,"threshold_uncertainty_score":0.01531595},"labels":[],"label_agreement":null},{"id":"W4399960956","doi":"10.1530/erc-23-0337","title":"Treatment of advanced BP-NETS with lanreotide autogel/depot vs placebo: the phase III SPINET study","year":2024,"lang":"en","type":"article","venue":"Endocrine Related Cancer","topic":"Neuroendocrine Tumor Research Advances","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Sunnybrook Health Science Centre","funders":"National Cancer Institute; Ipsen; Sanofi; Exelixis; Advanced Accelerator Applications; Gilead Sciences; Eisai; Amgen; Pfizer; AstraZeneca; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Lanreotide; Medicine; Clinical endpoint; Placebo; Internal medicine; Gastroenterology; Neuroendocrine tumors; Phases of clinical research; Surgery; Randomized controlled trial; Clinical trial; Pathology","score_opus":0.018403431309836123,"score_gpt":0.37337252416386624,"score_spread":0.3549690928540301,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399960956","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9850109,0.008306773,0.0006473311,0.0005396487,0.00042656335,0.0020123972,0.0009467504,0.0001178401,0.0019917376],"genre_scores_gemma":[0.97979933,0.007577893,0.0019741568,0.0016272264,0.00056081195,0.0030967463,0.0015868403,0.00003893189,0.0037381118],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99970645,0.00015412625,0.000014536965,0.000043531218,0.000039007147,0.000042407723],"domain_scores_gemma":[0.9995265,0.00009085389,0.00010346997,0.000031296862,0.000040157996,0.00020784132],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011423668,0.0011142822,0.0024358702,0.0003162267,0.0002718494,0.0008658956,0.0006673832,0.0011621519,0.003828935],"category_scores_gemma":[0.00068602007,0.00039250718,0.001617365,0.00028097903,0.0006781113,0.00071993633,0.00026259036,0.002132002,0.0008518074],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.90549654,0.025965575,0.0008593384,0.0011977816,0.0013286581,0.00008454462,0.000077630604,0.00053618656,0.015029251,0.00014495397,0.0012969048,0.047982633],"study_design_scores_gemma":[0.7482173,0.24630445,0.0023621707,0.000045694735,0.0004945937,0.00007287139,0.000027870474,0.00038637777,0.0008803398,0.0001298003,0.0010634316,0.00001511092],"about_ca_topic_score_codex":0.0006688314,"about_ca_topic_score_gemma":0.001932075,"teacher_disagreement_score":0.003828935,"about_ca_system_score_codex":0.0005091747,"about_ca_system_score_gemma":0.0010665968,"threshold_uncertainty_score":0.012809098},"labels":[],"label_agreement":null},{"id":"W4402581350","doi":"10.1530/erc-24-0029","title":"Cushing syndrome from an ACTH-producing pheochromocytoma or paraganglioma: structured review of 94 cases","year":2024,"lang":"en","type":"review","venue":"Endocrine Related Cancer","topic":"Pituitary Gland Disorders and Treatments","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; McMaster University","funders":"","keywords":"Metanephrines; Medicine; Paraganglioma; Pheochromocytoma; Adrenocorticotropic hormone; Neuroendocrine tumors; Cushing syndrome; Adrenalectomy; Internal medicine; Surgery; Hormone","score_opus":0.048390927367971855,"score_gpt":0.3997501162510605,"score_spread":0.35135918888308865,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402581350","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.010180604,0.9876512,0.00023289722,0.00014057795,0.0001305669,0.00007186363,0.00031534382,0.000015273561,0.0012616104],"genre_scores_gemma":[0.0378719,0.9597427,0.00068801804,0.00038970198,0.0002325619,0.00009698599,0.0006682885,0.000011824769,0.00029793326],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.99847096,0.00017435491,0.00083360577,0.00017321763,0.0002831196,0.00006463195],"domain_scores_gemma":[0.9967632,0.001748849,0.0009978202,0.0000960317,0.0003176358,0.00007639583],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010226887,0.00087696215,0.0012761416,0.008635111,0.0005056296,0.0010147556,0.0011603897,0.00086079445,0.0028133858],"category_scores_gemma":[0.004020996,0.0005146953,0.0012797066,0.00849223,0.0005520228,0.0015373182,0.00075287774,0.00041283807,0.0008409454],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004577446,0.00013682089,0.03304607,0.27973008,0.0021473712,0.09426779,0.0021005,0.00048282777,0.0059294356,0.0009785737,0.021614386,0.55910844],"study_design_scores_gemma":[0.0001499351,0.000480115,0.097005054,0.13349526,0.0072898082,0.53356504,0.0022754236,0.00022900027,0.0021073169,0.00093673123,0.22230661,0.00015967559],"about_ca_topic_score_codex":0.0013135575,"about_ca_topic_score_gemma":0.0019281097,"teacher_disagreement_score":0.008635111,"about_ca_system_score_codex":0.0007119312,"about_ca_system_score_gemma":0.0018248752,"threshold_uncertainty_score":0.009411752},"labels":[],"label_agreement":null},{"id":"W4403632643","doi":"10.1530/erc-24-0282","title":"In memoriam: Charis Eng MD PhD (1962–2024)","year":2024,"lang":"en","type":"editorial","venue":"Endocrine Related Cancer","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Publishing; Associate editor; Editorial board; Library science; Medicine; Psychoanalysis; Psychology; Political science; Law; Computer science","score_opus":0.011688799290568132,"score_gpt":0.3285436245086093,"score_spread":0.31685482521804115,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403632643","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000027335062,0.0022152509,0.00011045011,0.049846433,0.94567657,0.000022137832,0.000048987924,0.00006461911,0.0019881893],"genre_scores_gemma":[0.00068344484,0.003102539,0.00014468933,0.03723038,0.9367719,0.000040870233,0.000058043624,0.00007127433,0.02189679],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.996725,0.0005266166,0.00035511958,0.00045563615,0.0017179006,0.00021968773],"domain_scores_gemma":[0.97545004,0.006468491,0.0014747696,0.00044296533,0.012641547,0.0035221477],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0044923597,0.002529251,0.0019468016,0.002624722,0.0024087203,0.0061537675,0.002434118,0.008831405,0.033503596],"category_scores_gemma":[0.03885179,0.00083281123,0.0017414918,0.00079067744,0.0015858684,0.003620825,0.0013395362,0.015078371,0.033004418],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000015448075,0.000004895887,0.000020656573,0.00005641673,0.00000465716,0.00010265166,0.00000938012,0.000010840414,0.000015553891,0.00011601911,0.997216,0.0024274],"study_design_scores_gemma":[0.000041852905,0.000019026651,0.00014919335,0.00029632356,0.00002176099,0.000618228,0.000039597955,0.00009201201,0.0000818154,0.0005805145,0.99804604,0.0000135813525],"about_ca_topic_score_codex":0.0017795848,"about_ca_topic_score_gemma":0.0037007933,"teacher_disagreement_score":0.033503596,"about_ca_system_score_codex":0.0030387796,"about_ca_system_score_gemma":0.0031663538,"threshold_uncertainty_score":0.11208069},"labels":[],"label_agreement":null},{"id":"W4403678777","doi":"10.1530/erc-24-0187","title":"Cellular mechanisms of RET receptor dysfunction in multiple endocrine neoplasia 2","year":2024,"lang":"en","type":"review","venue":"Endocrine Related Cancer","topic":"Neuroendocrine Tumor Research Advances","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Multiple endocrine neoplasia type 2; Proto-Oncogene Proteins c-ret; Cancer research; Receptor tyrosine kinase; Multiple endocrine neoplasia; Mutation; Tyrosine kinase; Medullary thyroid cancer; Phenotype; Biology; Receptor; Downregulation and upregulation; Pheochromocytoma; Genetics; Endocrinology; Cancer; Germline mutation; Gene; Thyroid cancer","score_opus":0.03740499220856751,"score_gpt":0.35412523959535447,"score_spread":0.31672024738678695,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403678777","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00014014286,0.99827766,0.0000796692,0.00020769668,0.00021205204,0.0000025955203,0.000014815022,0.000007282726,0.0010581767],"genre_scores_gemma":[0.0009696074,0.99751246,0.000111460235,0.00016043172,0.00018082176,0.0000044984963,0.000031181506,0.0000013961566,0.0010280531],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99993014,0.000011848495,0.000009038185,0.000012500417,0.000027343447,0.00000918366],"domain_scores_gemma":[0.99989927,0.000033334847,0.0000147930805,0.0000030601575,0.000034629946,0.000014890632],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002794762,0.00061811577,0.00071549765,0.001722309,0.00018369556,0.0005962396,0.0005314372,0.0007344416,0.003095602],"category_scores_gemma":[0.00028269875,0.00014268034,0.0002317505,0.0012884039,0.00024742977,0.00073046196,0.00049059285,0.0009157673,0.0021562867],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009201426,0.000053917905,0.0001914745,0.009930512,0.000057289875,0.0003637427,0.000048321097,0.00031913008,0.0033233196,0.0044897515,0.030875294,0.95025533],"study_design_scores_gemma":[0.000014479866,0.00008634849,0.00071049196,0.0017666006,0.00006483908,0.0016424387,0.00003979145,0.00006635619,0.0007419187,0.0013254674,0.9935288,0.000012442443],"about_ca_topic_score_codex":0.00057981204,"about_ca_topic_score_gemma":0.0011831665,"teacher_disagreement_score":0.003095602,"about_ca_system_score_codex":0.00047005553,"about_ca_system_score_gemma":0.000617579,"threshold_uncertainty_score":0.01035583},"labels":[],"label_agreement":null},{"id":"W4404186630","doi":"10.1530/erc-24-0208","title":"Friend or foe? Deciphering androgen receptor action to improve bipolar androgen therapy for prostate cancer","year":2024,"lang":"en","type":"review","venue":"Endocrine Related Cancer","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Prostate cancer; Androgen receptor; Action (physics); Medicine; Androgen; Oncology; Cancer research; Internal medicine; Cancer; Hormone; Physics","score_opus":0.07290575837906706,"score_gpt":0.43238443650603164,"score_spread":0.3594786781269646,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404186630","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00013159879,0.99761605,0.00010923895,0.0005298656,0.00032227917,0.0000046716195,0.000018036008,0.000008575657,0.0012596995],"genre_scores_gemma":[0.0007599335,0.9978522,0.00013620821,0.00035035284,0.00015681073,0.0000042207953,0.000023195144,0.0000019540364,0.00071511103],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998709,0.000030467416,0.000015161031,0.00001663961,0.0000540716,0.000012695659],"domain_scores_gemma":[0.99983823,0.000082860235,0.00002010411,0.0000051140196,0.00003917517,0.000014366689],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004200205,0.00043843914,0.00085521874,0.0011767212,0.0001994996,0.00084907375,0.0006015618,0.00072406634,0.0047705923],"category_scores_gemma":[0.0005583229,0.00014901713,0.00044073458,0.0008968765,0.00031730908,0.0010098808,0.0003994935,0.0017889462,0.0021240828],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007266101,0.00005583612,0.00012929973,0.01873032,0.00011841855,0.00016277382,0.000079231635,0.00022899863,0.0016642774,0.0058380924,0.042239156,0.9306808],"study_design_scores_gemma":[0.000018513865,0.000084099054,0.0005017289,0.0039633475,0.000082072525,0.000752027,0.00006408905,0.00006105437,0.00026556978,0.0025812276,0.9916156,0.00001062957],"about_ca_topic_score_codex":0.00067539344,"about_ca_topic_score_gemma":0.0018607599,"teacher_disagreement_score":0.0047705923,"about_ca_system_score_codex":0.00038755682,"about_ca_system_score_gemma":0.0006210299,"threshold_uncertainty_score":0.015959263},"labels":[],"label_agreement":null},{"id":"W4407319642","doi":"10.1530/erc-24-0292","title":"Real-world outcomes of lenvatinib therapy for advanced neuroendocrine neoplasms","year":2025,"lang":"en","type":"article","venue":"Endocrine Related Cancer","topic":"Neuroendocrine Tumor Research Advances","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Victoria; Surrey Memorial Hospital; Abbotsford Veterinary Clinic; Burnaby Hospital; Sunnybrook Hospital; BC Cancer Agency","funders":"","keywords":"Lenvatinib; Medicine; Internal medicine; Cohort; Neuroendocrine tumors; Oncology; Systemic therapy; Gastroenterology; Diarrhea; Surgery; Cancer; Sorafenib; Hepatocellular carcinoma","score_opus":0.02118000165129208,"score_gpt":0.38192139906709394,"score_spread":0.36074139741580186,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407319642","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99537474,0.0015578527,0.00012580422,0.00020657119,0.000010917167,0.00001944394,0.0013801733,0.0000062920344,0.0013181183],"genre_scores_gemma":[0.9980192,0.0002479169,0.000040848925,0.000053347252,0.000014111088,0.000011178471,0.00153793,0.0000028608274,0.00007256319],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99834836,0.0006811056,0.00020291856,0.00022282098,0.00033996822,0.00020477585],"domain_scores_gemma":[0.99453086,0.0013196907,0.0025455821,0.00024471997,0.00055765006,0.00080146675],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022256582,0.00017272762,0.0005035066,0.000455092,0.00032913574,0.0014036301,0.0002909162,0.0004103919,0.0007099051],"category_scores_gemma":[0.0071264375,0.000096031144,0.00046641796,0.00084432657,0.0003791024,0.00085778255,0.0005363324,0.0005711853,0.00018569753],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0058424375,0.00019519239,0.9695236,0.00008804305,0.0005265643,0.00034764898,0.00017768588,0.002040314,0.0003864286,0.00014978027,0.0010057465,0.019716624],"study_design_scores_gemma":[0.00029136226,0.0023383545,0.9913822,0.00003577539,0.00025313074,0.0009862806,0.00028744782,0.0016577312,0.00035273482,0.0001983635,0.0021833475,0.00003337388],"about_ca_topic_score_codex":0.002730224,"about_ca_topic_score_gemma":0.0049019153,"teacher_disagreement_score":0.002730224,"about_ca_system_score_codex":0.0015117956,"about_ca_system_score_gemma":0.0005345321,"threshold_uncertainty_score":0.011770487},"labels":[],"label_agreement":null},{"id":"W4410162857","doi":"10.1530/erc-24-0219","title":"Efficacy and safety of RET-kinase inhibitors in RET-altered thyroid cancers: a systematic review and single-arm meta-analysis","year":2025,"lang":"en","type":"review","venue":"Endocrine Related Cancer","topic":"Thyroid Cancer Diagnosis and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Internal medicine; Thyroid cancer; Adverse effect; Medullary thyroid cancer; Vandetanib; Oncology; Thyroid; Cancer; Gastroenterology; Tyrosine kinase; Receptor","score_opus":0.047451778592254475,"score_gpt":0.35446531314171453,"score_spread":0.30701353454946007,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410162857","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.006766807,0.990892,0.00060198404,0.00018918871,0.00014635762,0.0003705808,0.0006926508,0.000029041983,0.00031153415],"genre_scores_gemma":[0.23704931,0.75545484,0.0023889935,0.0012492613,0.00032810873,0.0016361219,0.001305318,0.00005082923,0.0005372355],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9909853,0.004352256,0.002644113,0.000878068,0.00085574825,0.00028458357],"domain_scores_gemma":[0.9825984,0.012342387,0.0028513954,0.0005185487,0.0014335092,0.00025575553],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.013436186,0.0026708648,0.020797724,0.005007126,0.00058227364,0.0029706273,0.0021274337,0.002031977,0.0037323213],"category_scores_gemma":[0.025669642,0.0014065821,0.03554111,0.0057874965,0.0007453429,0.0016686536,0.0013278661,0.0016810091,0.00035603787],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002754741,0.000024713847,0.0020335251,0.3341068,0.65253687,0.000083290244,0.000055884408,0.00040169104,0.00023342724,0.000093518465,0.00046715513,0.007208359],"study_design_scores_gemma":[0.000680886,0.00017365598,0.0019635302,0.015837634,0.9798763,0.00005380945,0.000027498514,0.00013198292,0.00009115401,0.00012935919,0.0010166367,0.000017669512],"about_ca_topic_score_codex":0.0055847107,"about_ca_topic_score_gemma":0.012569061,"teacher_disagreement_score":0.020797724,"about_ca_system_score_codex":0.0027363615,"about_ca_system_score_gemma":0.0028166345,"threshold_uncertainty_score":0.071058154},"labels":[],"label_agreement":null},{"id":"W4414436421","doi":"10.1530/erc-24-0338","title":"Reciprocal cancer risks between thyroid and breast cancer: a systematic review and meta-analysis","year":2025,"lang":"en","type":"review","venue":"Endocrine Related Cancer","topic":"Thyroid Cancer Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Thyroid cancer; Incidence (geometry); Breast cancer; Thyroid; Radiation therapy; Epidemiology; Cancer; Systematic review","score_opus":0.08159025883510884,"score_gpt":0.4207137439304475,"score_spread":0.3391234850953387,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414436421","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.004363223,0.9938864,0.00055592926,0.00019283935,0.00011390876,0.00015964669,0.00049690995,0.000019236626,0.00021190714],"genre_scores_gemma":[0.16478847,0.829271,0.0024317543,0.000899699,0.00032781804,0.0008523636,0.0010266927,0.00003493064,0.00036727483],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9930623,0.0031992043,0.0018826954,0.00083828386,0.000740219,0.0002772254],"domain_scores_gemma":[0.983479,0.012835964,0.0018670573,0.00050484925,0.0011118517,0.00020122559],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009842362,0.002642893,0.014117283,0.0054734936,0.0007409803,0.0029745318,0.0017119918,0.002051665,0.0041177943],"category_scores_gemma":[0.025341274,0.0015638042,0.04052037,0.0064726397,0.0006127397,0.0015482567,0.0014376664,0.0019263075,0.00034967138],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014262194,0.000025073945,0.008220466,0.30451572,0.67389184,0.00020404762,0.00008631134,0.000666719,0.00022948148,0.00014713436,0.0006372948,0.009949744],"study_design_scores_gemma":[0.00022826859,0.00009906853,0.0039908458,0.015112928,0.9787684,0.00012467167,0.00003309692,0.0001658456,0.000075023294,0.00015136301,0.0012319976,0.000018562467],"about_ca_topic_score_codex":0.0080727255,"about_ca_topic_score_gemma":0.019029947,"teacher_disagreement_score":0.014117283,"about_ca_system_score_codex":0.002163936,"about_ca_system_score_gemma":0.003508813,"threshold_uncertainty_score":0.05205202},"labels":[],"label_agreement":null},{"id":"W4415862069","doi":"10.1530/erc-25-0326","title":"Sig27 stratifies prostate cancer recurrence by assessing the immunosuppressive properties of tumors","year":2025,"lang":"en","type":"article","venue":"Endocrine Related Cancer","topic":"Single-cell and spatial transcriptomics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Joseph's Hospital; McMaster University; St. Joseph’s Healthcare Hamilton","funders":"","keywords":"Prostate cancer; Immune system; Cancer; Cancer recurrence; Immune checkpoint; Prostate","score_opus":0.009273371622796707,"score_gpt":0.275231592657912,"score_spread":0.2659582210351153,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415862069","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9892197,0.0010316627,0.0019159603,0.00007429509,0.0000101431115,0.000018967037,0.006612336,0.00013254411,0.0009843819],"genre_scores_gemma":[0.98869073,0.00039028956,0.0013910359,0.00009205858,0.000009875817,0.000031747644,0.008696619,0.000038712362,0.000658984],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99986184,0.000014132141,0.0000076066653,0.00005961491,0.000027794562,0.00002898137],"domain_scores_gemma":[0.9997918,0.000058586236,0.000052740914,0.000022232842,0.000038211092,0.00003639104],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023609438,0.00028605116,0.00030174453,0.00068760273,0.00022647344,0.00044975893,0.0001751278,0.00020415212,0.0015902633],"category_scores_gemma":[0.0004430305,0.00012823947,0.00047827174,0.0005523212,0.00018675906,0.00013518186,0.00037900463,0.0002880915,0.0004050466],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011920293,0.00008919016,0.6864558,0.00045012572,0.00057763344,0.00017193457,0.00014291922,0.0047297706,0.26116946,0.00026437474,0.0033437188,0.04141305],"study_design_scores_gemma":[0.000053277923,0.00052845845,0.9022092,0.000047107005,0.0006034477,0.00072322343,0.00031745102,0.01629576,0.0683416,0.0005615693,0.010277427,0.000041461397],"about_ca_topic_score_codex":0.0021736822,"about_ca_topic_score_gemma":0.0045988834,"teacher_disagreement_score":0.0021736822,"about_ca_system_score_codex":0.00024355148,"about_ca_system_score_gemma":0.0003477696,"threshold_uncertainty_score":0.0053198934},"labels":[],"label_agreement":null}]}